{
  "@context": "https://schema.org",
  "@type": "DataCatalogItem",
  "name": "Interface 4ZHR_4",
  "description": "Protein-protein interaction interface between chains A and A",
  "identifier": "4ZHR_4",
  "mainEntity": {
    "@context": "https://schema.org",
    "@type": "Protein",
    "@id": "#protein_4ZHR",
    "dct:conformsTo": "https://bioschemas.org/profiles/Protein/0.11-RELEASE",
    "identifier": "4ZHR",
    "name": "Protein 4ZHR",
    "description": "Protein structure with PDB ID: 4ZHR. Part of the ELIXIR 3D-BioInfo benchmark dataset. This protein participates in interface 4ZHR_4 as a homodimer.",
    "url": "https://www.rcsb.org/structure/4ZHR",
    "taxonomicRange": {
      "@type": "DefinedTerm",
      "name": "Human immunodeficiency virus 1",
      "inDefinedTermSet": "https://www.ncbi.nlm.nih.gov/taxonomy",
      "description": "Organism taxonomy information from PDB metadata",
      "termCode": "11676",
      "url": "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=11676",
      "identifier": "taxonomy:11676"
    },
    "alternateName": [
      "PDB 4ZHR",
      "Protein ID 4ZHR"
    ],
    "hasRepresentation": [
      {
        "@type": "PropertyValue",
        "name": "PDB Structure",
        "value": "https://raw.githubusercontent.com/biofold/ppi-benchmark-fair/main/data/benchmark_pdb_format/4zhr_4.pdb.gz",
        "description": "Compressed PDB format structure file"
      },
      {
        "@type": "PropertyValue",
        "name": "mmCIF Structure",
        "value": "https://raw.githubusercontent.com/biofold/ppi-benchmark-fair/main/data/benchmark_mmcif_format/4zhr_4.cif.gz",
        "description": "Compressed mmCIF format structure file"
      },
      {
        "@type": "PropertyValue",
        "name": "PDB ID",
        "value": "4ZHR",
        "description": "RCSB PDB identifier"
      }
    ],
    "additionalProperty": [
      {
        "@type": "PropertyValue",
        "name": "PDB_ID",
        "value": "4ZHR",
        "description": "Protein Data Bank identifier (4 letters)"
      },
      {
        "@type": "PropertyValue",
        "name": "AssociatedInterface",
        "value": "4ZHR_4",
        "description": "Interface this protein participates in"
      },
      {
        "@type": "PropertyValue",
        "name": "InterfaceSource",
        "value": "ProtCID",
        "description": "Source of interface ID: ProtCID"
      },
      {
        "@type": "PropertyValue",
        "name": "InterfaceChains",
        "value": "A-A",
        "description": "Chains involved in the interface"
      },
      {
        "@type": "PropertyValue",
        "name": "InterfaceClassification",
        "value": "Non-physiological",
        "description": "Classification of the associated interface"
      },
      {
        "@type": "PropertyValue",
        "name": "LabelInterfaceChains",
        "value": "A-B",
        "description": "Chains involved in the assembly interface"
      },
      {
        "@type": "PropertyValue",
        "name": "Gene",
        "value": "gag-pol",
        "description": "Gene name associated with the protein"
      },
      {
        "@type": "PropertyValue",
        "name": "Superfamily",
        "value": "3.30.70.270;3.30.420.10;3.10.10.10",
        "description": "Protein superfamily classification"
      },
      {
        "@type": "PropertyValue",
        "name": "Pfam",
        "value": "PF06817;PF00075;PF06815;PF00078",
        "description": "Pfam domain classification"
      },
      {
        "@type": "PropertyValue",
        "name": "PDBStructureMetadata",
        "description": "Structural metadata from RCSB Protein Data Bank",
        "value": "{\"pdb_id\": \"4ZHR\", \"structure_metadata\": {\"pdb_id\": \"4ZHR\", \"resolution\": 2.601, \"deposition_date\": \"2015-04-27T00:00:00+0000\", \"release_date\": \"2015-11-11T00:00:00+0000\", \"experimental_method\": null, \"source_organism\": [\"Human immunodeficiency virus 1\"], \"citation\": {\"title\": \"Structure of the HIV-1 reverse transcriptase Q151M mutant: insights into the inhibitor resistance of HIV-1 reverse transcriptase and the structure of the nucleotide-binding pocket of Hepatitis B virus polymerase.\", \"doi\": \"10.1107/S2053230X15017896\", \"authors\": [\"Nakamura, A.\", \"Tamura, N.\", \"Yasutake, Y.\"]}, \"entity_count\": 3, \"r_factor\": null, \"space_group\": null, \"unit_cell\": {\"a\": 145.737, \"b\": 145.737, \"c\": 118.395, \"alpha\": 90.0, \"beta\": 90.0, \"gamma\": 120.0}, \"found_in_api\": true, \"obsolete\": false, \"replaced_by\": null, \"sequences\": {\"A\": \"MVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPMGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAIHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIRKVL\", \"B\": \"MGHHHHHHMVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFITPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQ\"}, \"chain_info\": {\"A\": {\"entity_id\": \"1\", \"organism\": \"Human immunodeficiency virus 1\", \"sequence_length\": 562, \"polymer_type\": \"polypeptide(L)\", \"gene_name\": null}, \"B\": {\"entity_id\": \"2\", \"organism\": \"Human immunodeficiency virus 1\", \"sequence_length\": 438, \"polymer_type\": \"polypeptide(L)\", \"gene_name\": null}}, \"entity_info\": {\"1\": {\"entity_id\": \"1\", \"sequence\": \"MVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPMGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAIHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIRKVL\", \"organism\": \"Human immunodeficiency virus 1\", \"taxonomy_id\": 11676, \"chain_ids\": [\"A\"], \"polymer_type\": \"polypeptide(L)\", \"sequence_length\": 562, \"gene_name\": null, \"uniprot_ids\": [\"P12497\"]}, \"2\": {\"entity_id\": \"2\", \"sequence\": \"MGHHHHHHMVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFITPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQ\", \"organism\": \"Human immunodeficiency virus 1\", \"taxonomy_id\": 11676, \"chain_ids\": [\"B\"], \"polymer_type\": \"polypeptide(L)\", \"sequence_length\": 438, \"gene_name\": null, \"uniprot_ids\": [\"P12497\"]}}, \"is_homomer\": false, \"sequence_clusters\": [{\"sequence\": \"MVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPMGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAIHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIRKVL\", \"entities\": [\"1\"], \"chain_count\": 1}, {\"sequence\": \"MGHHHHHHMVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFITPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQ\", \"entities\": [\"2\"], \"chain_count\": 1}], \"chain_ids\": [], \"entity_ids\": [\"1\", \"2\", \"3\"], \"polymer_composition\": \"heteromeric protein\", \"chain_count\": 2, \"unique_sequences\": 2, \"avg_sequence_length\": 500.0, \"min_sequence_length\": 438, \"max_sequence_length\": 562}, \"entity_metadata\": {\"1\": {\"entity_poly\": {\"nstd_linkage\": \"no\", \"nstd_monomer\": \"no\", \"pdbx_seq_one_letter_code\": \"MVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPMGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAIHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIRKVL\", \"pdbx_seq_one_letter_code_can\": \"MVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPMGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAIHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIRKVL\", \"pdbx_strand_id\": \"A\", \"rcsb_artifact_monomer_count\": 0, \"rcsb_conflict_count\": 0, \"rcsb_deletion_count\": 0, \"rcsb_entity_polymer_type\": \"Protein\", \"rcsb_insertion_count\": 0, \"rcsb_mutation_count\": 0, \"rcsb_non_std_monomer_count\": 0, \"rcsb_sample_sequence_length\": 562, \"type\": \"polypeptide(L)\"}, \"entity_src_gen\": [{\"gene_src_common_name\": \"HIV-1\", \"pdbx_alt_source_flag\": \"sample\", \"pdbx_beg_seq_num\": 1, \"pdbx_end_seq_num\": 562, \"pdbx_gene_src_ncbi_taxonomy_id\": \"11676\", \"pdbx_gene_src_scientific_name\": \"Human immunodeficiency virus 1\", \"pdbx_host_org_ncbi_taxonomy_id\": \"562\", \"pdbx_host_org_scientific_name\": \"Escherichia coli\", \"pdbx_host_org_strain\": \"BL21(DE3)-RIL\", \"pdbx_host_org_vector_type\": \"plasmid\", \"pdbx_seq_type\": \"Biological sequence\", \"pdbx_src_id\": 1, \"plasmid_name\": \"pCDF-Duet\"}], \"rcsb_cluster_flexibility\": {\"avg_rmsd\": 3.666, \"label\": \"Medium\", \"link\": \"http://pdbflex.org/cluster.html#!/2yniA/10776/4zhrA\", \"max_rmsd\": 23.456, \"provenance_code\": \"PDBFlex\"}, \"rcsb_cluster_membership\": [{\"cluster_id\": 650884, \"identity\": 100}, {\"cluster_id\": 4, \"identity\": 95}, {\"cluster_id\": 15, \"identity\": 90}, {\"cluster_id\": 26, \"identity\": 70}, {\"cluster_id\": 44, \"identity\": 50}, {\"cluster_id\": 46, \"identity\": 30}], \"rcsb_entity_host_organism\": [{\"beg_seq_num\": 1, \"end_seq_num\": 562, \"ncbi_common_names\": [\"Bacillus coli\", \"Bacterium coli\", \"Bacterium coli commune\", \"E. coli\", \"Enterococcus coli\", \"Escherichia/Shigella coli\"], \"ncbi_parent_scientific_name\": \"Bacteria\", \"ncbi_scientific_name\": \"Escherichia coli\", \"ncbi_taxonomy_id\": 562, \"pdbx_src_id\": 1, \"provenance_source\": \"Primary Data\", \"scientific_name\": \"Escherichia coli\", \"taxonomy_lineage\": [{\"depth\": 1, \"id\": \"131567\", \"name\": \"cellular organisms\"}, {\"depth\": 1, \"id\": \"131567\", \"name\": \"biota\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria (ex Cavalier-Smith 1987)\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria Woese et al. 2024\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteriobiota\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"bacteria\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"eubacteria\"}, {\"depth\": 3, \"id\": \"3379134\", \"name\": \"Pseudomonadati\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Pseudomonadota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"\\\"Alphaproteobacteriota\\\" Whitman et al. 2018\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Alphaproteobacteriota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Proteobacteria\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Proteobacteriota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"proteobacteria\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"purple photosynthetic bacteria and relatives\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Gammaproteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Proteobacteria gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Pseudomonadia\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Purple bacteria, gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"g-proteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma proteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma subgroup\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacterales\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriaceae and related endosymbionts\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriaceae group\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriales\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"Enterobacteriaceae\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"Enterobacteraceae\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"enterobacteria\"}, {\"depth\": 8, \"id\": \"561\", \"name\": \"Escherichia\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Escherichia coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacillus coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacterium coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacterium coli commune\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"E. coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Enterococcus coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Escherichia/Shigella coli\"}]}], \"rcsb_entity_source_organism\": [{\"beg_seq_num\": 1, \"common_name\": \"HIV-1\", \"end_seq_num\": 562, \"ncbi_common_names\": [\"HIV\", \"HIV-1\", \"HIV1\", \"Human immunodeficiency virus type 1\", \"LAV-1\", \"human immunodeficiency virus 1 HIV-1\", \"human immunodeficiency virus HIV-1\", \"human immunodeficiency virus type 1 HIV 1\", \"human immunodeficiency virus type 1 HIV-1\", \"human immunodeficiency virus type 1 HIV1\", \"human immunodeficiency virus type 1, HIV-1\", \"human immunodeficiency virus type I HIV-1\", \"human immunodeficiency virus type-1 HIV-1\", \"human immunodeficiency virus-1 HIV-1\"], \"ncbi_parent_scientific_name\": \"Riboviria\", \"ncbi_scientific_name\": \"Human immunodeficiency virus 1\", \"ncbi_taxonomy_id\": 11676, \"pdbx_src_id\": 1, \"provenance_source\": \"Primary Data\", \"scientific_name\": \"Human immunodeficiency virus 1\", \"source_type\": \"genetically engineered\", \"taxonomy_lineage\": [{\"depth\": 1, \"id\": \"10239\", \"name\": \"Viruses\"}, {\"depth\": 1, \"id\": \"10239\", \"name\": \"Vira\"}, {\"depth\": 1, \"id\": \"10239\", \"name\": \"Viridae\"}, {\"depth\": 2, \"id\": \"2559587\", \"name\": \"Riboviria\"}, {\"depth\": 2, \"id\": \"2559587\", \"name\": \"RNA viruses\"}, {\"depth\": 2, \"id\": \"2559587\", \"name\": \"RNA viruses and retroviruses\"}, {\"depth\": 2, \"id\": \"2559587\", \"name\": \"RNA viruses and viroids\"}, {\"depth\": 3, \"id\": \"2732397\", \"name\": \"Pararnavirae\"}, {\"depth\": 4, \"id\": \"2732409\", \"name\": \"Artverviricota\"}, {\"depth\": 5, \"id\": \"2732514\", \"name\": \"Revtraviricetes\"}, {\"depth\": 6, \"id\": \"2169561\", \"name\": \"Ortervirales\"}, {\"depth\": 7, \"id\": \"11632\", \"name\": \"Retroviridae\"}, {\"depth\": 8, \"id\": \"327045\", \"name\": \"Orthoretrovirinae\"}, {\"depth\": 9, \"id\": \"1233735\", \"name\": \"unclassified Orthoretrovirinae\"}, {\"depth\": 10, \"id\": \"11646\", \"name\": \"Lentivirus\"}, {\"depth\": 10, \"id\": \"11646\", \"name\": \"Lentivirinae\"}, {\"depth\": 11, \"id\": \"3418650\", \"name\": \"Lentivirus humimdef1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"Human immunodeficiency virus 1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"HIV\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"HIV1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"Human immunodeficiency virus type 1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"LAV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus 1 HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type 1 HIV 1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type 1 HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type 1 HIV1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type 1, HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type I HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type-1 HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus-1 HIV-1\"}]}], \"rcsb_polymer_entity\": {\"formula_weight\": 64.677, \"pdbx_description\": \"RT p66 subunit\", \"pdbx_ec\": \"2.7.7.49,2.7.7.7,3.1.26.13\", \"pdbx_mutation\": \"Q151M\", \"pdbx_number_of_molecules\": 1, \"rcsb_multiple_source_flag\": \"N\", \"rcsb_source_part_count\": 1, \"rcsb_source_taxonomy_count\": 1, \"src_method\": \"man\", \"rcsb_ec_lineage\": [{\"depth\": 1, \"id\": \"2\", \"name\": \"Transferases\"}, {\"depth\": 2, \"id\": \"2.7\", \"name\": \"Transferring phosphorus-containing groups\"}, {\"depth\": 3, \"id\": \"2.7.7\", \"name\": \"Nucleotidyltransferases\"}, {\"depth\": 4, \"id\": \"2.7.7.49\", \"name\": \"RNA-directed DNA polymerase\"}, {\"depth\": 1, \"id\": \"2\", \"name\": \"Transferases\"}, {\"depth\": 2, \"id\": \"2.7\", \"name\": \"Transferring phosphorus-containing groups\"}, {\"depth\": 3, \"id\": \"2.7.7\", \"name\": \"Nucleotidyltransferases\"}, {\"depth\": 4, \"id\": \"2.7.7.7\", \"name\": \"DNA-directed DNA polymerase\"}, {\"depth\": 1, \"id\": \"3\", \"name\": \"Hydrolases\"}, {\"depth\": 2, \"id\": \"3.1\", \"name\": \"Acting on ester bonds\"}, {\"depth\": 3, \"id\": \"3.1.26\", \"name\": \"Endoribonucleases producing 5'-phosphomonoesters\"}, {\"depth\": 4, \"id\": \"3.1.26.13\", \"name\": \"retroviral ribonuclease H\"}], \"rcsb_macromolecular_names_combined\": [{\"name\": \"RT p66 subunit\", \"provenance_code\": \"ECO:0000304\", \"provenance_source\": \"PDB Preferred Name\"}], \"rcsb_enzyme_class_combined\": [{\"depth\": 4, \"ec\": \"2.7.7.49\", \"provenance_source\": \"PDB Primary Data\"}, {\"depth\": 4, \"ec\": \"2.7.7.7\", \"provenance_source\": \"PDB Primary Data\"}, {\"depth\": 4, \"ec\": \"3.1.26.13\", \"provenance_source\": \"PDB Primary Data\"}], \"rcsb_polymer_name_combined\": {\"names\": [\"Gag-Pol polyprotein\"], \"provenance_source\": \"UniProt Name\"}}, \"rcsb_polymer_entity_align\": [{\"provenance_source\": \"SIFTS\", \"reference_database_accession\": \"P12497\", \"reference_database_name\": \"UniProt\", \"aligned_regions\": [{\"entity_beg_seq_id\": 3, \"length\": 560, \"ref_beg_seq_id\": 588}]}], \"rcsb_polymer_entity_annotation\": [{\"annotation_id\": \"PF06815\", \"assignment_version\": \"34.0\", \"name\": \"Reverse transcriptase connection domain (RVT_connect)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\"}, {\"annotation_id\": \"PF06817\", \"assignment_version\": \"34.0\", \"name\": \"Reverse transcriptase thumb domain (RVT_thumb)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\"}, {\"annotation_id\": \"PF00078\", \"assignment_version\": \"34.0\", \"name\": \"Reverse transcriptase (RNA-dependent DNA polymerase) (RVT_1)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\"}, {\"annotation_id\": \"PF00075\", \"assignment_version\": \"34.0\", \"name\": \"RNase H (RNase_H)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\"}, {\"annotation_id\": \"IPR036397\", \"name\": \"Ribonuclease H superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR036397\", \"name\": \"Ribonuclease H superfamily\"}]}, {\"annotation_id\": \"GO:0016020\", \"name\": \"membrane\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0016020\", \"name\": \"membrane\"}]}, {\"annotation_id\": \"GO:0004533\", \"name\": \"exoribonuclease H activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0140098\", \"name\": \"catalytic activity, acting on RNA\"}, {\"id\": \"GO:0016896\", \"name\": \"RNA exonuclease activity, producing 5'-phosphomonoesters\"}, {\"id\": \"GO:0140640\", \"name\": \"catalytic activity, acting on a nucleic acid\"}, {\"id\": \"GO:0004532\", \"name\": \"RNA exonuclease activity\"}, {\"id\": \"GO:0004540\", \"name\": \"RNA nuclease activity\"}, {\"id\": \"GO:0016787\", \"name\": \"hydrolase activity\"}, {\"id\": \"GO:0016788\", \"name\": \"hydrolase activity, acting on ester bonds\"}, {\"id\": \"GO:0004518\", \"name\": \"nuclease activity\"}, {\"id\": \"GO:0004533\", \"name\": \"exoribonuclease H activity\"}, {\"id\": \"GO:0004527\", \"name\": \"exonuclease activity\"}, {\"id\": \"GO:0003824\", \"name\": \"catalytic activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0039657\", \"name\": \"symbiont-mediated suppression of host gene expression\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044068\", \"name\": \"symbiont-mediated perturbation of host cellular process\"}, {\"id\": \"GO:0039657\", \"name\": \"symbiont-mediated suppression of host gene expression\"}, {\"id\": \"GO:0044419\", \"name\": \"biological process involved in interspecies interaction between organisms\"}, {\"id\": \"GO:0044003\", \"name\": \"symbiont-mediated perturbation of host process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0039656\", \"name\": \"symbiont-mediated perturbation of host gene expression\"}, {\"id\": \"GO:0035821\", \"name\": \"modulation of process of another organism\"}, {\"id\": \"GO:0051701\", \"name\": \"biological process involved in interaction with host\"}, {\"id\": \"GO:0044403\", \"name\": \"biological process involved in symbiotic interaction\"}]}, {\"annotation_id\": \"IPR043128\", \"name\": \"Reverse transcriptase/Diguanylate cyclase domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR043128\", \"name\": \"Reverse transcriptase/Diguanylate cyclase domain\"}]}, {\"annotation_id\": \"IPR001995\", \"name\": \"Peptidase A2A, retrovirus, catalytic\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR001995\", \"name\": \"Peptidase A2A, retrovirus, catalytic\"}]}, {\"annotation_id\": \"GO:0046718\", \"name\": \"symbiont entry into host cell\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044419\", \"name\": \"biological process involved in interspecies interaction between organisms\"}, {\"id\": \"GO:0046718\", \"name\": \"symbiont entry into host cell\"}, {\"id\": \"GO:0016032\", \"name\": \"viral process\"}, {\"id\": \"GO:0044409\", \"name\": \"symbiont entry into host\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019058\", \"name\": \"viral life cycle\"}, {\"id\": \"GO:0051701\", \"name\": \"biological process involved in interaction with host\"}, {\"id\": \"GO:0044403\", \"name\": \"biological process involved in symbiotic interaction\"}]}, {\"annotation_id\": \"IPR001878\", \"name\": \"Zinc finger, CCHC-type\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR001878\", \"name\": \"Zinc finger, CCHC-type\"}]}, {\"annotation_id\": \"IPR008919\", \"name\": \"Retrovirus capsid, N-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR008919\", \"name\": \"Retrovirus capsid, N-terminal\"}]}, {\"annotation_id\": \"IPR012344\", \"name\": \"Matrix protein, lentiviral and alpha-retroviral, N-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR012344\", \"name\": \"Matrix protein, lentiviral and alpha-retroviral, N-terminal\"}]}, {\"annotation_id\": \"GO:0044826\", \"name\": \"viral genome integration into host DNA\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044826\", \"name\": \"viral genome integration into host DNA\"}, {\"id\": \"GO:0016032\", \"name\": \"viral process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019058\", \"name\": \"viral life cycle\"}]}, {\"annotation_id\": \"IPR036862\", \"name\": \"Integrase, C-terminal domain superfamily, retroviral\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR036862\", \"name\": \"Integrase, C-terminal domain superfamily, retroviral\"}]}, {\"annotation_id\": \"IPR018061\", \"name\": \"Retropepsins\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR018061\", \"name\": \"Retropepsins\"}]}, {\"annotation_id\": \"GO:0003887\", \"name\": \"DNA-directed DNA polymerase activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0140097\", \"name\": \"catalytic activity, acting on DNA\"}, {\"id\": \"GO:0003887\", \"name\": \"DNA-directed DNA polymerase activity\"}, {\"id\": \"GO:0034061\", \"name\": \"DNA polymerase activity\"}, {\"id\": \"GO:0140640\", \"name\": \"catalytic activity, acting on a nucleic acid\"}, {\"id\": \"GO:0016740\", \"name\": \"transferase activity\"}, {\"id\": \"GO:0016779\", \"name\": \"nucleotidyltransferase activity\"}, {\"id\": \"GO:0003824\", \"name\": \"catalytic activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0016772\", \"name\": \"transferase activity, transferring phosphorus-containing groups\"}]}, {\"annotation_id\": \"GO:0003677\", \"name\": \"DNA binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"IPR010661\", \"name\": \"Reverse transcriptase thumb\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR010661\", \"name\": \"Reverse transcriptase thumb\"}]}, {\"annotation_id\": \"IPR002156\", \"name\": \"Ribonuclease H domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR002156\", \"name\": \"Ribonuclease H domain\"}]}, {\"annotation_id\": \"IPR036875\", \"name\": \"Zinc finger, CCHC-type superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR036875\", \"name\": \"Zinc finger, CCHC-type superfamily\"}]}, {\"annotation_id\": \"IPR003308\", \"name\": \"Integrase, N-terminal zinc-binding domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR003308\", \"name\": \"Integrase, N-terminal zinc-binding domain\"}]}, {\"annotation_id\": \"GO:0072494\", \"name\": \"host multivesicular body\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0033648\", \"name\": \"host intracellular membrane-bounded organelle\"}, {\"id\": \"GO:0018995\", \"name\": \"host cellular component\"}, {\"id\": \"GO:0033646\", \"name\": \"host intracellular part\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0072494\", \"name\": \"host multivesicular body\"}, {\"id\": \"GO:0044217\", \"name\": \"other organism part\"}, {\"id\": \"GO:0033655\", \"name\": \"host cell cytoplasm part\"}, {\"id\": \"GO:0033647\", \"name\": \"host intracellular organelle\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0030430\", \"name\": \"host cell cytoplasm\"}, {\"id\": \"GO:0033643\", \"name\": \"host cell part\"}, {\"id\": \"GO:0044184\", \"name\": \"host cell late endosome\"}, {\"id\": \"GO:0044174\", \"name\": \"host cell endosome\"}, {\"id\": \"GO:0043656\", \"name\": \"host intracellular region\"}]}, {\"annotation_id\": \"IPR001584\", \"name\": \"Integrase, catalytic core\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR001584\", \"name\": \"Integrase, catalytic core\"}]}, {\"annotation_id\": \"GO:0075732\", \"name\": \"viral penetration into host nucleus\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044419\", \"name\": \"biological process involved in interspecies interaction between organisms\"}, {\"id\": \"GO:0075732\", \"name\": \"viral penetration into host nucleus\"}, {\"id\": \"GO:0075733\", \"name\": \"intracellular transport of virus\"}, {\"id\": \"GO:0016032\", \"name\": \"viral process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019058\", \"name\": \"viral life cycle\"}, {\"id\": \"GO:0046794\", \"name\": \"transport of virus\"}, {\"id\": \"GO:0044403\", \"name\": \"biological process involved in symbiotic interaction\"}]}, {\"annotation_id\": \"GO:0003964\", \"name\": \"RNA-directed DNA polymerase activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003964\", \"name\": \"RNA-directed DNA polymerase activity\"}, {\"id\": \"GO:0140097\", \"name\": \"catalytic activity, acting on DNA\"}, {\"id\": \"GO:0034061\", \"name\": \"DNA polymerase activity\"}, {\"id\": \"GO:0140640\", \"name\": \"catalytic activity, acting on a nucleic acid\"}, {\"id\": \"GO:0016740\", \"name\": \"transferase activity\"}, {\"id\": \"GO:0016779\", \"name\": \"nucleotidyltransferase activity\"}, {\"id\": \"GO:0003824\", \"name\": \"catalytic activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0016772\", \"name\": \"transferase activity, transferring phosphorus-containing groups\"}]}, {\"annotation_id\": \"GO:0035613\", \"name\": \"RNA stem-loop binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003723\", \"name\": \"RNA binding\"}, {\"id\": \"GO:0035613\", \"name\": \"RNA stem-loop binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0019013\", \"name\": \"viral nucleocapsid\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0019013\", \"name\": \"viral nucleocapsid\"}, {\"id\": \"GO:0019028\", \"name\": \"viral capsid\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0044423\", \"name\": \"virion component\"}]}, {\"annotation_id\": \"GO:0015074\", \"name\": \"DNA integration\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0006259\", \"name\": \"DNA metabolic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0015074\", \"name\": \"DNA integration\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}]}, {\"annotation_id\": \"IPR045345\", \"name\": \"Retroviral nucleocapsid Gag protein p24, C-terminal domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR045345\", \"name\": \"Retroviral nucleocapsid Gag protein p24, C-terminal domain\"}]}, {\"annotation_id\": \"GO:0075713\", \"name\": \"establishment of integrated proviral latency\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0075713\", \"name\": \"establishment of integrated proviral latency\"}, {\"id\": \"GO:0019042\", \"name\": \"viral latency\"}, {\"id\": \"GO:0016032\", \"name\": \"viral process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019043\", \"name\": \"establishment of viral latency\"}]}, {\"annotation_id\": \"GO:0075523\", \"name\": \"viral translational frameshifting\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0019080\", \"name\": \"viral gene expression\"}, {\"id\": \"GO:0016032\", \"name\": \"viral process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0075523\", \"name\": \"viral translational frameshifting\"}, {\"id\": \"GO:0019081\", \"name\": \"viral translation\"}]}, {\"annotation_id\": \"GO:0020002\", \"name\": \"host cell plasma membrane\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0020002\", \"name\": \"host cell plasma membrane\"}, {\"id\": \"GO:0018995\", \"name\": \"host cellular component\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0033643\", \"name\": \"host cell part\"}, {\"id\": \"GO:0033644\", \"name\": \"host cell membrane\"}, {\"id\": \"GO:0044217\", \"name\": \"other organism part\"}]}, {\"annotation_id\": \"IPR010999\", \"name\": \"Retroviral matrix protein\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR010999\", \"name\": \"Retroviral matrix protein\"}]}, {\"annotation_id\": \"IPR021109\", \"name\": \"Aspartic peptidase domain superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR021109\", \"name\": \"Aspartic peptidase domain superfamily\"}]}, {\"annotation_id\": \"IPR001969\", \"name\": \"Aspartic peptidase, active site\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR001969\", \"name\": \"Aspartic peptidase, active site\"}]}, {\"annotation_id\": \"GO:0006310\", \"name\": \"DNA recombination\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0006310\", \"name\": \"DNA recombination\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0006259\", \"name\": \"DNA metabolic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}]}, {\"annotation_id\": \"IPR012337\", \"name\": \"Ribonuclease H-like superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR012337\", \"name\": \"Ribonuclease H-like superfamily\"}]}, {\"annotation_id\": \"IPR017856\", \"name\": \"Integrase-like, N-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR017856\", \"name\": \"Integrase-like, N-terminal\"}]}, {\"annotation_id\": \"IPR000071\", \"name\": \"Immunodeficiency lentiviral matrix, N-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR000071\", \"name\": \"Immunodeficiency lentiviral matrix, N-terminal\"}]}, {\"annotation_id\": \"GO:0043657\", \"name\": \"host cell\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0018995\", \"name\": \"host cellular component\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0043657\", \"name\": \"host cell\"}, {\"id\": \"GO:0044217\", \"name\": \"other organism part\"}]}, {\"annotation_id\": \"GO:0004190\", \"name\": \"aspartic-type endopeptidase activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0070001\", \"name\": \"aspartic-type peptidase activity\"}, {\"id\": \"GO:0008233\", \"name\": \"peptidase activity\"}, {\"id\": \"GO:0140096\", \"name\": \"catalytic activity, acting on a protein\"}, {\"id\": \"GO:0016787\", \"name\": \"hydrolase activity\"}, {\"id\": \"GO:0004190\", \"name\": \"aspartic-type endopeptidase activity\"}, {\"id\": \"GO:0003824\", \"name\": \"catalytic activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0004175\", \"name\": \"endopeptidase activity\"}]}, {\"annotation_id\": \"GO:0055036\", \"name\": \"virion membrane\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0044423\", \"name\": \"virion component\"}, {\"id\": \"GO:0055036\", \"name\": \"virion membrane\"}]}, {\"annotation_id\": \"GO:0008289\", \"name\": \"lipid binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0008289\", \"name\": \"lipid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"IPR043502\", \"name\": \"DNA/RNA polymerase superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR043502\", \"name\": \"DNA/RNA polymerase superfamily\"}]}, {\"annotation_id\": \"IPR001037\", \"name\": \"Integrase, C-terminal, retroviral\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR001037\", \"name\": \"Integrase, C-terminal, retroviral\"}]}, {\"annotation_id\": \"GO:0004523\", \"name\": \"RNA-DNA hybrid ribonuclease activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0004519\", \"name\": \"endonuclease activity\"}, {\"id\": \"GO:0016891\", \"name\": \"RNA endonuclease activity producing 5'-phosphomonoesters, hydrolytic mechanism\"}, {\"id\": \"GO:0140098\", \"name\": \"catalytic activity, acting on RNA\"}, {\"id\": \"GO:0004523\", \"name\": \"RNA-DNA hybrid ribonuclease activity\"}, {\"id\": \"GO:0140640\", \"name\": \"catalytic activity, acting on a nucleic acid\"}, {\"id\": \"GO:0004540\", \"name\": \"RNA nuclease activity\"}, {\"id\": \"GO:0016787\", \"name\": \"hydrolase activity\"}, {\"id\": \"GO:0016788\", \"name\": \"hydrolase activity, acting on ester bonds\"}, {\"id\": \"GO:0004518\", \"name\": \"nuclease activity\"}, {\"id\": \"GO:0004521\", \"name\": \"RNA endonuclease activity\"}, {\"id\": \"GO:0003824\", \"name\": \"catalytic activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"IPR034170\", \"name\": \"Retropepsin-like catalytic domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 2, \"id\": \"IPR034170\", \"name\": \"Retropepsin-like catalytic domain\"}, {\"depth\": 1, \"id\": \"IPR018061\", \"name\": \"Retropepsins\"}]}, {\"annotation_id\": \"IPR000477\", \"name\": \"Reverse transcriptase domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR000477\", \"name\": \"Reverse transcriptase domain\"}]}, {\"annotation_id\": \"GO:0042025\", \"name\": \"host cell nucleus\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0033648\", \"name\": \"host intracellular membrane-bounded organelle\"}, {\"id\": \"GO:0018995\", \"name\": \"host cellular component\"}, {\"id\": \"GO:0033646\", \"name\": \"host intracellular part\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0033643\", \"name\": \"host cell part\"}, {\"id\": \"GO:0043656\", \"name\": \"host intracellular region\"}, {\"id\": \"GO:0042025\", \"name\": \"host cell nucleus\"}, {\"id\": \"GO:0044217\", \"name\": \"other organism part\"}, {\"id\": \"GO:0033647\", \"name\": \"host intracellular organelle\"}]}, {\"annotation_id\": \"GO:0052151\", \"name\": \"symbiont-mediated activation of host apoptosis\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044068\", \"name\": \"symbiont-mediated perturbation of host cellular process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0052042\", \"name\": \"symbiont-mediated activation of host programmed cell death\"}, {\"id\": \"GO:0044419\", \"name\": \"biological process involved in interspecies interaction between organisms\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0052151\", \"name\": \"symbiont-mediated activation of host apoptosis\"}, {\"id\": \"GO:0052040\", \"name\": \"symbiont-mediated perturbation of host programmed cell death\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0051709\", \"name\": \"regulation of killing of cells of another organism\"}, {\"id\": \"GO:0141061\", \"name\": \"disruption of cell in another organism\"}, {\"id\": \"GO:0051701\", \"name\": \"biological process involved in interaction with host\"}, {\"id\": \"GO:0044403\", \"name\": \"biological process involved in symbiotic interaction\"}, {\"id\": \"GO:0044003\", \"name\": \"symbiont-mediated perturbation of host process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0031341\", \"name\": \"regulation of cell killing\"}, {\"id\": \"GO:0052150\", \"name\": \"symbiont-mediated perturbation of host apoptosis\"}, {\"id\": \"GO:0141060\", \"name\": \"disruption of anatomical structure in another organism\"}, {\"id\": \"GO:0035821\", \"name\": \"modulation of process of another organism\"}, {\"id\": \"GO:0001907\", \"name\": \"symbiont-mediated killing of host cell\"}, {\"id\": \"GO:0031640\", \"name\": \"killing of cells of another organism\"}, {\"id\": \"GO:0001906\", \"name\": \"cell killing\"}]}, {\"annotation_id\": \"IPR010659\", \"name\": \"Reverse transcriptase connection\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR010659\", \"name\": \"Reverse transcriptase connection\"}]}, {\"annotation_id\": \"GO:0005198\", \"name\": \"structural molecule activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005198\", \"name\": \"structural molecule activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0008270\", \"name\": \"zinc ion binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0043169\", \"name\": \"cation binding\"}, {\"id\": \"GO:0046914\", \"name\": \"transition metal ion binding\"}, {\"id\": \"GO:0008270\", \"name\": \"zinc ion binding\"}, {\"id\": \"GO:0043167\", \"name\": \"ion binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0046872\", \"name\": \"metal ion binding\"}, {\"id\": \"GO:0036094\", \"name\": \"small molecule binding\"}]}, {\"annotation_id\": \"GO:0006508\", \"name\": \"proteolysis\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0006508\", \"name\": \"proteolysis\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0019538\", \"name\": \"protein metabolic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}]}, {\"annotation_id\": \"IPR008916\", \"name\": \"Retrovirus capsid, C-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR008916\", \"name\": \"Retrovirus capsid, C-terminal\"}]}], \"rcsb_polymer_entity_container_identifiers\": {\"asym_ids\": [\"A\"], \"auth_asym_ids\": [\"A\"], \"chem_comp_monomers\": [\"ALA\", \"ARG\", \"ASN\", \"ASP\", \"CYS\", \"GLN\", \"GLU\", \"GLY\", \"HIS\", \"ILE\", \"LEU\", \"LYS\", \"MET\", \"PHE\", \"PRO\", \"SER\", \"THR\", \"TRP\", \"TYR\", \"VAL\"], \"entity_id\": \"1\", \"entry_id\": \"4ZHR\", \"rcsb_id\": \"4ZHR_1\", \"uniprot_ids\": [\"P12497\"], \"reference_sequence_identifiers\": [{\"database_accession\": \"P12497\", \"database_name\": \"UniProt\", \"entity_sequence_coverage\": 0.99644128113879, \"provenance_source\": \"SIFTS\", \"reference_sequence_coverage\": 0.3902439024390244}]}, \"rcsb_polymer_entity_feature\": [{\"assignment_version\": \"34.0\", \"feature_id\": \"PF06817\", \"name\": \"Reverse transcriptase thumb domain (RVT_thumb)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\", \"feature_positions\": [{\"beg_seq_id\": 243, \"end_seq_id\": 306}]}, {\"assignment_version\": \"34.0\", \"feature_id\": \"PF00078\", \"name\": \"Reverse transcriptase (RNA-dependent DNA polymerase) (RVT_1)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\", \"feature_positions\": [{\"beg_seq_id\": 65, \"end_seq_id\": 236}]}, {\"assignment_version\": \"34.0\", \"feature_id\": \"PF06815\", \"name\": \"Reverse transcriptase connection domain (RVT_connect)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\", \"feature_positions\": [{\"beg_seq_id\": 320, \"end_seq_id\": 421}]}, {\"name\": \"Hydropathy values\", \"provenance_source\": \"biojava-7.2.4\", \"type\": \"hydropathy\", \"feature_positions\": [{\"beg_seq_id\": 5, \"values\": [0.77, 1.02, 0.38, 1.02, 0.09, 0.6, 0.34, -0.33, 0.01, 0.3, -0.56, -0.42, -1.07, -1.07, -1.02, -1.02, -1.23, -1.29, -1.68, -0.87, -0.9, -1.11, -1.07, -1.97, -1.03, -1.08, -0.78, -0.18, -0.13, -0.44, 0.44, 1.11, 1.47, 0.58, 1.22, 0.63, -0.22, -1.08, -0.73, -1.67, -1.44, -1.46, -1.5, -1.21, -0.87, -0.61, -0.61, -0.96, -0.7, -1.34, -1.64, -1.29, -1.97, -1.46, -0.97, -0.38, 0.51, 0.26, -0.03, -0.08, -0.39, -0.3, -0.84, -1.59, -1.89, -2.89, -2.89, -2.03, -1.13, -1.13, -0.73, -1.16, -1.11, -0.59, -0.48, -0.48, -1.4, -1.94, -1.94, -2.64, -1.83, -1.54, -2.36, -1.5, -1.46, -0.53, -0.5, 0.39, 0.6, -0.07, -0.14, 0.44, -0.07, 0.74, -0.11, -0.46, -1.39, -1.64, -1.38, -0.73, -1.01, -0.5, -0.5, -0.46, 0.4, 0.79, 0.83, 1.12, 0.51, 0.9, 0.34, 0.39, 0.6, 0.56, 0.21, 0.17, -0.42, 0.03, -0.78, -1.12, -1.73, -1.63, -1.86, -1.16, -0.8, 0.09, -0.4, 0.01, 0.94, 0.7, 0.39, -0.2, -0.59, -0.69, -1.23, -0.56, -0.97, -1.61, -1.61, -1.37, -1.37, -0.82, -0.22, -0.36, -0.64, -0.19, -0.14, -0.19, -0.09, 0.21, -0.43, -0.66, 0.02, 0.12, -0.22, 0.16, 0.5, 0.76, 0.77, 0.51, 0.81, 0.73, 0.03, 0.24, 0.28, -0.13, -0.78, -1.09, -1.04, -1.72, -2.53, -1.64, -1.0, -0.81, -0.46, -0.41, -0.17, 0.43, 0.22, 0.22, 0.14, -0.47, -0.5, -0.4, -0.1, -0.34, -0.13, -0.13, 0.76, 0.29, 0.04, -0.78, -1.23, -1.22, -1.27, -1.19, -1.19, -2.08, -1.61, -1.72, -1.76, -1.61, -1.11, -0.26, -1.26, -0.97, -0.62, -0.73, -0.31, 0.0, 0.18, -0.63, -1.49, -1.42, -1.68, -2.02, -2.77, -3.08, -3.18, -3.18, -2.48, -1.62, -1.29, -0.72, -0.38, -0.09, -0.09, 0.51, 0.33, -0.16, -0.97, -1.3, -1.61, -1.64, -1.03, -1.03, -1.63, -0.78, -0.13, 0.68, 0.93, 0.64, 0.29, -0.57, -0.27, -0.19, -0.77, -0.77, -1.58, -1.79, -0.9, -0.86, -0.9, -0.39, 0.18, 0.21, -0.69, 0.12, 0.12, -0.48, 0.11, 0.46, -0.36, -0.32, -0.42, 0.21, -0.26, 0.63, 0.3, 0.57, 0.16, 0.16, 0.08, 0.5, -0.13, 0.33, 0.26, 0.19, -0.32, 0.1, 0.06, -0.17, -0.02, 0.33, -0.48, -0.43, 0.53, 0.4, 0.9, 1.26, 0.67, -0.14, 0.13, 0.13, 0.09, -0.77, -0.17, -0.39, -0.7, -0.7, -0.81, -1.4, -0.51, -0.51, -0.56, -1.37, -1.74, -0.89, -0.86, -0.4, 0.46, -0.19, -0.76, -0.71, -0.5, -0.41, -1.31, -1.34, -0.88, -0.84, -0.5, -0.74, 0.14, -0.07, -0.41, -0.37, -0.02, -0.83, -1.38, -1.97, -1.68, -2.26, -2.01, -1.97, -1.08, -1.18, -1.18, -1.52, -1.31, -0.9, -1.26, -1.5, -0.69, -1.62, -1.56, -1.21, -1.26, -1.22, -1.33, -1.4, -0.8, -1.66, -1.27, -0.99, -1.3, -0.94, -1.19, -1.78, -0.81, -1.46, -1.41, -0.94, -1.22, -1.26, -0.98, -0.12, -0.12, -1.02, -0.09, 0.5, 0.0, -0.31, -0.01, 0.29, 0.29, 1.18, 1.51, 0.97, 0.33, 0.33, 0.54, 0.2, 0.01, -0.89, -0.97, -1.04, -0.5, -0.46, -0.81, -1.02, -0.67, -1.08, -1.03, -1.26, -1.18, -1.78, -1.47, -1.42, -1.18, -1.2, -1.49, -0.9, -1.18, -1.18, -0.58, -0.68, -0.68, -0.63, -0.92, -0.22, 0.04, -0.27, -0.24, -0.92, -0.92, -0.11, 0.46, 0.41, 0.52, -0.04, 0.2, -0.11, 0.49, 0.28, -0.58, -1.43, -1.18, -1.1, -0.5, -0.4, 0.19, -0.62, -0.31, 0.43, 0.68, 1.32, 0.43, -0.11, 0.13, 0.13, 0.13, -0.29, -0.99, -0.92, -1.82, -1.01, -1.01, -1.64, -1.64, -1.3, -0.94, -0.09, -0.09, -0.04, -0.97, -0.97, -1.03, -1.62, -2.01, -1.4, -1.4, -1.5, -0.69, -0.27, -0.61, -0.19, 0.12, 0.17, -0.69, -1.59, -1.49, -2.3, -1.8, -1.8, -1.52, -0.94, -0.91, -0.1, 0.53, 1.03, 1.03, 0.22, 0.52, 0.28, 0.2, 0.17, 0.21, -0.38, -0.3, 0.56, 0.87, 0.57, 0.52, -0.29, -0.04, -0.31, 0.5, -0.04, -0.01, 0.57, 0.57, 0.86, 0.86, 0.82, 0.23, -0.62, -0.67, -1.56, -2.14, -2.14, -1.92, -1.07, -0.98, -0.98, -0.04, 0.54, 0.54, 0.24, 1.06, 1.13, 0.23, -0.11, -0.11, -1.04, -1.08, -0.83, -0.02, -0.24, -0.84, 0.06, 0.31, 0.9, 0.98, 0.08, 0.18, 0.26, 0.01, 0.07, -0.79, -1.0, -1.59, -0.77, -0.72, -1.11, -1.19, -0.68, -0.72, -0.13, 0.21, 1.1, 0.13, 0.09, 0.99, 0.99]}]}, {\"name\": \"Disordered binding sites\", \"provenance_source\": \"Anchor2\", \"type\": \"disorder_binding\", \"feature_positions\": [{\"beg_seq_id\": 1, \"values\": [0.42, 0.42, 0.42, 0.42, 0.42, 0.42, 0.43, 0.43, 0.43, 0.43, 0.43, 0.42, 0.42, 0.42, 0.42, 0.42, 0.43, 0.43, 0.43, 0.43, 0.43, 0.43, 0.43, 0.43, 0.43, 0.42, 0.42, 0.42, 0.42, 0.42, 0.42, 0.42, 0.41, 0.41, 0.41, 0.41, 0.41, 0.41, 0.41, 0.41, 0.42, 0.42, 0.43, 0.43, 0.42, 0.42, 0.41, 0.41, 0.41, 0.4, 0.39, 0.39, 0.39, 0.39, 0.39, 0.4, 0.41, 0.42, 0.42, 0.43, 0.43, 0.42, 0.41, 0.41, 0.41, 0.42, 0.42, 0.43, 0.43, 0.42, 0.42, 0.42, 0.41, 0.42, 0.42, 0.42, 0.42, 0.42, 0.42, 0.42, 0.43, 0.43, 0.42, 0.41, 0.4, 0.41, 0.41, 0.42, 0.43, 0.43, 0.43, 0.42, 0.42, 0.41, 0.42, 0.43, 0.43, 0.41, 0.4, 0.38, 0.36, 0.36, 0.34, 0.33, 0.32, 0.32, 0.32, 0.33, 0.33, 0.34, 0.35, 0.36, 0.37, 0.38, 0.39, 0.41, 0.42, 0.43, 0.42, 0.41, 0.4, 0.4, 0.39, 0.38, 0.37, 0.36, 0.34, 0.33, 0.31, 0.31, 0.3, 0.3, 0.29, 0.28, 0.27, 0.26, 0.26, 0.25, 0.25, 0.24, 0.24, 0.23, 0.23, 0.23, 0.23, 0.22, 0.21, 0.21, 0.2, 0.19, 0.19, 0.19, 0.2, 0.2, 0.21, 0.22, 0.24, 0.26, 0.28, 0.3, 0.33, 0.35, 0.37, 0.38, 0.38, 0.38, 0.38, 0.37, 0.37, 0.36, 0.35, 0.34, 0.34, 0.33, 0.32, 0.33, 0.34, 0.36, 0.38, 0.39, 0.41, 0.42, 0.43, 0.43, 0.42, 0.42, 0.42, 0.42, 0.43, 0.42, 0.4, 0.38, 0.36, 0.35, 0.34, 0.33, 0.32, 0.3, 0.29, 0.28, 0.28, 0.28, 0.29, 0.29, 0.3, 0.31, 0.33, 0.33, 0.35, 0.37, 0.39, 0.39, 0.39, 0.38, 0.37, 0.36, 0.34, 0.33, 0.32, 0.32, 0.32, 0.32, 0.33, 0.35, 0.37, 0.4, 0.42, 0.41, 0.39, 0.37, 0.36, 0.36, 0.36, 0.38, 0.4, 0.42, 0.43, 0.41, 0.39, 0.37, 0.36, 0.34, 0.32, 0.32, 0.32, 0.33, 0.33, 0.33, 0.32, 0.32, 0.31, 0.31, 0.32, 0.33, 0.32, 0.31, 0.3, 0.3, 0.3, 0.3, 0.3, 0.3, 0.3, 0.3, 0.29, 0.3, 0.31, 0.32, 0.31, 0.29, 0.28, 0.28, 0.28, 0.28, 0.27, 0.27, 0.26, 0.26, 0.25, 0.26, 0.28, 0.29, 0.29, 0.29, 0.29, 0.28, 0.29, 0.29, 0.29, 0.29, 0.29, 0.28, 0.28, 0.28, 0.28, 0.28, 0.29, 0.29, 0.28, 0.28, 0.28, 0.29, 0.29, 0.29, 0.3, 0.3, 0.3, 0.3, 0.31, 0.32, 0.34, 0.35, 0.36, 0.38, 0.39, 0.41, 0.43, 0.42, 0.39, 0.37, 0.36, 0.36, 0.36, 0.36, 0.37, 0.38, 0.38, 0.41, 0.43, 0.4, 0.38, 0.36, 0.35, 0.34, 0.34, 0.34, 0.34, 0.36, 0.38, 0.39, 0.41, 0.42, 0.43, 0.43, 0.43, 0.43, 0.43, 0.43, 0.42, 0.4, 0.4, 0.39, 0.38, 0.38, 0.38, 0.38, 0.38, 0.37, 0.36, 0.35, 0.34, 0.33, 0.32, 0.31, 0.3, 0.3, 0.29, 0.28, 0.28, 0.28, 0.28, 0.28, 0.29, 0.3, 0.32, 0.35, 0.37, 0.39, 0.4, 0.41, 0.43, 0.41, 0.4, 0.4, 0.4, 0.43, 0.4, 0.37, 0.34, 0.33, 0.33, 0.31, 0.3, 0.31, 0.33, 0.34, 0.38, 0.43, 0.37, 0.32, 0.29, 0.25, 0.22, 0.21, 0.21, 0.21, 0.21, 0.2, 0.21, 0.22, 0.24, 0.24, 0.28, 0.32, 0.34, 0.35, 0.38, 0.4, 0.43, 0.4, 0.37, 0.35, 0.33, 0.34, 0.34, 0.34, 0.35, 0.37, 0.36, 0.36, 0.37, 0.38, 0.39, 0.41, 0.43, 0.41, 0.4, 0.39, 0.39, 0.39, 0.38, 0.38, 0.39, 0.4, 0.41, 0.43, 0.41, 0.4, 0.38, 0.37, 0.37, 0.37, 0.37, 0.37, 0.37, 0.37, 0.37, 0.37, 0.38, 0.38, 0.37, 0.37, 0.37, 0.36, 0.36, 0.36, 0.36, 0.36, 0.36, 0.36, 0.36, 0.36, 0.35, 0.35, 0.35, 0.36, 0.37, 0.38, 0.39, 0.41, 0.42, 0.43, 0.42, 0.4, 0.38, 0.38, 0.38, 0.39, 0.4, 0.41, 0.43, 0.42, 0.41, 0.4, 0.38, 0.37, 0.37, 0.36, 0.36, 0.37, 0.36, 0.36, 0.36, 0.36, 0.35, 0.34, 0.33, 0.32, 0.31, 0.31, 0.3, 0.3, 0.29, 0.27, 0.26, 0.24, 0.23, 0.22, 0.21, 0.2, 0.19, 0.17, 0.16, 0.16, 0.16, 0.16, 0.17, 0.18, 0.2, 0.21, 0.24, 0.26, 0.29, 0.32, 0.34, 0.35, 0.36, 0.35, 0.34, 0.32, 0.31, 0.28, 0.26, 0.24, 0.23, 0.22, 0.21, 0.2, 0.19, 0.19, 0.19, 0.19, 0.18, 0.18, 0.17, 0.17, 0.16, 0.15, 0.16, 0.16, 0.15, 0.15]}]}, {\"name\": \"Disordered regions\", \"provenance_source\": \"IUPred2(short)\", \"type\": \"disorder\", \"feature_positions\": [{\"beg_seq_id\": 1, \"values\": [0.87, 0.78, 0.74, 0.64, 0.6, 0.57, 0.54, 0.47, 0.45, 0.41, 0.38, 0.4, 0.4, 0.38, 0.45, 0.38, 0.39, 0.39, 0.38, 0.38, 0.45, 0.42, 0.43, 0.43, 0.48, 0.44, 0.38, 0.38, 0.34, 0.28, 0.27, 0.26, 0.25, 0.31, 0.31, 0.31, 0.37, 0.34, 0.34, 0.34, 0.33, 0.26, 0.27, 0.35, 0.35, 0.37, 0.44, 0.41, 0.41, 0.47, 0.53, 0.49, 0.43, 0.44, 0.38, 0.38, 0.37, 0.36, 0.37, 0.43, 0.42, 0.43, 0.42, 0.41, 0.39, 0.33, 0.27, 0.25, 0.26, 0.26, 0.26, 0.17, 0.22, 0.27, 0.29, 0.34, 0.35, 0.35, 0.28, 0.21, 0.2, 0.16, 0.17, 0.17, 0.18, 0.12, 0.19, 0.23, 0.27, 0.31, 0.31, 0.24, 0.3, 0.31, 0.3, 0.29, 0.3, 0.23, 0.22, 0.23, 0.23, 0.24, 0.23, 0.22, 0.3, 0.27, 0.28, 0.18, 0.18, 0.11, 0.15, 0.1, 0.16, 0.16, 0.16, 0.1, 0.11, 0.1, 0.1, 0.1, 0.12, 0.11, 0.1, 0.1, 0.11, 0.1, 0.08, 0.12, 0.17, 0.18, 0.23, 0.23, 0.3, 0.21, 0.22, 0.14, 0.23, 0.15, 0.16, 0.16, 0.11, 0.15, 0.19, 0.2, 0.2, 0.18, 0.18, 0.26, 0.28, 0.25, 0.17, 0.12, 0.11, 0.08, 0.12, 0.09, 0.14, 0.13, 0.13, 0.08, 0.13, 0.22, 0.12, 0.15, 0.14, 0.22, 0.22, 0.24, 0.25, 0.16, 0.14, 0.14, 0.15, 0.14, 0.13, 0.11, 0.15, 0.16, 0.1, 0.11, 0.12, 0.11, 0.1, 0.17, 0.11, 0.12, 0.07, 0.07, 0.06, 0.06, 0.09, 0.13, 0.18, 0.18, 0.18, 0.26, 0.21, 0.19, 0.2, 0.27, 0.27, 0.27, 0.27, 0.16, 0.16, 0.17, 0.17, 0.24, 0.26, 0.25, 0.26, 0.27, 0.26, 0.27, 0.35, 0.35, 0.37, 0.48, 0.41, 0.35, 0.27, 0.31, 0.39, 0.31, 0.42, 0.35, 0.4, 0.42, 0.42, 0.39, 0.31, 0.31, 0.25, 0.27, 0.28, 0.21, 0.16, 0.09, 0.09, 0.14, 0.18, 0.27, 0.31, 0.21, 0.29, 0.21, 0.28, 0.31, 0.2, 0.19, 0.19, 0.19, 0.14, 0.18, 0.17, 0.09, 0.14, 0.12, 0.16, 0.14, 0.13, 0.08, 0.04, 0.04, 0.06, 0.04, 0.05, 0.03, 0.03, 0.05, 0.03, 0.02, 0.03, 0.03, 0.01, 0.01, 0.03, 0.03, 0.04, 0.04, 0.03, 0.03, 0.05, 0.05, 0.04, 0.05, 0.05, 0.05, 0.09, 0.1, 0.09, 0.15, 0.13, 0.15, 0.15, 0.19, 0.21, 0.21, 0.2, 0.23, 0.18, 0.21, 0.19, 0.2, 0.31, 0.31, 0.28, 0.38, 0.31, 0.24, 0.17, 0.22, 0.25, 0.33, 0.31, 0.41, 0.37, 0.29, 0.26, 0.27, 0.19, 0.27, 0.32, 0.34, 0.32, 0.3, 0.36, 0.36, 0.27, 0.32, 0.32, 0.39, 0.31, 0.21, 0.21, 0.23, 0.24, 0.24, 0.31, 0.35, 0.28, 0.35, 0.33, 0.34, 0.33, 0.26, 0.23, 0.24, 0.2, 0.29, 0.3, 0.34, 0.34, 0.39, 0.47, 0.46, 0.39, 0.35, 0.42, 0.36, 0.35, 0.41, 0.38, 0.33, 0.34, 0.34, 0.34, 0.34, 0.32, 0.36, 0.36, 0.29, 0.27, 0.2, 0.17, 0.17, 0.16, 0.2, 0.23, 0.2, 0.2, 0.19, 0.13, 0.16, 0.15, 0.14, 0.13, 0.18, 0.2, 0.17, 0.17, 0.16, 0.17, 0.16, 0.22, 0.27, 0.16, 0.12, 0.13, 0.1, 0.12, 0.12, 0.09, 0.15, 0.14, 0.16, 0.17, 0.12, 0.07, 0.07, 0.1, 0.11, 0.13, 0.11, 0.1, 0.09, 0.05, 0.08, 0.06, 0.06, 0.04, 0.04, 0.06, 0.11, 0.11, 0.06, 0.06, 0.06, 0.08, 0.12, 0.12, 0.08, 0.05, 0.03, 0.05, 0.08, 0.08, 0.11, 0.15, 0.23, 0.23, 0.31, 0.29, 0.24, 0.23, 0.2, 0.26, 0.34, 0.27, 0.25, 0.24, 0.24, 0.32, 0.39, 0.46, 0.46, 0.45, 0.43, 0.41, 0.45, 0.38, 0.37, 0.38, 0.39, 0.44, 0.44, 0.46, 0.47, 0.46, 0.53, 0.51, 0.52, 0.48, 0.39, 0.4, 0.32, 0.3, 0.23, 0.28, 0.34, 0.31, 0.37, 0.3, 0.31, 0.26, 0.27, 0.19, 0.14, 0.14, 0.16, 0.16, 0.22, 0.15, 0.15, 0.15, 0.14, 0.13, 0.09, 0.14, 0.12, 0.1, 0.12, 0.13, 0.18, 0.16, 0.23, 0.23, 0.31, 0.28, 0.22, 0.2, 0.2, 0.13, 0.13, 0.17, 0.25, 0.18, 0.18, 0.26, 0.25, 0.3, 0.3, 0.2, 0.13, 0.09, 0.07, 0.04, 0.03, 0.03, 0.05, 0.07, 0.07, 0.07, 0.06, 0.1, 0.1, 0.1, 0.15, 0.22, 0.16, 0.17, 0.17, 0.11, 0.12, 0.17, 0.2, 0.22, 0.2, 0.26, 0.23, 0.21, 0.14, 0.18, 0.21, 0.36, 0.4, 0.44, 0.48, 0.52, 0.55, 0.66, 0.69]}]}], \"rcsb_polymer_entity_feature_summary\": [{\"count\": 3, \"coverage\": 0.60142, \"type\": \"Pfam\"}], \"rcsb_polymer_entity_group_membership\": [{\"aggregation_method\": \"sequence_identity\", \"group_id\": \"46_30\", \"similarity_cutoff\": 30.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 150, \"ref_beg_seq_id\": 204}, {\"entity_beg_seq_id\": 151, \"length\": 91, \"ref_beg_seq_id\": 366}, {\"entity_beg_seq_id\": 242, \"length\": 22, \"ref_beg_seq_id\": 458}, {\"entity_beg_seq_id\": 264, \"length\": 69, \"ref_beg_seq_id\": 482}, {\"entity_beg_seq_id\": 333, \"length\": 14, \"ref_beg_seq_id\": 560}, {\"entity_beg_seq_id\": 347, \"length\": 68, \"ref_beg_seq_id\": 575}, {\"entity_beg_seq_id\": 415, \"length\": 7, \"ref_beg_seq_id\": 647}, {\"entity_beg_seq_id\": 422, \"length\": 93, \"ref_beg_seq_id\": 655}, {\"entity_beg_seq_id\": 515, \"length\": 48, \"ref_beg_seq_id\": 762}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"44_50\", \"similarity_cutoff\": 50.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 27, \"ref_beg_seq_id\": 204}, {\"entity_beg_seq_id\": 28, \"length\": 49, \"ref_beg_seq_id\": 238}, {\"entity_beg_seq_id\": 77, \"length\": 173, \"ref_beg_seq_id\": 295}, {\"entity_beg_seq_id\": 250, \"length\": 28, \"ref_beg_seq_id\": 481}, {\"entity_beg_seq_id\": 278, \"length\": 68, \"ref_beg_seq_id\": 516}, {\"entity_beg_seq_id\": 346, \"length\": 63, \"ref_beg_seq_id\": 585}, {\"entity_beg_seq_id\": 409, \"length\": 19, \"ref_beg_seq_id\": 649}, {\"entity_beg_seq_id\": 428, \"length\": 85, \"ref_beg_seq_id\": 669}, {\"entity_beg_seq_id\": 513, \"length\": 50, \"ref_beg_seq_id\": 768}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"26_70\", \"similarity_cutoff\": 70.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 513, \"ref_beg_seq_id\": 207}, {\"entity_beg_seq_id\": 514, \"length\": 3, \"ref_beg_seq_id\": 734}, {\"entity_beg_seq_id\": 517, \"length\": 25, \"ref_beg_seq_id\": 741}, {\"entity_beg_seq_id\": 542, \"length\": 21, \"ref_beg_seq_id\": 767}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"15_90\", \"similarity_cutoff\": 90.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 562, \"ref_beg_seq_id\": 207}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"650884_100\", \"similarity_cutoff\": 100.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 562, \"ref_beg_seq_id\": 1}]}, {\"aggregation_method\": \"matching_uniprot_accession\", \"group_id\": \"P12497\", \"aligned_regions\": [{\"entity_beg_seq_id\": 3, \"length\": 560, \"ref_beg_seq_id\": 588}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"4_95\", \"similarity_cutoff\": 95.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 562, \"ref_beg_seq_id\": 204}]}], \"rcsb_related_target_references\": [{\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL3638326\", \"target_taxonomy_id\": 11686, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 600}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL3638360\", \"target_taxonomy_id\": 11706, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 588}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL5823\", \"target_taxonomy_id\": 11678, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 600}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL247\", \"target_taxonomy_id\": 11676, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 1}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL3638331\", \"target_taxonomy_id\": 11685, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 590}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL2366516\", \"target_taxonomy_id\": 11676, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 254, \"target_beg_seq_id\": 1}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"Q72547\", \"target_taxonomy_id\": 11676, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 1}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P35963\", \"target_taxonomy_id\": 362651, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 588}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P03366\", \"target_taxonomy_id\": 11678, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 600}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P12499\", \"target_taxonomy_id\": 11683, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 589}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P03367\", \"target_taxonomy_id\": 11686, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 600}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P03369\", \"target_taxonomy_id\": 11685, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 590}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P04585\", \"target_taxonomy_id\": 11706, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 588}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P04587\", \"target_taxonomy_id\": 11682, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 600}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P12497\", \"target_taxonomy_id\": 11698, \"aligned_target\": [{\"entity_beg_seq_id\": 3, \"length\": 559, \"target_beg_seq_id\": 588}]}], \"rcsb_target_cofactors\": [{\"binding_assay_value\": 3.25, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"VURPZLFEGYPUOH-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC(C(=O)O)c1c(-c2ccccc2)nc2sc3c(c2c1-c1ccc(C)cc1)CCC3\", \"cofactor_resource_id\": \"CHEMBL3670967\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638326\"}, {\"binding_assay_value\": 3.22, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"JGTHHBDDAAPDQR-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1ccc(-c2c(C(C(=O)O)C(C)C)c(C)nc3sc4c(c23)CCCC4)cc1\", \"cofactor_resource_id\": \"CHEMBL3670994\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638326\"}, {\"binding_assay_value\": 3.2, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"DGFBIAPZXZOLRG-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC(C(N)=O)c1c(C)nc2sc3c(c2c1-c1ccc(C)cc1)CCCC3\", \"cofactor_resource_id\": \"CHEMBL3671004\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638326\"}, {\"binding_assay_value\": 3.19, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"OIUNBEXMAQRORF-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCc1sc2nc(C)c(CC(=O)O)c(-c3ccc(C)cc3)c2c1C\", \"cofactor_resource_id\": \"CHEMBL3670949\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638326\"}, {\"binding_assay_value\": 3.17, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"QMZSRWKQXUGYBE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOC(=O)c1cc(F)ccc1C#N\", \"cofactor_resource_id\": \"CHEMBL3669302\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638326\"}, {\"binding_assay_value\": 3.13, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"AKBBHUWFVVUZJB-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC(C(=O)O)c1c(C)nc2sc3c(c2c1-c1ccc(CC)cc1)CCCC3\", \"cofactor_resource_id\": \"CHEMBL3670989\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638326\"}, {\"binding_assay_value\": 3.11, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"CGFYYZDTAHYBCR-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COCC(C(=O)O)c1c(C)nc2sc3c(c2c1-c1ccc(C)cc1)CCC3\", \"cofactor_resource_id\": \"CHEMBL3670966\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638326\"}, {\"binding_assay_value\": 3.1, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"HTWXWRNUDPWWLL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC(c1c(C)nc2sc3c(c2c1-c1ccc(C)cc1)CCCC3)C1SC(=O)NC1=O\", \"cofactor_resource_id\": \"CHEMBL3671011\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638326\"}, {\"binding_assay_value\": 3.09, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"HEZRSSZBPSHYNO-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1ccc(-c2c(C(CCc3ccccc3)C(=O)O)c(C)nc3sc4c(c23)CCCC4)cc1\", \"cofactor_resource_id\": \"CHEMBL3639698\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638326\"}, {\"binding_assay_value\": 3.08, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"AOGSAGPHQVDAOA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1ccc(-c2c(C(Cc3ccccc3)C(=O)O)c(C)nc3sc4c(c23)CCC4)cc1\", \"cofactor_resource_id\": \"CHEMBL3670975\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638326\"}, {\"binding_assay_value\": 3.1, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"RGCKGOZRHPZPFP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"O=C1c2ccccc2C(=O)c2c1ccc(O)c2O\", \"cofactor_name\": \"ATHRAQUINONES A\", \"cofactor_resource_id\": \"CHEMBL55814\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3638360\"}, {\"binding_assay_value\": 0.92, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"ZJXCBXBCZFLMTP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"N#Cc1c(N)cccc1Sc1cccc(F)c1\", \"cofactor_resource_id\": \"CHEMBL449041\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL247\"}, {\"binding_assay_value\": 0.92, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"BMPCEVULSYDKKW-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COc1ccccc1[S+]([O-])c1cccc(N)c1C#N\", \"cofactor_resource_id\": \"CHEMBL293331\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL247\"}, {\"binding_assay_value\": 0.92, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"WBNCALTXWWEQQV-UHFFFAOYSA-N\", \"cofactor_smiles\": \"N#Cc1c(N)cccc1S(=O)(=O)c1ccccc1Br\", \"cofactor_resource_id\": \"CHEMBL293780\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL247\"}, {\"binding_assay_value\": 0.92, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"GYICYNRXLTUTRB-UHFFFAOYSA-N\", \"cofactor_smiles\": \"N#Cc1c(N)cccc1Sc1ccc(Cl)cc1\", \"cofactor_resource_id\": \"CHEMBL55747\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL247\"}, {\"binding_assay_value\": 0.89, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"DHSNTVSWLMJJAD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COc1ccc(S(=O)(=O)c2cccc(N)c2C#N)cc1\", \"cofactor_resource_id\": \"CHEMBL55043\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL247\"}, {\"binding_assay_value\": 0.89, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"UEQHPFQYOWLASA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COc1cc(Sc2cccc(N)c2C#N)cc(C(F)(F)F)c1\", \"cofactor_resource_id\": \"CHEMBL54970\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL247\"}, {\"binding_assay_value\": 0.82, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"DAHSRCREKZVLOW-UHFFFAOYSA-N\", \"cofactor_smiles\": \"N#Cc1c(N)cccc1Sc1cccc(Br)c1\", \"cofactor_resource_id\": \"CHEMBL56465\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL247\"}, {\"binding_assay_value\": 0.8, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"IQGAOZOACGWEAI-UHFFFAOYSA-N\", \"cofactor_smiles\": \"N#Cc1c(N)cccc1Sc1cccc(Cl)c1\", \"cofactor_resource_id\": \"CHEMBL55599\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL247\"}, {\"binding_assay_value\": 0.8, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"JLSKPBDKNIXMBS-VIFPVBQESA-N\", \"cofactor_smiles\": \"NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12\", \"cofactor_chem_comp_id\": \"LTN\", \"cofactor_resource_id\": \"CHEMBL227123\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL247\"}, {\"binding_assay_value\": 0.72, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"DTAPEXKJTDIXLQ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COc1cccc([S+]([O-])c2cccc(N)c2C#N)c1\", \"cofactor_resource_id\": \"CHEMBL55007\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL247\"}, {\"binding_assay_value\": 2.45, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"NQDJXKOVJZTUJA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1\", \"cofactor_chem_comp_id\": \"NVP\", \"cofactor_name\": \"NEVIRAPINE\", \"cofactor_resource_id\": \"CHEMBL57\", \"mechanism_of_action\": \"Human immunodeficiency virus type 1 reverse transcriptase inhibitor\", \"neighbor_flag\": \"Y\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2366516\"}, {\"binding_assay_value\": 1.52, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"UHMLHIRSNCDVOO-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COc1cc(-c2ccc(C#N)cc2)ccc1C(O)c1ccnc(Nc2ccc(C#N)cc2)n1\", \"cofactor_resource_id\": \"CHEMBL4795242\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2366516\"}, {\"binding_assay_value\": 1.4, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"XUQMYSDQQXQODI-AREMUKBSSA-N\", \"cofactor_smiles\": \"Cc1cc(-c2ccc(C#N)cc2)cc(C)c1[C@H](O)c1ccnc(Nc2ccc(C#N)cc2)n1\", \"cofactor_resource_id\": \"CHEMBL4796383\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2366516\"}, {\"binding_assay_value\": 0.28, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"LRGUYOVPBIAHKP-XMMPIXPASA-N\", \"cofactor_smiles\": \"N#Cc1ccc(Nc2nccc([C@H](O)c3ccc(-c4ccc(C#N)cc4)cc3Cl)n2)cc1\", \"cofactor_resource_id\": \"CHEMBL4789602\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2366516\"}, {\"cofactor_in_ch_ikey\": \"NQDJXKOVJZTUJA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1\", \"cofactor_chem_comp_id\": \"NVP\", \"cofactor_name\": \"Nevirapine\", \"cofactor_resource_id\": \"DB00238\", \"mechanism_of_action\": \"Nevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates.\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [19193782, 20219933, 19654858], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"JFVZFKDSXNQEJW-CQSZACIVSA-N\", \"cofactor_smiles\": \"[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C\", \"cofactor_name\": \"Tenofovir disoproxil\", \"cofactor_resource_id\": \"DB00300\", \"mechanism_of_action\": \"Tenofovir belongs to a class of antiretroviral drugs known as nucleotide analog reverse transcriptase inhibitors (NtRTIs), which block reverse transcriptase, an enzyme necessary for viral production in HIV-infected individuals. This enables the management of HIV viral load through decreased viral replication [FDA label].\\r\\n\\r\\nTenofovir disoproxil fumarate is the fumarate salt of the prodrug _tenofovir disoproxil_. Tenofovir disoproxil is absorbed and converted to its active form, _tenofovir_,  a nucleoside monophosphate (nucleotide) analog. Tenofovir is then converted to the active metabolite, _tenofovir diphosphate_, a chain terminator, by constitutively expressed enzymes in the cell. Tenofovir diphosphate inhibits HIV-1 reverse transcriptase and the Hepatitis B polymerase by direct binding competition with the natural deoxyribonucleotide substrate (deoxyadenosine 5\\u2019-triphosphate) and, after integration into DNA, causes viral DNA chain termination [F3442], [FDA label]. \\r\\n\\r\\n**A note on resistance**\\r\\n\\r\\nHIV-1 isolates with decreased susceptibility to tenofovir have been identified in cell culture studies. These viruses expressed a _K65R_ substitution in reverse transcriptase and showed a 2\\u2013 4 fold decrease in susceptibility to treatment with tenofovir [FDA label].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [12462284, 14725126], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"HBOMLICNUCNMMY-XLPZGREQSA-N\", \"cofactor_smiles\": \"CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O\", \"cofactor_chem_comp_id\": \"AZZ\", \"cofactor_name\": \"Zidovudine\", \"cofactor_resource_id\": \"DB00495\", \"mechanism_of_action\": \"Zidovudine, a structural analog of thymidine, is a prodrug that must be phosphorylated to its active 5\\u2032-triphosphate metabolite, zidovudine triphosphate (ZDV-TP). It inhibits the activity of HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. It competes with the natural substrate dGTP and incorporates itself into viral DNA. It is also a weak inhibitor of cellular DNA polymerase \\u03b1 and \\u03b3.  \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [9084959, 20471318, 15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"XPOQHMRABVBWPR-ZDUSSCGKSA-N\", \"cofactor_smiles\": \"FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC1CC1\", \"cofactor_chem_comp_id\": \"EFZ\", \"cofactor_name\": \"Efavirenz\", \"cofactor_resource_id\": \"DB00625\", \"mechanism_of_action\": \"Similar to zidovudine, efavirenz inhibits the activity of viral RNA-directed DNA polymerase (i.e., reverse transcriptase). Antiviral activity of efavirenz is dependent on intracellular conversion to the active triphosphorylated form. The rate of efavirenz phosphorylation varies, depending on cell type. It is believed that inhibition of reverse transcriptase interferes with the generation of DNA copies of viral RNA, which, in turn, are necessary for synthesis of new virions. Intracellular enzymes subsequently eliminate the HIV particle that previously had been uncoated, and left unprotected, during entry into the host cell. Thus, reverse transcriptase inhibitors are virustatic and do not eliminate HIV from the body. Even though human DNA polymerase is less susceptible to the pharmacologic effects of triphosphorylated efavirenz, this action may nevertheless account for some of the drug's toxicity.\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10344069, 9878993], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"XNKLLVCARDGLGL-JGVFFNPUSA-N\", \"cofactor_smiles\": \"CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O\", \"cofactor_name\": \"Stavudine\", \"cofactor_resource_id\": \"DB00649\", \"mechanism_of_action\": \"Stavudine inhibits the activity of HIV-1 reverse transcriptase (RT) both by competing with the natural substrate dGTP and by its incorporation into viral DNA.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [8861550, 15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"WHBIGIKBNXZKFE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)NC1=C(N=CC=C1)N1CCN(CC1)C(=O)C1=CC2=C(N1)C=CC(NS(C)(=O)=O)=C2\", \"cofactor_chem_comp_id\": \"SPP\", \"cofactor_name\": \"Delavirdine\", \"cofactor_resource_id\": \"DB00705\", \"mechanism_of_action\": \"Delavirdine binds directly to viral reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by disrupting the enzyme's catalytic site.\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [16610780, 17656585, 8815692], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"JTEGQNOMFQHVDC-NKWVEPMBSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1\", \"cofactor_chem_comp_id\": \"3TC\", \"cofactor_name\": \"Lamivudine\", \"cofactor_resource_id\": \"DB00709\", \"mechanism_of_action\": \"Lamivudine is a synthetic nucleoside analogue and is phosphorylated intracellularly to its active 5'-triphosphate metabolite, lamivudine triphosphate (L-TP). This nucleoside analogue is incorporated into viral DNA by HIV reverse transcriptase and HBV polymerase, resulting in DNA chain termination.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [1283519, 15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"XQSPYNMVSIKCOC-NTSWFWBYSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1\", \"cofactor_chem_comp_id\": \"ETV\", \"cofactor_name\": \"Emtricitabine\", \"cofactor_resource_id\": \"DB00879\", \"mechanism_of_action\": \"Emtricitabine is a cytidine analog which, when phosphorylated to emtricitabine 5'-triphosphate, competes with deoxycytidine 5'-triphosphate for HIV-1 reverse transcriptase.[L9019] As HIV-1 reverse transcriptase incorporates emtricitabine into forming DNA strands, new nucleotides are unable to be incorporated, leading to  viral DNA chain termination.[L9019] Inhibition of reverse transcriptase prevents transcription of viral RNA into DNA, therefore the virus is unable to incorporate its DNA into host DNA and replicate using host cell machinery. This reduces viral load.[A187688]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15121999, 14609348, 16034488], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"BXZVVICBKDXVGW-NKWVEPMBSA-N\", \"cofactor_smiles\": \"OC[C@@H]1CC[C@@H](O1)N1C=NC2=C1NC=NC2=O\", \"cofactor_chem_comp_id\": \"2DI\", \"cofactor_name\": \"Didanosine\", \"cofactor_resource_id\": \"DB00900\", \"mechanism_of_action\": \"Didanosine (ddI) is metabolized intracellularly by a series of cellular enzymes to its active moiety, dideoxyadenosine triphosphate (ddATP), which inhibits the HIV reverse transcriptase enzyme competitively by competing with natural dATP. It also acts as a chain terminator by its incorporation into viral DNA as the lack of a 3'-OH group in the incorporated nucleoside analogue prevents the formation of the 5' to 3' phosphodiester linkage essential for DNA chain elongation, and therefore, the viral DNA growth is terminated.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [1379914, 15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"WREGKURFCTUGRC-POYBYMJQSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](CO)O1\", \"cofactor_name\": \"Zalcitabine\", \"cofactor_resource_id\": \"DB00943\", \"mechanism_of_action\": \"Zalcitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Within cells, zalcitabine is converted to its active metabolite, dideoxycytidine 5'-triphosphate (ddCTP), by the sequential action of cellular enzymes. ddCTP interferes with viral RNA-directed DNA polymerase (reverse transcriptase) by competing for utilization of the natural substrate deoxycytidine 5'-triphosphate (dCTP), as well as incorpating into viral DNA. Due to it's lack of a 3'-OH group, the formation of a 5' to 3' phosphodiester linkage that is necessary for DNA chain elongation is inhibited, thus leading to the termination of viral DNA growth.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [7614775, 9179531, 15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"MCGSCOLBFJQGHM-SCZZXKLOSA-N\", \"cofactor_smiles\": \"NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1\", \"cofactor_chem_comp_id\": \"1KX\", \"cofactor_name\": \"Abacavir\", \"cofactor_resource_id\": \"DB01048\", \"mechanism_of_action\": \"Abacavir is a carbocyclic synthetic nucleoside analogue and an antiviral agent. Intracellularly, abacavir is converted by cellular enzymes to the active metabolite carbovir triphosphate, an analogue of deoxyguanosine-5'-triphosphate (dGTP). Carbovir triphosphate inhibits the activity of HIV-1 reverse transcriptase (RT) both by competing with the natural substrate dGTP and by its incorporation into viral DNA. Viral DNA growth is terminated because the incorporated nucleotide lacks a 3'-OH group, which is needed to form the 5\\u2032 to 3\\u2032 phosphodiester linkage essential for DNA chain elongation. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [12369088, 9145876, 11667311], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"UXCAQJAQSWSNPQ-XLPZGREQSA-N\", \"cofactor_smiles\": \"CC1=CN([C@H]2C[C@H](F)[C@@H](CO)O2)C(=O)NC1=O\", \"cofactor_name\": \"Alovudine\", \"cofactor_resource_id\": \"DB06198\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"HSBKFSPNDWWPSL-VDTYLAMSSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1F)[C@H]1O[C@@H](CO)C=C1\", \"cofactor_name\": \"Elvucitabine\", \"cofactor_resource_id\": \"DB06236\", \"mechanism_of_action\": \"Elvucitabine is a L-cytosine Nucleoside analog Reverse Transcriptase Inhibitor (NRTIs) anti-HIV drug. NRTI's inhibit the activity of viral RNA-directed DNA polymerase (i.e., reverse transcriptase). It is believed that inhibition of reverse transcriptase interferes with the generation of DNA copies of viral RNA, which, in turn, are necessary for synthesis of new virions. Intracellular enzymes subsequently eliminate the HIV particle that previously had been uncoated, and left unprotected, during entry into the host cell. Thus, reverse transcriptase inhibitors are virustatic and do not eliminate HIV from the body. \\r\\n\\r\\n\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"PYGWGZALEOIKDF-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=CC(=CC(C)=C1OC1=C(Br)C(N)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N\", \"cofactor_chem_comp_id\": \"65B\", \"cofactor_name\": \"Etravirine\", \"cofactor_resource_id\": \"DB06414\", \"mechanism_of_action\": \"Etravirine exerts its effects via direct inhibition of the reverse transcriptase enzyme of human immunodeficiency virus type 1 (HIV-1).  It directly binds reverse transcriptase and consequently blocks DNA-dependent and RNA-dependent polymerase activity. Etravirine does not inhibit human DNA polymerase alpha, beta or gamma. \\r\\n\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"RLAHNGKRJJEIJL-RFZPGFLSSA-N\", \"cofactor_smiles\": \"NC1=NC(N)=C2N=CN([C@H]3CO[C@@H](CO)O3)C2=N1\", \"cofactor_name\": \"Amdoxovir\", \"cofactor_resource_id\": \"DB06619\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"JYAHFMKZJRVTDT-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=NNC2=C1C(OC1=CC(=CC(=C1)C#N)C#N)=C(F)C=C2\", \"cofactor_chem_comp_id\": \"I15\", \"cofactor_name\": \"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile\", \"cofactor_resource_id\": \"DB07935\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"YQXCVAGCMNFUMQ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)C1=C(SC2=CC(Cl)=CC(Cl)=C2)N(CC2=CC=NC=C2)C(COC(N)=O)=N1\", \"cofactor_chem_comp_id\": \"S11\", \"cofactor_name\": \"Capravirine\", \"cofactor_resource_id\": \"DB08502\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"YIBOMRUWOWDFLG-ONEGZZNKSA-N\", \"cofactor_smiles\": \"CC1=CC(\\\\C=C\\\\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1\", \"cofactor_chem_comp_id\": \"T27\", \"cofactor_name\": \"Rilpivirine\", \"cofactor_resource_id\": \"DB08864\", \"mechanism_of_action\": \"Rilpivirine is a non-competitive NNRTI that binds to reverse transcriptase.[L7069] Its binding results in the blockage of RNA and DNA- dependent DNA polymerase activities, like HIV-1 replication. It does not present activity against human DNA polymerases \\u03b1, \\u03b2 and \\u03b3.[L1032,L7069] Rilpivirine's flexible structure around the aromatic rings allows the adaptation to changes in the non-nucleoside RT binding pocket, reducing the likelihood of viral mutations conferring resistance.[A31335]\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [19548857, 15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"LDEKQSIMHVQZJK-CAQYMETFSA-N\", \"cofactor_smiles\": \"CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)CN1C=NC2=C(N)N=CN=C12)OC1=CC=CC=C1\", \"cofactor_name\": \"Tenofovir alafenamide\", \"cofactor_resource_id\": \"DB09299\", \"mechanism_of_action\": \"Tenofovir alafenamide presents 91% lower plasma concentration with an intracellular presence of about 20-fold higher when compared to [tenofovir disoproxil].[A178219] This is due to its prolonged systemic exposure and its higher intracellular accumulation of the active metabolite tenofovir diphosphate.[A18473]\\r\\n\\r\\nTenofovir alafenamide accumulates more in peripheral blood mononuclear cells compared to red blood cells.[A18473]\\r\\n\\r\\nOnce activated, tenofovir acts with different mechanisms including the inhibition of viral polymerase, causing chain termination and the inhibition of viral synthesis.[L6241] To know more about the specific mechanism of action of the active form, please visit the drug entry of [tenofovir].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [24741339, 26640223], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"IPQVTOJGNYVQEO-UHFFFAOYSA-N\", \"cofactor_smiles\": \"OCC1OC(OC2=C3C(=O)C4=C(C=C(C=C4O)C(O)=O)C(C4C5=CC=CC(OC6OC(CO)C(O)C(O)C6O)=C5C(=O)C5=C4C=C(C=C5O)C(O)=O)C3=CC=C2)C(O)C(O)C1O\", \"cofactor_name\": \"Sennosides\", \"cofactor_resource_id\": \"DB11365\", \"mechanism_of_action\": \"Sennoside A and B, the components of senna, are metabolized by gut bacteria into the active metabolite rheinanthrone [DB13175][A19235]. Rheinanthrone [DB13175] appears to increase cyclooxegenase 2 (COX2) expression in macrophage cells leading to an increase in prostaglandin E2 (PGE2)[A19235]. This increase in PGE2 is associated with a decrease in aquaporin 3 expression in mucosal epithelial cells of the large intestine[A19235]. A decrease in aquaporin 3 expression likely produces the laxative effect by restricting water reabsorption by the large intestine thereby increasing fecal water content[A19235]. The exact mechanism by which rheinanthrone increases COX2 expression is unknown[A19235]. Rheinanthrone [DB13175] also stimulates peristalsis in the large intestine although the mechanism behind this effect is unknown[A19239]. Rhein [DB13174], another active metabolite is thought to excite submucosal acetylcholinergic neurons resulting in increased chloride and prostaglandin secretion[A19247,A19258]. The movement of chloride ions into the large intestine would also help to draw water into the lumen[A19258].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [27765358], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"SOLUWJRYJLAZCX-LYOVBCGYSA-N\", \"cofactor_smiles\": \"OC1=C2N(C[C@H]3O[C@@H]4CC[C@@H](C4)N3C2=O)C=C(C(=O)NCC2=C(F)C=C(F)C=C2F)C1=O\", \"cofactor_chem_comp_id\": \"KLQ\", \"cofactor_name\": \"Bictegravir\", \"cofactor_resource_id\": \"DB11799\", \"mechanism_of_action\": \"This single dose medication inhibits the strand transfer of viral DNA into the human genome, preventing HIV-1 virus replication and propagation [L1218].\\r\\n\\r\\nIn vitro, bictegravir has shown powerful antiviral activity against HIV-2 and various subtypes of HIV-1. It has shown synergistic effects when combined with other ARVs, including tenofovir alafenamide (TAF), emtricitabine (FTC), and darunavir (DRV). The three components of the first USA approved medication ( trade name: Biktarvy ) are as follows:\\r\\n\\r\\nBictegravir: \\r\\nintegrase strand transfer inhibitor; INSTI), an HIV-1 encoded enzyme necessary for viral replication. Inhibition of the integrase enzyme prevents the integration of HIV-1 into host DNA, blocking the conversion of the HIV-1 provirus and progression of the virus [FDA LABEL]. \\r\\n\\r\\nEmtricitabine: FTC, is phosphorylated by cellular enzymes to form emtricitabine 5'-triphosphate. Emtricitabine is phosphorylated to form emtricitabine 5'-triphosphate intracellularly. This metabolite inhibits the activity of human immunodeficiency virus (HIV) reverse transcriptase by competing with the substrate deoxycytidine 5'-triphosphate and by incorporating itself into viral DNA preventing DNA chain elongation [FDA LABEL].\\r\\n\\r\\nTenofovir Alafenamide: TAF is a phosphonamidate prodrug of tenofovir (2\\u2032-deoxyadenosine monophosphate analog). \\r\\nPlasma exposure to TAF leads to leakage into cells and then TAF is intracellularly converted to tenofovir by hydrolysis by cathepsin. Tenofovir is subsequently phosphorylated by cellular kinases to the metabolite tenofovir diphosphate, which is the active form of the drug. Tenofovir diphosphate inhibits HIV-1 replication by incorporating into viral DNA by the HIV reverse transcriptase, resulting in DNA chain-termination. Tenofovir diphosphate also weakly inhibits mammalian DNA polymerases [FDA LABEL].\", \"neighbor_flag\": \"N\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"ZIAOVIPSKUPPQW-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CN1C(=O)NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F\", \"cofactor_chem_comp_id\": \"2KW\", \"cofactor_name\": \"Doravirine\", \"cofactor_resource_id\": \"DB12301\", \"mechanism_of_action\": \"Doravirine is a pyridinone non-nucleoside reverse transcriptase inhibitor of HIV-1.[L12729,A38823,A38824] Reverse transcriptase is the enzyme with which HIV generates complementary DNA (cDNA) to its RNA genome - this cDNA is then inserted into the host cell genome, where it can be transcribed into viral RNA for the purposes of replication.[A38825] Doravirine inhibits HIV-1 replication by non-competitively inhibiting HIV-1 reverse transcriptase.[L12729] Doravirine does not, however, inhibit the human cellular DNA polymerases \\u03b1, \\u00df, and mitochondrial DNA polymerase \\u03b3.[L12729]\", \"neighbor_flag\": \"Y\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"HSBKFSPNDWWPSL-CAHLUQPWSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](CO)C=C1\", \"cofactor_name\": \"Dexelvucitabine\", \"cofactor_resource_id\": \"DB12470\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"XQSPYNMVSIKCOC-UHFFFAOYSA-N\", \"cofactor_smiles\": \"OCC1OC(CS1)N1C=C(F)C(=N)N=C1O\", \"cofactor_name\": \"Racivir\", \"cofactor_resource_id\": \"DB12753\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15934866], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"RYMCFYKJDVMSIR-RNFRBKRXSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1)[C@H]1CO[C@@H](CO)S1\", \"cofactor_name\": \"Apricitabine\", \"cofactor_resource_id\": \"DB12855\", \"mechanism_of_action\": \"Apricitabine is a type of medicine called a nucleoside reverse transcriptase inhibitor (NRTI). NRTIs work by blocking reverse transcriptase, a protein that HIV needs to make more copies of itself.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [19737995], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"SGOIRFVFHAKUTI-ZCFIWIBFSA-N\", \"cofactor_smiles\": \"C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O\", \"cofactor_chem_comp_id\": \"TFO\", \"cofactor_name\": \"Tenofovir\", \"cofactor_resource_id\": \"DB14126\", \"mechanism_of_action\": \"Once tenofovir is activated by a bi-phosphorylation it acts as an antiviral acyclic nucleoside phosphonate. It is a potent inhibitor of the viral reverse transcriptase with an inhibitory constant of approximately 0.022 micromolar.[A18473] \\r\\n\\r\\nOnce activated, tenofovir acts with different mechanisms including the inhibition of viral polymerase causing chain termination and the inhibition of viral synthesis.[L6241] All these activities are attained by its competition with deoxyadenosine 5'-triphosphate in the generation of new viral DNA. Once tenofovir is incorporated in the chain, it induces a chain termination which in order inhibits viral replication.[A178330] The safety of tenofovir relies on its low affinity towards the cellular DNA polymerase including the mitochondrial DNA polymerase gamma.[T324]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [24741339, 26640223, 22430977], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"Q72547\"}, {\"cofactor_in_ch_ikey\": \"MJIRDPUZGGHJMX-XPYHLXFLSA-N\", \"cofactor_smiles\": \"[H]N([C@@H]1[C@H](O)CC2=CC=CC=C12)C(=O)[C@H](C[C@H](O)CN1CCN(CC2=CC3=C(OCO3)C=C2)C[C@H]1C(=O)N([H])C(C)(C)C)[C@H](C)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"XN2\", \"cofactor_name\": \"N-[2-hydroxy-1-indanyl]-5-[(2-tertiarybutylaminocarbonyl)-4(benzo[1,3]dioxol-5-ylmethyl)-piperazino]-4-hydroxy-2-(1-phenylethyl)-pentanamide\", \"cofactor_resource_id\": \"DB01721\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P35963\"}, {\"cofactor_in_ch_ikey\": \"CBVCZFGXHXORBI-PXQQMZJSSA-N\", \"cofactor_smiles\": \"CC(C)(C)NC(=O)[C@@H]1CN(CC2=CN=CC=C2)CCN1C[C@@H](O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12\", \"cofactor_chem_comp_id\": \"MK1\", \"cofactor_name\": \"Indinavir\", \"cofactor_resource_id\": \"DB00224\", \"mechanism_of_action\": \"Indinavir inhibits the HIV viral protease enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"NQDJXKOVJZTUJA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1\", \"cofactor_chem_comp_id\": \"NVP\", \"cofactor_name\": \"Nevirapine\", \"cofactor_resource_id\": \"DB00238\", \"mechanism_of_action\": \"Nevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates.\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"JFVZFKDSXNQEJW-CQSZACIVSA-N\", \"cofactor_smiles\": \"[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C\", \"cofactor_name\": \"Tenofovir disoproxil\", \"cofactor_resource_id\": \"DB00300\", \"mechanism_of_action\": \"Tenofovir belongs to a class of antiretroviral drugs known as nucleotide analog reverse transcriptase inhibitors (NtRTIs), which block reverse transcriptase, an enzyme necessary for viral production in HIV-infected individuals. This enables the management of HIV viral load through decreased viral replication [FDA label].\\r\\n\\r\\nTenofovir disoproxil fumarate is the fumarate salt of the prodrug _tenofovir disoproxil_. Tenofovir disoproxil is absorbed and converted to its active form, _tenofovir_,  a nucleoside monophosphate (nucleotide) analog. Tenofovir is then converted to the active metabolite, _tenofovir diphosphate_, a chain terminator, by constitutively expressed enzymes in the cell. Tenofovir diphosphate inhibits HIV-1 reverse transcriptase and the Hepatitis B polymerase by direct binding competition with the natural deoxyribonucleotide substrate (deoxyadenosine 5\\u2019-triphosphate) and, after integration into DNA, causes viral DNA chain termination [F3442], [FDA label]. \\r\\n\\r\\n**A note on resistance**\\r\\n\\r\\nHIV-1 isolates with decreased susceptibility to tenofovir have been identified in cell culture studies. These viruses expressed a _K65R_ substitution in reverse transcriptase and showed a 2\\u2013 4 fold decrease in susceptibility to treatment with tenofovir [FDA label].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"HBOMLICNUCNMMY-XLPZGREQSA-N\", \"cofactor_smiles\": \"CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O\", \"cofactor_chem_comp_id\": \"AZZ\", \"cofactor_name\": \"Zidovudine\", \"cofactor_resource_id\": \"DB00495\", \"mechanism_of_action\": \"Zidovudine, a structural analog of thymidine, is a prodrug that must be phosphorylated to its active 5\\u2032-triphosphate metabolite, zidovudine triphosphate (ZDV-TP). It inhibits the activity of HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. It competes with the natural substrate dGTP and incorporates itself into viral DNA. It is also a weak inhibitor of cellular DNA polymerase \\u03b1 and \\u03b3.  \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"NCDNCNXCDXHOMX-XGKFQTDJSA-N\", \"cofactor_smiles\": \"CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"RIT\", \"cofactor_name\": \"Ritonavir\", \"cofactor_resource_id\": \"DB00503\", \"mechanism_of_action\": \"Ritonavic inhibits the HIV viral proteinase enzyme that normally cleaves the structural and replicative proteins that arise from major HIV genes, such as *gag* and *pol*. *Gag* encodes proteins involved in the core and the nucleocapsid, while *pol* encodes the the HIV reverse transcriptase, ribonuclease H, integrase, and protease [A19647]. The *pol*-encoded proteins are initially translated in the form of a larger precursoe polypeptide, *gag-pol*, and needs to be cleaved by HIV protease to form other complement proteins [A19647]. Ritonavir prevents the cleavage of the *gag-pol* polyprotein, which results in noninfectious, immature viral particles. Ritonavir is a potent inhibitor of cytochrome P450 CYP3A4 isoenzyme present both in the intestinal tract and liver [A19647]. It is a type II ligand that perfectly fits into the CYP3A4 active site cavity and irreversibly binds to the heme iron via the thiazole nitrogen, which decreases the redox potential of the protein and precludes its reduction with the redox partner, cytochrome P450 reductase [A19648]. Ritonavir may also play a role in limiting cellular transport and efflux of other protease inhibitors via the P-glycoprotein and MRP efflux channels [A19647].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"XPOQHMRABVBWPR-ZDUSSCGKSA-N\", \"cofactor_smiles\": \"FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC1CC1\", \"cofactor_chem_comp_id\": \"EFZ\", \"cofactor_name\": \"Efavirenz\", \"cofactor_resource_id\": \"DB00625\", \"mechanism_of_action\": \"Similar to zidovudine, efavirenz inhibits the activity of viral RNA-directed DNA polymerase (i.e., reverse transcriptase). Antiviral activity of efavirenz is dependent on intracellular conversion to the active triphosphorylated form. The rate of efavirenz phosphorylation varies, depending on cell type. It is believed that inhibition of reverse transcriptase interferes with the generation of DNA copies of viral RNA, which, in turn, are necessary for synthesis of new virions. Intracellular enzymes subsequently eliminate the HIV particle that previously had been uncoated, and left unprotected, during entry into the host cell. Thus, reverse transcriptase inhibitors are virustatic and do not eliminate HIV from the body. Even though human DNA polymerase is less susceptible to the pharmacologic effects of triphosphorylated efavirenz, this action may nevertheless account for some of the drug's toxicity.\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"XNKLLVCARDGLGL-JGVFFNPUSA-N\", \"cofactor_smiles\": \"CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O\", \"cofactor_name\": \"Stavudine\", \"cofactor_resource_id\": \"DB00649\", \"mechanism_of_action\": \"Stavudine inhibits the activity of HIV-1 reverse transcriptase (RT) both by competing with the natural substrate dGTP and by its incorporation into viral DNA.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"YMARZQAQMVYCKC-OEMFJLHTSA-N\", \"cofactor_smiles\": \"CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1\", \"cofactor_chem_comp_id\": \"478\", \"cofactor_name\": \"Amprenavir\", \"cofactor_resource_id\": \"DB00701\", \"mechanism_of_action\": \"Amprenavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"WHBIGIKBNXZKFE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)NC1=C(N=CC=C1)N1CCN(CC1)C(=O)C1=CC2=C(N1)C=CC(NS(C)(=O)=O)=C2\", \"cofactor_chem_comp_id\": \"SPP\", \"cofactor_name\": \"Delavirdine\", \"cofactor_resource_id\": \"DB00705\", \"mechanism_of_action\": \"Delavirdine binds directly to viral reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by disrupting the enzyme's catalytic site.\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"JTEGQNOMFQHVDC-NKWVEPMBSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1\", \"cofactor_chem_comp_id\": \"3TC\", \"cofactor_name\": \"Lamivudine\", \"cofactor_resource_id\": \"DB00709\", \"mechanism_of_action\": \"Lamivudine is a synthetic nucleoside analogue and is phosphorylated intracellularly to its active 5'-triphosphate metabolite, lamivudine triphosphate (L-TP). This nucleoside analogue is incorporated into viral DNA by HIV reverse transcriptase and HBV polymerase, resulting in DNA chain termination.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"XQSPYNMVSIKCOC-NTSWFWBYSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1\", \"cofactor_chem_comp_id\": \"ETV\", \"cofactor_name\": \"Emtricitabine\", \"cofactor_resource_id\": \"DB00879\", \"mechanism_of_action\": \"Emtricitabine is a cytidine analog which, when phosphorylated to emtricitabine 5'-triphosphate, competes with deoxycytidine 5'-triphosphate for HIV-1 reverse transcriptase.[L9019] As HIV-1 reverse transcriptase incorporates emtricitabine into forming DNA strands, new nucleotides are unable to be incorporated, leading to  viral DNA chain termination.[L9019] Inhibition of reverse transcriptase prevents transcription of viral RNA into DNA, therefore the virus is unable to incorporate its DNA into host DNA and replicate using host cell machinery. This reduces viral load.[A187688]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"BXZVVICBKDXVGW-NKWVEPMBSA-N\", \"cofactor_smiles\": \"OC[C@@H]1CC[C@@H](O1)N1C=NC2=C1NC=NC2=O\", \"cofactor_chem_comp_id\": \"2DI\", \"cofactor_name\": \"Didanosine\", \"cofactor_resource_id\": \"DB00900\", \"mechanism_of_action\": \"Didanosine (ddI) is metabolized intracellularly by a series of cellular enzymes to its active moiety, dideoxyadenosine triphosphate (ddATP), which inhibits the HIV reverse transcriptase enzyme competitively by competing with natural dATP. It also acts as a chain terminator by its incorporation into viral DNA as the lack of a 3'-OH group in the incorporated nucleoside analogue prevents the formation of the 5' to 3' phosphodiester linkage essential for DNA chain elongation, and therefore, the viral DNA growth is terminated.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"SUJUHGSWHZTSEU-FYBSXPHGSA-N\", \"cofactor_smiles\": \"[H][C@@](CC)(C1=CC(NS(=O)(=O)C2=NC=C(C=C2)C(F)(F)F)=CC=C1)C1=C(O)C[C@@](CCC)(CCC2=CC=CC=C2)OC1=O\", \"cofactor_chem_comp_id\": \"TPV\", \"cofactor_name\": \"Tipranavir\", \"cofactor_resource_id\": \"DB00932\", \"mechanism_of_action\": \"Tipranavir (TPV) is a non-peptidic HIV-1 protease inhibitor that inhibits the processing of the viral Gag and Gag-Pol polyproteins in HIV-1 infected cells, thus preventing formation of mature virions. Two mechanisms are suggested in regards to the potency of tipranavir: 1. Tipravanir may bind to the active site of the protease enzyme with fewer hydrogen bonds than peptidic protease inhibitors, which results in increased flexibility, allowing it to fit into the active site of the enzyme in viruses that have become resistance to other protease inhibitors. This also enables tipranavir to adjust to amino acid substitutions at the active site. 2. Tipranavir's strong hydrogen bonding interaction with the amide backbone of the protease active site Asp30 may lead to its activity against resistant viruses.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"WREGKURFCTUGRC-POYBYMJQSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](CO)O1\", \"cofactor_name\": \"Zalcitabine\", \"cofactor_resource_id\": \"DB00943\", \"mechanism_of_action\": \"Zalcitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Within cells, zalcitabine is converted to its active metabolite, dideoxycytidine 5'-triphosphate (ddCTP), by the sequential action of cellular enzymes. ddCTP interferes with viral RNA-directed DNA polymerase (reverse transcriptase) by competing for utilization of the natural substrate deoxycytidine 5'-triphosphate (dCTP), as well as incorpating into viral DNA. Due to it's lack of a 3'-OH group, the formation of a 5' to 3' phosphodiester linkage that is necessary for DNA chain elongation is inhibited, thus leading to the termination of viral DNA growth.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"MCGSCOLBFJQGHM-SCZZXKLOSA-N\", \"cofactor_smiles\": \"NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1\", \"cofactor_chem_comp_id\": \"1KX\", \"cofactor_name\": \"Abacavir\", \"cofactor_resource_id\": \"DB01048\", \"mechanism_of_action\": \"Abacavir is a carbocyclic synthetic nucleoside analogue and an antiviral agent. Intracellularly, abacavir is converted by cellular enzymes to the active metabolite carbovir triphosphate, an analogue of deoxyguanosine-5'-triphosphate (dGTP). Carbovir triphosphate inhibits the activity of HIV-1 reverse transcriptase (RT) both by competing with the natural substrate dGTP and by its incorporation into viral DNA. Viral DNA growth is terminated because the incorporated nucleotide lacks a 3'-OH group, which is needed to form the 5\\u2032 to 3\\u2032 phosphodiester linkage essential for DNA chain elongation. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"AXRYRYVKAWYZBR-GASGPIRDSA-N\", \"cofactor_smiles\": \"COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C\", \"cofactor_chem_comp_id\": \"DR7\", \"cofactor_name\": \"Atazanavir\", \"cofactor_resource_id\": \"DB01072\", \"mechanism_of_action\": \"Atazanavir selectively inhibits the virus-specific processing of viral Gag and Gag-Pol polyproteins in HIV-1 infected cells by binding to the active site of HIV-1 protease, thus preventing the formation of mature virions. Atazanavir is not active against HIV-2.[L48636] \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"QWAXKHKRTORLEM-UGJKXSETSA-N\", \"cofactor_smiles\": \"[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=NC3=C(C=CC=C3)C=C1)[C@@H](C2)C(=O)NC(C)(C)C\", \"cofactor_chem_comp_id\": \"ROC\", \"cofactor_name\": \"Saquinavir\", \"cofactor_resource_id\": \"DB01232\", \"mechanism_of_action\": \"The HIV lifecycle is comprised of 3 distinct stages: assembly, involving creation and packaging of essential viral components; budding, wherein the viral particle crosses the host cell plasma membrane and forms a lipid envelope; and maturation, wherein the viral particle alters its structure and becomes infectious.[A191712] At the center of this lifecycle is the Gag polyprotein which, along with the products of its proteolysis, coordinate these stages and function as the major structural proteins of the virus. The HIV-1 protease enzyme, a dimeric aspartic protease, is the enzyme responsible for cleaving the Gag polyprotein and thus plays a critical role in many aspects of the HIV viral lifecycle.[A191712]\\r\\n\\r\\nSaquinavir is an inhibitor of the HIV-1 protease enzyme.[L3450] Its design is based on the \\\"peptidomimetic\\\" principle, wherein the molecule contains a hydroxyethylene scaffold that mimics the normal peptide linkage (cleaved by HIV protease) but which itself cannot be cleaved.[A191757] By preventing HIV-1 protease activity, and thus the proteolysis of the Gag polyprotein, saquinavir results in the production of immature, non-infectious viral particles.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"CJBJHOAVZSMMDJ-HEXNFIEUSA-N\", \"cofactor_smiles\": \"[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1\", \"cofactor_chem_comp_id\": \"017\", \"cofactor_name\": \"Darunavir\", \"cofactor_resource_id\": \"DB01264\", \"mechanism_of_action\": \"The HIV-1 protease enzyme is necessary for viral precursor protein processing and viral maturation in preparation for infection, and is therefore a target for antiretroviral therapy for HIV.  Protease inhibitors are used as a part of highly active antiretroviral therapy (HAART) in patients diagnosed with HIV infection. It has been shown to effectively suppress the virus, leading to significantly decreased morbidity and mortality rates.[A2281]\\r\\n\\r\\nDarunavir, a HIV protease inhibitor, prevents HIV replication through binding to the enzyme, stopping the dimerization and the catalytic activity of HIV-1 protease. In particular, it inhibits the cleavage of HIV encoded Gag-Pol proteins[A191556] in cells that have been infected with the virus, halting the formation of mature virus particles, which spread the infection. The close contact that darunavir makes with the primary chains of the active site amino acids (Asp-29 and Asp-30) on the protease likely contributes to its potency and efficacy against resistant variants of HIV-1.[A2281] \\r\\n\\r\\nDarunavir is known to bind to different sites on the enzyme: the active site cavity and the surface of one of the flexible flaps in the protease dimer. Darunavir can adapt to changes in the shape of a protease enzyme due to its molecular flexibility.[A2281,A191526]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"MLBVMOWEQCZNCC-OEMFJLHTSA-N\", \"cofactor_smiles\": \"CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1\", \"cofactor_name\": \"Fosamprenavir\", \"cofactor_resource_id\": \"DB01319\", \"mechanism_of_action\": \"Fosamprenavir is a prodrug that is rapidly hydrolyzed to amprenavir by cellular phosphatases in the gut epithelium as it is absorbed. Amprenavir is an inhibitor of HIV-1 protease. During HIV replication, HIV protease cleaves viral polypeptide products of the Gag and Gag-Pol genes to form structural proteins of the virion core and essential viral enzymes. Amprenavir interferes with this process by binding to the active site of HIV-1 protease, thereby preventing the processing of viral Gag and Gag-Pol polyprotein precursors, resulting in the formation of immature non-infectious viral particles.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"SQBOSZXDOHQFAA-ZRTHHSRSSA-N\", \"cofactor_smiles\": \"O[C@@H]1[C@@H](O)[C@@H](COC2=CC=CC=C2)N(CC2=CC=CC=C2)C(=O)N(CC2=CC=CC=C2)[C@@H]1COC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"AH1\", \"cofactor_name\": \"(4R,5S,6S,7R)-1,3-dibenzyl-4,7-bis(phenoxymethyl)-5,6-dihydroxy-1,3 diazepan-2-one\", \"cofactor_resource_id\": \"DB01732\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"BYWKHOXUUACYRY-RJAVELRTSA-N\", \"cofactor_smiles\": \"[H]N([H])[C@@]([H])(O)O[C@]1([H])CC2=CC=CC=C2[C@]1([H])[C@]1([H])CN([H])[C@@](CC2=CC=CC=C2)(CC([H])(O)C([H])(CC2=CC=CC=C2)N([H])C(=O)O[C@@]2([H])CCOC2)C1=O\", \"cofactor_chem_comp_id\": \"3NH\", \"cofactor_name\": \"(3S)-Tetrahydro-3-furanyl {(2S,3S)-4-[(2S,4R)-4-{(1S,2R)-2-[(S)-amino(hydroxy)methoxy]-2,3-dihydro-1H-inden-1-yl}-2-benzyl-3-oxo-2-pyrrolidinyl]-3-hydroxy-1-phenyl-2-butanyl}carbamate\", \"cofactor_resource_id\": \"DB01824\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"HLBCBFBFJWGTFR-QKXNMUHCSA-N\", \"cofactor_smiles\": \"[H]N([C@@H]1CO[C@H](CO)C1)C(=O)[C@H](OCC1=CC=CC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=CC=C1)C(=O)N([H])[C@@H]1[C@H](O)CC2=CC=CC=C12\", \"cofactor_chem_comp_id\": \"568\", \"cofactor_name\": \"N,N-[2,5-O-Dibenzyl-glucaryl]-DI-[1-amino-indan-2-OL]\", \"cofactor_resource_id\": \"DB01887\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"QLOIOASGERKBSU-NYVOZVTQSA-N\", \"cofactor_smiles\": \"[H][C@@](CO)(CC1=CC=CC=C1)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(C)NC(=O)OCC1=CC=CC=C1)C(C)C\", \"cofactor_name\": \"Tl-3-093\", \"cofactor_resource_id\": \"DB01891\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"AOMZDQMIOCTPQP-CFSTZTOESA-N\", \"cofactor_smiles\": \"CC(C)(C)NC(=O)[C@@H]1CN(CC2=CC3=C(O2)C=CC=C3)CCN1C[C@@H](O)C[C@@H](CC1=CC=CC=C1)C(=O)NC1[C@H](O)CC2=C1C=CC=C2\", \"cofactor_chem_comp_id\": \"L75\", \"cofactor_name\": \"L-756423\", \"cofactor_resource_id\": \"DB02009\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"GDRNWAKVNIROCG-DEOSSOPVSA-N\", \"cofactor_smiles\": \"OC1=C([C@@H](C2CC2)C2=CC=CC(NS(=O)(=O)C3=CC=CC=C3)=C2)C(=O)OC2=C1CCCCCC2\", \"cofactor_chem_comp_id\": \"INU\", \"cofactor_name\": \"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide\", \"cofactor_resource_id\": \"DB02033\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"KYRSNWPSSXSNEP-ZRTHHSRSSA-N\", \"cofactor_smiles\": \"NC1=CC(CN2[C@H](CC3=CC=CC=C3)[C@H](O)[C@@H](O)[C@@H](CC3=CC=CC=C3)N(CC3=CC(N)=CC=C3)C2=O)=CC=C1\", \"cofactor_chem_comp_id\": \"DMQ\", \"cofactor_name\": \"Mozenavir\", \"cofactor_resource_id\": \"DB02102\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"OAKPWEUQDVLTCN-NKWVEPMBSA-N\", \"cofactor_smiles\": \"NC1=C2N=CN([C@H]3CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O3)C2=NC=N1\", \"cofactor_chem_comp_id\": \"DDS\", \"cofactor_name\": \"2',3'-Dideoxyadenosine triphosphate\", \"cofactor_resource_id\": \"DB02189\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"NHVNXKFIZYSCEB-XLPZGREQSA-N\", \"cofactor_smiles\": \"CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O\", \"cofactor_chem_comp_id\": \"TTP\", \"cofactor_name\": \"Thymidine 5'-triphosphate\", \"cofactor_resource_id\": \"DB02452\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"LYHLPPXMBKMSSZ-JQFCFGFHSA-N\", \"cofactor_smiles\": \"O[C@H]([C@@H](O)[C@@H](OCC1=C(F)C=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12)[C@@H](OCC1=CC=CC=C1F)C(=O)N[C@@H]1[C@H](O)CC2=C1C=CC=C2\", \"cofactor_chem_comp_id\": \"BED\", \"cofactor_name\": \"N,N-[2,5-O-di-2-fluoro-benzyl-glucaryl]-di-[1-amino-indan-2-ol]\", \"cofactor_resource_id\": \"DB02629\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"CUFQBQOBLVLKRF-RZDMPUFOSA-N\", \"cofactor_smiles\": \"CC1=CC=CC=C1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CC=CC(O)=C1C\", \"cofactor_chem_comp_id\": \"JE2\", \"cofactor_name\": \"JE-2147\", \"cofactor_resource_id\": \"DB02668\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"FOBRXMROTNVGST-CXPJILFNSA-N\", \"cofactor_smiles\": \"[H][C@@](O)([C@@]([H])(O)[C@@]([H])(OCC1=CC=C(C=C1)C1=CN=CC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NC)[C@@]([H])(OCC1=CC=C(C=C1)C1=CN=CC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NC\", \"cofactor_chem_comp_id\": \"BEJ\", \"cofactor_name\": \"Inhibitor Bea428\", \"cofactor_resource_id\": \"DB02683\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"GQKBYZPVKVXMJL-LAFNQVRVSA-N\", \"cofactor_smiles\": \"O[C@@H]([C@H](O)[C@@H](CCC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=C1C=CC=C2)[C@@H](CCC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=C1C=CC=C2\", \"cofactor_chem_comp_id\": \"BLL\", \"cofactor_name\": \"(2R,3R,4R,5R)-3,4-Dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide\", \"cofactor_resource_id\": \"DB02704\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"RUPAXCPQAAOIPB-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)(C)OC=O\", \"cofactor_chem_comp_id\": \"TBF\", \"cofactor_name\": \"Tert-Butyloxycarbonyl Group\", \"cofactor_resource_id\": \"DB02768\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"SQZXWXXIPWXBCL-CYTJBAGBSA-N\", \"cofactor_smiles\": \"[H]N([C@H]1[C@@H](C)CC[C@H]1O)C(=O)[C@@H](C[C@H](O)CN1CCN(C[C@H]1C(=O)N([H])C(C)(C)C)C(=O)C1=CN=C(N2CCN(C)CC2)C(Cl)=N1)CC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"3IN\", \"cofactor_name\": \"(2S)-1-[(2S,4R)-4-Benzyl-2-hydroxy-5-{[(1S,2R,5S)-2-hydroxy-5-methylcyclopentyl]amino}-5-oxopentyl]-4-{[6-chloro-5-(4-methyl-1-piperazinyl)-2-pyrazinyl]carbonyl}-N-(2-methyl-2-propanyl)-2-piperazineca rboxamide\", \"cofactor_resource_id\": \"DB02785\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"IOLQWLOHKZENDW-JTQLQIEISA-N\", \"cofactor_smiles\": \"CC[C@H](N)CC1=CC=CC=C1\", \"cofactor_name\": \"1-Benzyl-(R)-Propylamine\", \"cofactor_resource_id\": \"DB02972\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"CGBDAHCDSVOMCF-FYZVQMPESA-N\", \"cofactor_smiles\": \"CNC(=O)C1=CC=CC(CN2[C@H](COC3=CC=CC=C3)[C@H](O)[C@@H](O)[C@@H](COC3=CC=CC=C3)N(CC3=CC=CC=C3)S2(=O)=O)=C1\", \"cofactor_chem_comp_id\": \"NM1\", \"cofactor_name\": \"3-[[(3R,4S,5S,6R)-7-Benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide\", \"cofactor_resource_id\": \"DB03076\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"UYUWNNRWESUYOB-FIRIVFDPSA-N\", \"cofactor_smiles\": \"O[C@@H]1CN(N(CC2=CC=C(O)C=C2)C(=O)N(CC2=CC=C(O)C=C2)[C@@H]1CC1=CC=CC=C1)S(=O)(=O)C1=CC(=CC=C1)C#N\", \"cofactor_chem_comp_id\": \"BH0\", \"cofactor_name\": \"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril\", \"cofactor_resource_id\": \"DB03141\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"SVFLQOLSPWURCD-CXPJILFNSA-N\", \"cofactor_smiles\": \"CC(C)[C@H](NC(=O)[C@H](OCC1=CC=CC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)NCC1=NC=CC=C1)C(=O)NCC1=CC=CC=N1\", \"cofactor_chem_comp_id\": \"MS3\", \"cofactor_name\": \"N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine]\", \"cofactor_resource_id\": \"DB03803\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"GLKONBHDVMFJNJ-XAOMMOPXSA-N\", \"cofactor_smiles\": \"[H]N(C)C(=O)[C@@H](N([H])C(=O)[C@H](OCC1=CC=CC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=CC=C1)C(=O)N([H])[C@@H]([C@@H](C)CC)C(=O)N([H])C)[C@@H](C)CC\", \"cofactor_chem_comp_id\": \"BEI\", \"cofactor_name\": \"N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane]\", \"cofactor_resource_id\": \"DB03908\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"XLJNZONSWKENRP-VABIIVNOSA-N\", \"cofactor_smiles\": \"[H][C@](O)(OC)C1=CC=C(CN2[C@]([H])(COC3=CC=CC=C3)[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(COC3=CC=CC=C3)N(CC3=CC=C(CO)C=C3)S2(=O)=O)C=C1\", \"cofactor_chem_comp_id\": \"AHF\", \"cofactor_name\": \"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol\", \"cofactor_resource_id\": \"DB04042\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"AHAVBKNGKPWROK-UMFPTGFGSA-N\", \"cofactor_smiles\": \"O[C@H](C[C@@H](OCC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12)[C@@H](OCC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12\", \"cofactor_chem_comp_id\": \"BEG\", \"cofactor_name\": \"2,5-dibenzyloxy-3-hydroxy-hexanedioic acid bis-[(2-hydroxy-indan-1-yl)-amide]\", \"cofactor_resource_id\": \"DB04190\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"VZNNJZGVQVNHCM-CDNLURBZSA-N\", \"cofactor_smiles\": \"CNC(=O)[C@@H](NC(=O)[C@H](OCC1=CC=CC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12)C(C)C\", \"cofactor_chem_comp_id\": \"BEC\", \"cofactor_name\": \"Inhibitor BEA388\", \"cofactor_resource_id\": \"DB04255\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"AJZAPEZJWWQJHC-UWNKZCSISA-N\", \"cofactor_smiles\": \"CNC(=O)[C@@H](NC(=O)[C@H](OCC1=CC=C(C=C1)C1=CSC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=C(C=C1)C1=CSC=C1)C(=O)N[C@@H](C(C)C)C(=O)NC)C(C)C\", \"cofactor_chem_comp_id\": \"BEE\", \"cofactor_name\": \"Inhibitor BEA409\", \"cofactor_resource_id\": \"DB04547\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"NIDRYBLTWYFCFV-FMTVUPSXSA-N\", \"cofactor_smiles\": \"CCCC1=CC(=O)OC2=C1C1=C(C=CC(C)(C)O1)C1=C2[C@@H](O)[C@H](C)[C@@H](C)O1\", \"cofactor_name\": \"Calanolide A\", \"cofactor_resource_id\": \"DB04886\", \"mechanism_of_action\": \"Viral life-cycle studies indicate that calanolide A acts early in the infection process, similar to the known HIV reverse transcriptase (RT) inhibitor 2', 3'-dideoxycytidine. In enzyme inhibition assays, calanolide A potently and selectively inhibits recombinant HIV type 1 RT but not cellular DNA polymerases or HIV type 2 RT within the concentration range tested.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"JORVRJNILJXMMG-OLNQLETPSA-N\", \"cofactor_smiles\": \"[H][C@]12OCC[C@@]1([H])[C@H](CO2)OC(=O)N[C@@H](CC1=CC=C(OCC2=CSC(C)=N2)C=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC2=C(OCO2)C=C1\", \"cofactor_chem_comp_id\": \"385\", \"cofactor_name\": \"Brecanavir\", \"cofactor_resource_id\": \"DB04887\", \"mechanism_of_action\": \"Brecanavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"KMCBHFNNVRCAAH-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCCCCCCCCCC[N+](C)(C)[O-].CCCCCCCCCCCC[N+](C)(C)CC([O-])=O\", \"cofactor_name\": \"C31G\", \"cofactor_resource_id\": \"DB05398\", \"mechanism_of_action\": \"The range of organisms killed by C31G has been extended to include enveloped viruses. Coupled with data indicating a low toxicity for mammalian cells, and a much wider range of anti-microbial activity than Nonoxynol-9, it appears that C31G is an ideal agent for use in decreasing the risk of transmission of organisms associated with STD. C31G is developed as a topical vaginal microbicide with broad-spectrum antibacterial and antiviral properties. C31G which has a high affinity for bacteria, fungi, yeast, and viruses while exhibiting low mammalian cell toxicity. \", \"neighbor_flag\": \"N\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"YZHIXLCGPOTQNB-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)=CCOC1=C(Cl)C=CC(NC(=S)C2=C(C)OC=C2)=C1\", \"cofactor_chem_comp_id\": \"UC1\", \"cofactor_name\": \"UC-781\", \"cofactor_resource_id\": \"DB05871\", \"mechanism_of_action\": \"UC-781 is an HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) that has shown in vitro to be very active specifically against HIV-1. UC-781 exhibits synergy with the NRTI zidovudine in vitro.[12] The combination of UC-781 and another candidate microbicide, cellulose acetate 1,2-benzenedicarboxylate, resulted in effective synergy for inhibition of HIV-1 in vitro and in peripheral blood mononuclear cells\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"QAHLFXYLXBBCPS-IZEXYCQBSA-N\", \"cofactor_smiles\": \"COC(=O)N[C@@H](C(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)NCCCC[C@@H](CO)N(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1\", \"cofactor_chem_comp_id\": \"A00\", \"cofactor_name\": \"PPL-100\", \"cofactor_resource_id\": \"DB05961\", \"mechanism_of_action\": \"PPL-100 is a promising protease inhibitor which binds specifically to HIV-1 protease. It has been shown activity against several HIV-1 strains specifically selected for key mutations that render these strains resistant to currently marketed protease inhibitors\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"UXCAQJAQSWSNPQ-XLPZGREQSA-N\", \"cofactor_smiles\": \"CC1=CN([C@H]2C[C@H](F)[C@@H](CO)O2)C(=O)NC1=O\", \"cofactor_name\": \"Alovudine\", \"cofactor_resource_id\": \"DB06198\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"HSBKFSPNDWWPSL-VDTYLAMSSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1F)[C@H]1O[C@@H](CO)C=C1\", \"cofactor_name\": \"Elvucitabine\", \"cofactor_resource_id\": \"DB06236\", \"mechanism_of_action\": \"Elvucitabine is a L-cytosine Nucleoside analog Reverse Transcriptase Inhibitor (NRTIs) anti-HIV drug. NRTI's inhibit the activity of viral RNA-directed DNA polymerase (i.e., reverse transcriptase). It is believed that inhibition of reverse transcriptase interferes with the generation of DNA copies of viral RNA, which, in turn, are necessary for synthesis of new virions. Intracellular enzymes subsequently eliminate the HIV particle that previously had been uncoated, and left unprotected, during entry into the host cell. Thus, reverse transcriptase inhibitors are virustatic and do not eliminate HIV from the body. \\r\\n\\r\\n\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"PYGWGZALEOIKDF-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=CC(=CC(C)=C1OC1=C(Br)C(N)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N\", \"cofactor_chem_comp_id\": \"65B\", \"cofactor_name\": \"Etravirine\", \"cofactor_resource_id\": \"DB06414\", \"mechanism_of_action\": \"Etravirine exerts its effects via direct inhibition of the reverse transcriptase enzyme of human immunodeficiency virus type 1 (HIV-1).  It directly binds reverse transcriptase and consequently blocks DNA-dependent and RNA-dependent polymerase activity. Etravirine does not inhibit human DNA polymerase alpha, beta or gamma. \\r\\n\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"RLAHNGKRJJEIJL-RFZPGFLSSA-N\", \"cofactor_smiles\": \"NC1=NC(N)=C2N=CN([C@H]3CO[C@@H](CO)O3)C2=N1\", \"cofactor_name\": \"Amdoxovir\", \"cofactor_resource_id\": \"DB06619\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"CZFFBEXEKNGXKS-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1\", \"cofactor_chem_comp_id\": \"RLT\", \"cofactor_name\": \"Raltegravir\", \"cofactor_resource_id\": \"DB06817\", \"mechanism_of_action\": \"Raltegravir inhibits HIV integrase to prevent the viral genome being incorporated into the human genome. Raltegravir is primarily metabolized by glucuronidation.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"LSIZSSASMKSUIU-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=CC(=CC(C)=C1OC1=C(Br)C(CO)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N\", \"cofactor_chem_comp_id\": \"185\", \"cofactor_name\": \"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL\", \"cofactor_resource_id\": \"DB06874\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"USWKTQVAABDFSY-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCC1=C(C)NC(=O)C(N(C)CCOC)=C1CC1=CC=CC(C)=C1\", \"cofactor_chem_comp_id\": \"357\", \"cofactor_name\": \"5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE\", \"cofactor_resource_id\": \"DB07018\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"XMFUXIRAVPMVRS-FNORWQNLSA-N\", \"cofactor_smiles\": \"CCC1=C(C)NC(=O)C(I)=C1OC1=CC=CC(\\\\C=C\\\\C#N)=C1\", \"cofactor_chem_comp_id\": \"3AC\", \"cofactor_name\": \"(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE\", \"cofactor_resource_id\": \"DB07035\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"FELUFXCUIYHAPB-INIZCTEOSA-N\", \"cofactor_smiles\": \"CC(=O)C1=C(N[C@H](C(N)=O)C2=C(Br)C=CC=C2Br)C=C(C)C=C1\", \"cofactor_chem_comp_id\": \"AAA\", \"cofactor_name\": \"R-95845\", \"cofactor_resource_id\": \"DB07327\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"CJPLEFFCVDQQFZ-INIZCTEOSA-N\", \"cofactor_smiles\": \"[H][C@@](NC1=C(C=CC(C)=C1)C(C)=O)(C(N)=O)C1=C(Cl)C=CC=C1Cl\", \"cofactor_chem_comp_id\": \"AAP\", \"cofactor_name\": \"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE\", \"cofactor_resource_id\": \"DB07332\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"SOKOHDQTKSROQZ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"NC1=NC(CC2=C3C=CNC3=CC=C2Cl)=NC(NC2=CC=C(C=C2)C#N)=N1\", \"cofactor_chem_comp_id\": \"ABZ\", \"cofactor_name\": \"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE\", \"cofactor_resource_id\": \"DB07337\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"NFNNMVVXXITVGD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"NC1=NC(OC2=C(Cl)C=CC=C2Cl)=NC(NC2=CC=C(C=C2)C#N)=N1\", \"cofactor_chem_comp_id\": \"ADB\", \"cofactor_name\": \"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE\", \"cofactor_resource_id\": \"DB07343\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"VRAJWAGCJIXJHQ-YPMHNXCESA-N\", \"cofactor_smiles\": \"[H][C@@]1(C[C@@]1([H])C1=C(F)C=CC(C(=O)CC)=C1O)NC(=O)NC1=NC=C(Br)C=C1\", \"cofactor_chem_comp_id\": \"BFU\", \"cofactor_name\": \"1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA\", \"cofactor_resource_id\": \"DB07451\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"WUOLYUKMMRCXGH-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=NC2=C(C=CN=C2)N1C1=CC=C(CN2C(=O)SC3=CC=CC=C23)C=C1\", \"cofactor_chem_comp_id\": \"CP9\", \"cofactor_name\": \"CP-94707\", \"cofactor_resource_id\": \"DB07578\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"UDMBRVGTYILYDX-SVFBPWRDSA-N\", \"cofactor_smiles\": \"[H][C@@](NC(=O)CC1=CC=CC=C1)(C(=O)NCC1=CC=CC=C1)[C@]1([H])N[C@@]([H])(C(O)=O)C(C)(C)S1\", \"cofactor_chem_comp_id\": \"G23\", \"cofactor_name\": \"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID\", \"cofactor_resource_id\": \"DB07806\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"KELNNWMENBUHNS-NSHDSACASA-N\", \"cofactor_smiles\": \"CC[C@@H]1N(C(=O)OC(C)C)C2=C(NC1=O)C=CC(F)=C2\", \"cofactor_chem_comp_id\": \"HBQ\", \"cofactor_name\": \"Opaviraline\", \"cofactor_resource_id\": \"DB07884\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"GWKIPRVERALPRD-ZDUSSCGKSA-N\", \"cofactor_smiles\": \"[H][C@@]1(CSC)N(C(=O)OC(C)C)C2=C(NC1=S)C=CC(OC)=C2\", \"cofactor_chem_comp_id\": \"HBY\", \"cofactor_name\": \"Talviraline\", \"cofactor_resource_id\": \"DB07885\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"HDMHBHNRWDNNCD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C(SC2=CC=CC=C2)N(COCCO)C(=O)NC1=O\", \"cofactor_chem_comp_id\": \"HEF\", \"cofactor_name\": \"1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE\", \"cofactor_resource_id\": \"DB07892\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"NWKJBFSBEAMDBE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"[H]N([H])C(\\\\CC1=C(Cl)C=CC=C1Cl)=N/C(=S)N([H])C1=CC=C(C=C1)C#N\", \"cofactor_chem_comp_id\": \"IET\", \"cofactor_name\": \"1-(4-Cyano-phenyl)-3-[2-(2,6-dichloro-phenyl)-1-imino-ethyl]-thiourea\", \"cofactor_resource_id\": \"DB07961\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"TVOPERZEGKBKAY-RGVLZGJSSA-N\", \"cofactor_smiles\": \"COC1=C(\\\\C=N\\\\NC(=O)C2=CC(O)=C(O)C=C2)C2=CC=CC=C2C=C1\", \"cofactor_chem_comp_id\": \"K05\", \"cofactor_name\": \"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE\", \"cofactor_resource_id\": \"DB08034\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"MLILORUFDVLTSP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOCN1C(=O)NC(=O)C(C(C)C)=C1CC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"MKC\", \"cofactor_name\": \"Emivirine\", \"cofactor_resource_id\": \"DB08188\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"FSRLCMRWYUJTNT-UONOGXRCSA-N\", \"cofactor_smiles\": \"[H][C@]1(C[C@]1([H])C1=C(OC)C=CC(C(C)=O)=C1O)NC(=S)NC1=NC=C(C=C1)C#N\", \"cofactor_chem_comp_id\": \"MSD\", \"cofactor_name\": \"1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA\", \"cofactor_resource_id\": \"DB08212\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"BDVAWAILQCYMQE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"BrC1=CC=C(NC(=S)OCCN2C(=O)C3=C(C=CC=C3)C2=O)C=C1\", \"cofactor_chem_comp_id\": \"NNB\", \"cofactor_name\": \"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate\", \"cofactor_resource_id\": \"DB08281\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"BWRRXOIACQYNEK-UHFFFAOYSA-N\", \"cofactor_smiles\": \"ClC1=CC=C(NC(=S)OCCN2C(=O)C3=C(C=CC=C3)C2=O)C=C1\", \"cofactor_chem_comp_id\": \"NNC\", \"cofactor_name\": \"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate\", \"cofactor_resource_id\": \"DB08282\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"CYYIBMGIJWXZEP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"IC1=CC=C(NC(=S)OCCN2C(=O)C3=C(C=CC=C3)C2=O)C=C1\", \"cofactor_chem_comp_id\": \"NNI\", \"cofactor_name\": \"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate\", \"cofactor_resource_id\": \"DB08284\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"QOVMZMFNTIUFLU-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOC1=C(F)C(CCNC(=S)NC2=CC=C(C)C=N2)=NC=C1\", \"cofactor_chem_comp_id\": \"PC0\", \"cofactor_name\": \"1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA\", \"cofactor_resource_id\": \"DB08372\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"ATCRIOJPQXDFNY-ZETCQYMHSA-N\", \"cofactor_smiles\": \"C[C@H](SC1=NC(Cl)=CC(N)=N1)C1=CC2=C(OC=C2)C=N1\", \"cofactor_chem_comp_id\": \"PNU\", \"cofactor_name\": \"PNU-142721\", \"cofactor_resource_id\": \"DB08414\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"SMZUMFSKQVVOOV-WPRPVWTQSA-N\", \"cofactor_smiles\": \"[H][C@@](C)(O)[C@@]([H])(N)CC1=CC=CC=C1\", \"cofactor_name\": \"3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL\", \"cofactor_resource_id\": \"DB08428\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"YZLKVEDFWLGNQP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C(CSCC2=CC=CO2)C(OC2=CC(C)=CC(C)=C2)=C(I)C(=O)N1\", \"cofactor_chem_comp_id\": \"R22\", \"cofactor_name\": \"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE\", \"cofactor_resource_id\": \"DB08457\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"YQXCVAGCMNFUMQ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)C1=C(SC2=CC(Cl)=CC(Cl)=C2)N(CC2=CC=NC=C2)C(COC(N)=O)=N1\", \"cofactor_chem_comp_id\": \"S11\", \"cofactor_name\": \"Capravirine\", \"cofactor_resource_id\": \"DB08502\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"RCSLUNOLLUVOOG-NSHDSACASA-N\", \"cofactor_smiles\": \"C[C@H]1CN2C(=S)NC3=CC(Cl)=CC(CN1CC=C(C)C)=C23\", \"cofactor_chem_comp_id\": \"TB9\", \"cofactor_name\": \"R-82913\", \"cofactor_resource_id\": \"DB08598\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"ZNFFMCYSMBXZQU-NSHDSACASA-N\", \"cofactor_smiles\": \"[H]N1C(=S)N2C[C@H](C)N(CC=C(C)C)CC3=C(Cl)C=CC1=C23\", \"cofactor_chem_comp_id\": \"TBO\", \"cofactor_name\": \"Tivirapine\", \"cofactor_resource_id\": \"DB08600\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"KSAAUHMSLCPIEX-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)C1=C(CC2=CC=CC=C2)N(COCC2=CC=CC=C2)C(=O)NC1=O\", \"cofactor_chem_comp_id\": \"TNK\", \"cofactor_name\": \"6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL\", \"cofactor_resource_id\": \"DB08634\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"ILAYIAGXTHKHNT-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=CC(C)=C(NC2=NC(NC3=CC=C(C=C3)C#N)=NC=C2)C(C)=C1\", \"cofactor_chem_comp_id\": \"TPB\", \"cofactor_name\": \"Dapivirine\", \"cofactor_resource_id\": \"DB08639\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"AXTNFJKQZPETJA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)OC(=S)NC1=CC(C(=O)OC(C)C)=C(Cl)C=C1\", \"cofactor_chem_comp_id\": \"UC3\", \"cofactor_name\": \"1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE\", \"cofactor_resource_id\": \"DB08681\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"FMQGUMRNTBJHEA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)OC(=O)C1=C(Cl)C=CC(NC(=O)C2=C(C)OCCS2)=C1\", \"cofactor_chem_comp_id\": \"UC4\", \"cofactor_name\": \"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE\", \"cofactor_resource_id\": \"DB08682\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"YIBOMRUWOWDFLG-ONEGZZNKSA-N\", \"cofactor_smiles\": \"CC1=CC(\\\\C=C\\\\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1\", \"cofactor_chem_comp_id\": \"T27\", \"cofactor_name\": \"Rilpivirine\", \"cofactor_resource_id\": \"DB08864\", \"mechanism_of_action\": \"Rilpivirine is a non-competitive NNRTI that binds to reverse transcriptase.[L7069] Its binding results in the blockage of RNA and DNA- dependent DNA polymerase activities, like HIV-1 replication. It does not present activity against human DNA polymerases \\u03b1, \\u03b2 and \\u03b3.[L1032,L7069] Rilpivirine's flexible structure around the aromatic rings allows the adaptation to changes in the non-nucleoside RT binding pocket, reducing the likelihood of viral mutations conferring resistance.[A31335]\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"RHWKPHLQXYSBKR-BMIGLBTASA-N\", \"cofactor_smiles\": \"[H][C@]12CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N1[C@H](C)CCO2\", \"cofactor_chem_comp_id\": \"DLU\", \"cofactor_name\": \"Dolutegravir\", \"cofactor_resource_id\": \"DB08930\", \"mechanism_of_action\": \"Dolutegravir is an HIV-1 antiviral agent. It inhibits HIV integrase by binding to the active site and blocking the strand transfer step of retroviral DNA integration in the host cell. The strand transfer step is essential in the HIV replication cycle and results in the inhibition of viral activity. Dolutegravir has a mean EC50 value of 0.5 nM (0.21 ng/mL) to 2.1 nM (0.85 ng/mL) in peripheral blood mononuclear cells (PBMCs) and MT-4 cells.[A7517]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"JUZYLCPPVHEVSV-LJQANCHMSA-N\", \"cofactor_smiles\": \"[H][C@@](CO)(C(C)C)N1C=C(C(O)=O)C(=O)C2=C1C=C(OC)C(CC1=C(F)C(Cl)=CC=C1)=C2\", \"cofactor_chem_comp_id\": \"ELV\", \"cofactor_name\": \"Elvitegravir\", \"cofactor_resource_id\": \"DB09101\", \"mechanism_of_action\": \"Elvitegravir is an HIV-1 integrase strand transfer inhibitor (INSTI). Integrase is an HIV-1 encoded enzyme that is required for viral replication. Inhibition of integrase prevents the integration of HIV-1 DNA into host genomic DNA, blocking the formation of the HIV-1 provirus and propagation of the viral infection. Elvitegravir does not inhibit human topoisomerases I or II.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"UAUIUKWPKRJZJV-QPLHLKROSA-N\", \"cofactor_smiles\": \"[H][C@@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](CN1C(=O)[C@H](CCCCC\\\\C=C/2)NC(=O)C1=CN=C(C)C=N1)OC1=NC2=C(C=CC=C2)C2=C1C=CC=C2)C(=O)NS(=O)(=O)C1CC1\", \"cofactor_name\": \"Paritaprevir\", \"cofactor_resource_id\": \"DB09297\", \"mechanism_of_action\": \"Paritaprevir is a potent inhibitor of the NS3/4A serine protease of Hepatitis C Virus (HCV) [FDA Label]. Following viral replication of HCV genetic material and translation into a single polypeptide, Nonstructural Protein 3 (NS3) and its activating cofactor Nonstructural Protein 4A (NS4A) are responsible for cleaving it into the following structural and nonstructural proteins required for assembly into mature virus: NS3, NS4A, NS4B, NS5A, and NS5B. By inhibiting viral protease NS3/4A, paritaprevir therefore prevents viral replication and function.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"LDEKQSIMHVQZJK-CAQYMETFSA-N\", \"cofactor_smiles\": \"CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)CN1C=NC2=C(N)N=CN=C12)OC1=CC=CC=C1\", \"cofactor_name\": \"Tenofovir alafenamide\", \"cofactor_resource_id\": \"DB09299\", \"mechanism_of_action\": \"Tenofovir alafenamide presents 91% lower plasma concentration with an intracellular presence of about 20-fold higher when compared to [tenofovir disoproxil].[A178219] This is due to its prolonged systemic exposure and its higher intracellular accumulation of the active metabolite tenofovir diphosphate.[A18473]\\r\\n\\r\\nTenofovir alafenamide accumulates more in peripheral blood mononuclear cells compared to red blood cells.[A18473]\\r\\n\\r\\nOnce activated, tenofovir acts with different mechanisms including the inhibition of viral polymerase, causing chain termination and the inhibition of viral synthesis.[L6241] To know more about the specific mechanism of action of the active form, please visit the drug entry of [tenofovir].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"XRWSZZJLZRKHHD-WVWIJVSJSA-N\", \"cofactor_smiles\": \"COC1=CN=C(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C2CC2)C2=C1C=CC(Cl)=C2\", \"cofactor_chem_comp_id\": \"2R9\", \"cofactor_name\": \"Asunaprevir\", \"cofactor_resource_id\": \"DB11586\", \"mechanism_of_action\": \"Asunaprevir is a highly active HCV NS3 protease inhibitor.[A32527] The genome of HCV has a positive polarity which allows it to be translated into a protein in the host cell without further transformation steps. However, the resultant protein needs to be divided by the enzyme NS3 protease into single proteins in order to be able to exert its enzymatic activity or structural role. Therefore, due to NS3 vital importance for viral replication, the inhibiting action of asunaprevir causes a robust antiviral activity.[A18434]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"MCPUZZJBAHRIPO-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCC1=NN(CCO)C(CC)=C1OC1=CC(=CC(=C1)C#N)C#N\", \"cofactor_chem_comp_id\": \"ZZE\", \"cofactor_name\": \"Lersivirine\", \"cofactor_resource_id\": \"DB11649\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"WCWSTNLSLKSJPK-LKFCYVNXSA-N\", \"cofactor_smiles\": \"[H][C@@]12CN3C=C(C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)C(O)=C3C(=O)N1[C@@H](C)CO2\", \"cofactor_name\": \"Cabotegravir\", \"cofactor_resource_id\": \"DB11751\", \"mechanism_of_action\": \"Cabotegravir binds to the active site of HIV integrase, preventing strand transfer of the viral genome into the host genome, and preventing replication of the virus.[L31188,L31193]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"ZVTDLPBHTSMEJZ-JSZLBQEHSA-N\", \"cofactor_smiles\": \"CC(C)(C)OC(=O)N[C@H]1CCCCC\\\\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1CC2=CC=CC(F)=C2C1)C(=O)NS(=O)(=O)C1CC1\", \"cofactor_name\": \"Danoprevir\", \"cofactor_resource_id\": \"DB11779\", \"mechanism_of_action\": \"Danoprevir is a NS3/4A protease inhibitor. The HCV NS3/4A protease is an attractive drug target because of its potential involvement in viral replication and suppressive effects on host response to viral infection. Inhibitors of the HCV protease, such as Danoprevir, represent a promising new class of drugs for HCV.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"LLGDPTDZOVKFDU-XUHJSTDZSA-N\", \"cofactor_smiles\": \"COC1=C(Br)C2=C(C=C1)C(O[C@@H]1C[C@H](N(C1)C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1C=C)C(O)=O)=CC(=N2)C1=CSC(NC(=O)C(C)C)=N1\", \"cofactor_chem_comp_id\": \"L4T\", \"cofactor_name\": \"Faldaprevir\", \"cofactor_resource_id\": \"DB11808\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"KUQWGLQLLVFLSM-ONAXAZCASA-N\", \"cofactor_smiles\": \"[H][C@]1(C[C@@H]2CN1C(=O)[C@@H](NC(=O)OCC(C)(C)CCCCC1=C3CN(CC3=CC=C1)C(=O)O2)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1CC)C(=O)NS(=O)(=O)C1CC1\", \"cofactor_chem_comp_id\": \"SU3\", \"cofactor_name\": \"Vaniprevir\", \"cofactor_resource_id\": \"DB11929\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"GCQYYIHYQMVWLT-HQNLTJAPSA-N\", \"cofactor_smiles\": \"OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N1C=C(\\\\C=C\\\\Br)C(=O)NC1=O\", \"cofactor_name\": \"Sorivudine\", \"cofactor_resource_id\": \"DB11998\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"MHFMTUBUVQZIRE-WINRQGAFSA-N\", \"cofactor_smiles\": \"COC1=CC2=NC(=CC(O[C@@H]3C[C@H](N(C3)C(=O)[C@@H](CC(=O)N3CCCCC3)C(C)(C)C)C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C3CC3)=C2C=C1)C1=CC=CC=C1\", \"cofactor_name\": \"Sovaprevir\", \"cofactor_resource_id\": \"DB12069\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"OSYWBJSVKUFFSU-SKDRFNHKSA-N\", \"cofactor_smiles\": \"CC1=CN([C@@H]2O[C@](CO)(C=C2)C#C)C(=O)NC1=O\", \"cofactor_name\": \"Censavudine\", \"cofactor_resource_id\": \"DB12074\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"WMBWREPUVVBILR-WIYYLYMNSA-N\", \"cofactor_smiles\": \"OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1\", \"cofactor_chem_comp_id\": \"KDH\", \"cofactor_name\": \"Epigallocatechin gallate\", \"cofactor_resource_id\": \"DB12116\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"ZILOOGIOHVCEKS-HZFUHODCSA-N\", \"cofactor_smiles\": \"CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=CC=C2C=CC=CC2=N1)C(=O)NC(C)(C)C\", \"cofactor_name\": \"Telinavir\", \"cofactor_resource_id\": \"DB12178\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"UCPOMLWZWRTIAA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCNC1=CC=CN=C1N1CCN(CC1)C(=O)C1=CC2=CC(OC)=CC=C2N1\", \"cofactor_name\": \"Atevirdine\", \"cofactor_resource_id\": \"DB12264\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"ZIAOVIPSKUPPQW-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CN1C(=O)NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F\", \"cofactor_chem_comp_id\": \"2KW\", \"cofactor_name\": \"Doravirine\", \"cofactor_resource_id\": \"DB12301\", \"mechanism_of_action\": \"Doravirine is a pyridinone non-nucleoside reverse transcriptase inhibitor of HIV-1.[L12729,A38823,A38824] Reverse transcriptase is the enzyme with which HIV generates complementary DNA (cDNA) to its RNA genome - this cDNA is then inserted into the host cell genome, where it can be transcribed into viral RNA for the purposes of replication.[A38825] Doravirine inhibits HIV-1 replication by non-competitively inhibiting HIV-1 reverse transcriptase.[L12729] Doravirine does not, however, inhibit the human cellular DNA polymerases \\u03b1, \\u00df, and mitochondrial DNA polymerase \\u03b3.[L12729]\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"HOGVTUZUJGHKPL-HTVVRFAVSA-N\", \"cofactor_smiles\": \"CN1N=C(N)C2=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C3=C2C1=NC=N3\", \"cofactor_chem_comp_id\": \"ZJB\", \"cofactor_name\": \"Triciribine\", \"cofactor_resource_id\": \"DB12405\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"IBHARWXWOCPXCR-WELGVCPWSA-N\", \"cofactor_smiles\": \"CCCCCCCCCCCCSCC(COP(O)(=O)OC[C@H]1O[C@H](C[C@@H]1N=[N+]=[N-])N1C=C(C)C(=O)NC1=O)OCCCCCCCCCC\", \"cofactor_name\": \"Fozivudine Tidoxil\", \"cofactor_resource_id\": \"DB12423\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"GWFOVSGRNGAGDL-FSDSQADBSA-N\", \"cofactor_smiles\": \"NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)[C@H]2CO)C(=O)N1\", \"cofactor_name\": \"Lobucavir\", \"cofactor_resource_id\": \"DB12531\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"RYMCFYKJDVMSIR-RNFRBKRXSA-N\", \"cofactor_smiles\": \"NC1=NC(=O)N(C=C1)[C@H]1CO[C@@H](CO)S1\", \"cofactor_name\": \"Apricitabine\", \"cofactor_resource_id\": \"DB12855\", \"mechanism_of_action\": \"Apricitabine is a type of medicine called a nucleoside reverse transcriptase inhibitor (NRTI). NRTIs work by blocking reverse transcriptase, a protein that HIV needs to make more copies of itself.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"RFGUWOCFYCYEDM-ZOMNBDOOSA-N\", \"cofactor_smiles\": \"COC1=C(Cl)C2=NC(=CC(O[C@@H]3C[C@@H]4N(C3)C(=O)[C@H](CCCCCCC[C@@H]3C[C@]3(NC4=O)P(O)(=O)CC3=C(F)C=CC=C3F)NC(=O)OC3CCCC3)=C2C=C1)C1=CSC(NC(C)C)=N1\", \"cofactor_name\": \"GS-9256\", \"cofactor_resource_id\": \"DB12876\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"WKVDSZYIGHLONN-RRKCRQDMSA-N\", \"cofactor_smiles\": \"OC[C@H]1O[C@H](C[C@@H]1F)N1C=C(Cl)C(=O)NC1=O\", \"cofactor_name\": \"Raluridine\", \"cofactor_resource_id\": \"DB12894\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"FZBAOOQVQXATRL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"ClC1=CC(OC2=C3C=NN(CC4=NNC5=NC=CC=C45)C3=CC=C2Cl)=CC(=C1)C#N\", \"cofactor_name\": \"MK-6186\", \"cofactor_resource_id\": \"DB12999\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"PEJLNXHANOHNSU-UHFFFAOYSA-N\", \"cofactor_smiles\": \"[Cl-].NC1=CC2=NC3=C(C=CC(N)=C3)C=C2C=C1.C[N+]1=C2C=C(N)C=CC2=CC2=C1C=C(N)C=C2\", \"cofactor_name\": \"Acriflavine\", \"cofactor_resource_id\": \"DB13373\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"SGOIRFVFHAKUTI-ZCFIWIBFSA-N\", \"cofactor_smiles\": \"C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O\", \"cofactor_chem_comp_id\": \"TFO\", \"cofactor_name\": \"Tenofovir\", \"cofactor_resource_id\": \"DB14126\", \"mechanism_of_action\": \"Once tenofovir is activated by a bi-phosphorylation it acts as an antiviral acyclic nucleoside phosphonate. It is a potent inhibitor of the viral reverse transcriptase with an inhibitory constant of approximately 0.022 micromolar.[A18473] \\r\\n\\r\\nOnce activated, tenofovir acts with different mechanisms including the inhibition of viral polymerase causing chain termination and the inhibition of viral synthesis.[L6241] All these activities are attained by its competition with deoxyadenosine 5'-triphosphate in the generation of new viral DNA. Once tenofovir is incorporated in the chain, it induces a chain termination which in order inhibits viral replication.[A178330] The safety of tenofovir relies on its low affinity towards the cellular DNA polymerase including the mitochondrial DNA polymerase gamma.[T324]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"SCTJKHUUZLXJIP-RUZDIDTESA-N\", \"cofactor_smiles\": \"CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](C)CN1C=NC2=C1N=CN=C2N\", \"cofactor_name\": \"Tenofovir exalidex\", \"cofactor_resource_id\": \"DB14925\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"JQUNFHFWXCXPRK-AMMMHQJVSA-N\", \"cofactor_smiles\": \"[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C2N=C(NC3CCN(CC3)C3CCCC3)SC2=C1\", \"cofactor_chem_comp_id\": \"74T\", \"cofactor_name\": \"TMC-310911\", \"cofactor_resource_id\": \"DB15623\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"HFHDGHOGHWXXDT-ZSOIEALJSA-N\", \"cofactor_smiles\": \"O\\\\C(=C/C(=O)C1=CC=C(CC2=CC=C(F)C=C2)O1)C1=NNC=N1\", \"cofactor_name\": \"GW810781\", \"cofactor_resource_id\": \"DB16032\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"ZSNNBSPEFVIUDS-SHYZEUOFSA-N\", \"cofactor_smiles\": \"OC[C@H]1O[C@H](C[C@@H]1N=[N+]=[N-])N1C=CC(=O)NC1=O\", \"cofactor_name\": \"Navuridine\", \"cofactor_resource_id\": \"DB17759\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03366\"}, {\"cofactor_in_ch_ikey\": \"HLBCBFBFJWGTFR-QKXNMUHCSA-N\", \"cofactor_smiles\": \"[H]N([C@@H]1CO[C@H](CO)C1)C(=O)[C@H](OCC1=CC=CC=C1)[C@H](O)[C@@H](O)[C@@H](OCC1=CC=CC=C1)C(=O)N([H])[C@@H]1[C@H](O)CC2=CC=CC=C12\", \"cofactor_chem_comp_id\": \"568\", \"cofactor_name\": \"N,N-[2,5-O-Dibenzyl-glucaryl]-DI-[1-amino-indan-2-OL]\", \"cofactor_resource_id\": \"DB01887\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12499\"}, {\"cofactor_in_ch_ikey\": \"PMBZSBGCSQGJAQ-GRKNLSHJSA-N\", \"cofactor_smiles\": \"[H][C@@]1(O)CN(CC2=CC=CC=C2)N(CC2=CC(OC)=C(O)C=C2)C(=O)N(CC2=CC(OC)=C(O)C=C2)[C@]1([H])CC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"A88\", \"cofactor_name\": \"A-98881\", \"cofactor_resource_id\": \"DB02804\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12499\"}, {\"cofactor_in_ch_ikey\": \"DDOOHEYBNHOFCV-ORYMTKCHSA-N\", \"cofactor_smiles\": \"[H]N([H])C(=O)CC[C@H](N([H])C(=O)[C@H](CC(=O)[C@H](CC1=CC=CC=C1)N([H])C(=O)OC(C)(C)C)CC1=CC=CC=C1)C(=O)N([H])[C@@H](CC1=CC=CC=C1)C(=O)N([H])[H]\", \"cofactor_chem_comp_id\": \"Q50\", \"cofactor_name\": \"Tert-butyl N-[(2S,5R)-6-[[(2S)-5-amino-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-benzyl-3,6-dioxo-1-phenylhexan-2-yl]carbamate\", \"cofactor_resource_id\": \"DB04353\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12499\"}, {\"cofactor_in_ch_ikey\": \"FELUFXCUIYHAPB-INIZCTEOSA-N\", \"cofactor_smiles\": \"CC(=O)C1=C(N[C@H](C(N)=O)C2=C(Br)C=CC=C2Br)C=C(C)C=C1\", \"cofactor_chem_comp_id\": \"AAA\", \"cofactor_name\": \"R-95845\", \"cofactor_resource_id\": \"DB07327\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03367\"}, {\"cofactor_in_ch_ikey\": \"DGURGFSAQIBQCO-FGZHOGPDSA-N\", \"cofactor_smiles\": \"[H][C@]1(COCC2=CC=CC=C2)CNC[C@]1([H])CN(CC(C)C)S(=O)(=O)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"BZN\", \"cofactor_name\": \"N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide\", \"cofactor_resource_id\": \"DB07505\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03367\"}, {\"cofactor_in_ch_ikey\": \"JXJYTERRLRAUSF-JKSUJKDBSA-N\", \"cofactor_smiles\": \"[H][C@@](CC1=CC=CC=C1)(NC(=O)OCC1=CC=CC=C1)[C@@]([H])(O)C(O)=O\", \"cofactor_chem_comp_id\": \"KI2\", \"cofactor_name\": \"3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID\", \"cofactor_resource_id\": \"DB08041\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03367\"}, {\"cofactor_in_ch_ikey\": \"SMZUMFSKQVVOOV-WPRPVWTQSA-N\", \"cofactor_smiles\": \"[H][C@@](C)(O)[C@@]([H])(N)CC1=CC=CC=C1\", \"cofactor_name\": \"3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL\", \"cofactor_resource_id\": \"DB08428\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03367\"}, {\"cofactor_in_ch_ikey\": \"KGDWLSFLMSFPSU-INIZCTEOSA-N\", \"cofactor_smiles\": \"[H][C@](C(C)C)(C1=CC=C(Br)C=C1)C1=C(O)C2=C(OC1=O)C=CC=C2\", \"cofactor_chem_comp_id\": \"U01\", \"cofactor_name\": \"3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE\", \"cofactor_resource_id\": \"DB08662\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03367\"}, {\"cofactor_in_ch_ikey\": \"HOUHLOFMBSYNBO-KKUQBAQOSA-N\", \"cofactor_smiles\": \"CC(C)CCN(C[C@@H](O)[C@@H]1CC2=CC=C(OCCCC(=O)N[C@@H](CC(N)=O)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"HBH\", \"cofactor_name\": \"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2\", \"cofactor_resource_id\": \"DB02411\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03369\"}, {\"cofactor_in_ch_ikey\": \"CUFQBQOBLVLKRF-RZDMPUFOSA-N\", \"cofactor_smiles\": \"CC1=CC=CC=C1CNC(=O)[C@H]1N(CSC1(C)C)C(=O)[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CC=CC(O)=C1C\", \"cofactor_chem_comp_id\": \"JE2\", \"cofactor_name\": \"JE-2147\", \"cofactor_resource_id\": \"DB02668\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03369\"}, {\"cofactor_in_ch_ikey\": \"WRUVOSYKHXGAQN-GKRYNVPLSA-N\", \"cofactor_smiles\": \"CC(C)CCN(C[C@@H](O)[C@@H]1CC2=CC=C(OCCCC(=O)N[C@@H](C(C)C)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"HBB\", \"cofactor_name\": \"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3\", \"cofactor_resource_id\": \"DB03768\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03369\"}, {\"cofactor_in_ch_ikey\": \"QWCKQJZIFLGMSD-GSVOUGTGSA-N\", \"cofactor_smiles\": \"CC[C@@H](N)C(O)=O\", \"cofactor_chem_comp_id\": \"DBB\", \"cofactor_name\": \"Alpha-Aminobutyric Acid\", \"cofactor_resource_id\": \"DB04454\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03369\"}, {\"cofactor_in_ch_ikey\": \"NIDRYBLTWYFCFV-FMTVUPSXSA-N\", \"cofactor_smiles\": \"CCCC1=CC(=O)OC2=C1C1=C(C=CC(C)(C)O1)C1=C2[C@@H](O)[C@H](C)[C@@H](C)O1\", \"cofactor_name\": \"Calanolide A\", \"cofactor_resource_id\": \"DB04886\", \"mechanism_of_action\": \"Viral life-cycle studies indicate that calanolide A acts early in the infection process, similar to the known HIV reverse transcriptase (RT) inhibitor 2', 3'-dideoxycytidine. In enzyme inhibition assays, calanolide A potently and selectively inhibits recombinant HIV type 1 RT but not cellular DNA polymerases or HIV type 2 RT within the concentration range tested.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [11366704, 12501127], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03369\"}, {\"cofactor_name\": \"RDEA806\", \"cofactor_resource_id\": \"DB05228\", \"mechanism_of_action\": \"RDEA806 binds directly to viral reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by disrupting the enzyme's catalytic site.\", \"neighbor_flag\": \"N\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03369\"}, {\"cofactor_in_ch_ikey\": \"SZWIAFVYPPMZML-YNEHKIRRSA-N\", \"cofactor_smiles\": \"CCCCCCCOC(=O)NC1=NC(=O)N(CN1)[C@H]1C[C@H](O)[C@@H](CO)O1\", \"cofactor_name\": \"KP-1461\", \"cofactor_resource_id\": \"DB05644\", \"mechanism_of_action\": \"KP-1461 is the oral prodrug of KP-1212. KP-1461 is also known as SN1212. KP-1461 introduces continual mutations into HIV during viral replication by reverse transcriptase (RT). These mutations decrease virus viability and are eventually lethal. This mechanism, selective viral mutagenesis or lethal mutagenesis, is novel to the nucleoside analogue class. Unlike approved nucleoside RT inhibitors (NRTIs) that contain a modified sugar and unmodified base, KP-1461 has a modified base that allows multiple base pairing. Because KP-1461 pairs with multiple bases, it is able to target all viral proteins rather than a single protein. KP-1461, after conversion to KP-1212, is metabolized to a triphosphate and incorporated into the HIV-1 genome by RT. The drug is similarly incorporated into human mitochondrial DNA polymerase. The active substance KP-1212 has been shown to inhibit antiviral activity in tissues after just one pass; accumulation has been shown to eradicate the virus entirely. HIV strains treated with KP-1212 also showed increased sensitivity to zidovudine.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15890415], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03369\"}, {\"cofactor_in_ch_ikey\": \"RRAAROKJUVKWAF-RDJZCZTQSA-N\", \"cofactor_smiles\": \"[H][C@]1(CC2=CC=C(OCCCCC(=O)N[C@@]([H])(C(C)C)C(=O)N1)C=C2)C(O)=O\", \"cofactor_chem_comp_id\": \"DRS\", \"cofactor_name\": \"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid\", \"cofactor_resource_id\": \"DB07679\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03369\"}, {\"cofactor_in_ch_ikey\": \"IFTWVTAUEXLCHB-QMMMGPOBSA-N\", \"cofactor_smiles\": \"[H][C@](N)(CC1=CC=CC=C1)C(O)O\", \"cofactor_chem_comp_id\": \"HPH\", \"cofactor_name\": \"(2S)-2-amino-3-phenylpropane-1,1-diol\", \"cofactor_resource_id\": \"DB07910\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03369\"}, {\"cofactor_in_ch_ikey\": \"KVDKNVPAAQKHKD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"OC1(CCN(CCCC2(SCCS2)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1\", \"cofactor_chem_comp_id\": \"THK\", \"cofactor_name\": \"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL\", \"cofactor_resource_id\": \"DB08622\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P03369\"}, {\"cofactor_in_ch_ikey\": \"KYRSNWPSSXSNEP-ZRTHHSRSSA-N\", \"cofactor_smiles\": \"NC1=CC(CN2[C@H](CC3=CC=CC=C3)[C@H](O)[C@@H](O)[C@@H](CC3=CC=CC=C3)N(CC3=CC(N)=CC=C3)C2=O)=CC=C1\", \"cofactor_chem_comp_id\": \"DMQ\", \"cofactor_name\": \"Mozenavir\", \"cofactor_resource_id\": \"DB02102\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"JDALSSGOBMTZEP-NWJWHWDBSA-N\", \"cofactor_smiles\": \"[H][C@]1(CC2=CC=CC=C2)N(CC2=CC(=CC=C2)C(=O)NC2=NC=CS2)C(=O)N(CC2=CC(=CC=C2)C(=O)NC2=NC=CS2)[C@]([H])(CC2=CC=CC=C2)[C@]([H])(O)[C@@]1([H])O\", \"cofactor_chem_comp_id\": \"XV6\", \"cofactor_name\": \"XV638\", \"cofactor_resource_id\": \"DB02702\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"UWSVAGUSMAEUKO-QHQGJXSCSA-N\", \"cofactor_smiles\": \"O[C@@H]1[C@@H](O)[C@@H](CC2=CC=CC=C2)N(CC2=CC=CC(=C2)C(=O)NC2=NC3=C(N2)C=CC=C3)C(=O)N(CC2=CC(=CC=C2)C(=O)NC2=NC3=C(N2)C=CC=C3)[C@@H]1CC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"146\", \"cofactor_name\": \"SD146\", \"cofactor_resource_id\": \"DB02729\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"HFLCERPZYCWLSZ-VKONIRKNSA-N\", \"cofactor_smiles\": \"O[C@@H]1[C@@H](O)[C@@H](CC2=CC=CC=C2)N(CC2=CC(=CC=C2)C(=O)NC2=NC=CS2)C(=O)N(CC2CC2)[C@@H]1CC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"846\", \"cofactor_name\": \"INHIBITOR Q8467 OF DUPONT MERCK\", \"cofactor_resource_id\": \"DB04609\", \"neighbor_flag\": \"N\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_name\": \"VGV-1\", \"cofactor_resource_id\": \"DB05328\", \"mechanism_of_action\": \"VGV-1 is appears to work through a mechanism that involves the use of the immune system, rather than attacking the virus itself. VGV-1 also has minimal side effects and is projected to be cost-effective. Because a treatment cycle with VGV-1 consists of just 16 injections, it is substantially less expensive than ART or HAART which require that drugs be taken once a day, or even more frequently. \", \"neighbor_flag\": \"N\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"PYGWGZALEOIKDF-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=CC(=CC(C)=C1OC1=C(Br)C(N)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N\", \"cofactor_chem_comp_id\": \"65B\", \"cofactor_name\": \"Etravirine\", \"cofactor_resource_id\": \"DB06414\", \"mechanism_of_action\": \"Etravirine exerts its effects via direct inhibition of the reverse transcriptase enzyme of human immunodeficiency virus type 1 (HIV-1).  It directly binds reverse transcriptase and consequently blocks DNA-dependent and RNA-dependent polymerase activity. Etravirine does not inhibit human DNA polymerase alpha, beta or gamma. \\r\\n\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"YJEJKUQEXFSVCJ-WRFMNRASSA-N\", \"cofactor_smiles\": \"[H][C@]12[C@@H](CC[C@@]1(CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O)C(C)=C\", \"cofactor_chem_comp_id\": \"2I4\", \"cofactor_name\": \"Bevirimat\", \"cofactor_resource_id\": \"DB06581\", \"mechanism_of_action\": \"Bevirimat has a novel mechanism of action, specifically inhibiting cleavage of spacer peptide 1 (SP1) from the C-terminus of capsid which results in defective core condensation. Specifically, bevirimat binds at the SP1/capsid junction, preventing cleavage by HIV protease.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [18043758], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"IWJSQELMWLOYSO-LWSSLDFYSA-N\", \"cofactor_smiles\": \"[H][C@]1(CC2=CC=CC=C2)N(CC=C)C(=O)N(CC=C)[C@]([H])(CC2=CC=CC=C2)[C@]([H])(O)[C@@]1([H])O\", \"cofactor_chem_comp_id\": \"216\", \"cofactor_name\": \"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE\", \"cofactor_resource_id\": \"DB06910\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"JKXLRLDPSLZEDD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOCN1C(=O)NC(=O)C(C(C)C)=C1SC1CCCCC1\", \"cofactor_chem_comp_id\": \"612\", \"cofactor_name\": \"6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione\", \"cofactor_resource_id\": \"DB07184\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"CJPLEFFCVDQQFZ-INIZCTEOSA-N\", \"cofactor_smiles\": \"[H][C@@](NC1=C(C=CC(C)=C1)C(C)=O)(C(N)=O)C1=C(Cl)C=CC=C1Cl\", \"cofactor_chem_comp_id\": \"AAP\", \"cofactor_name\": \"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE\", \"cofactor_resource_id\": \"DB07332\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"FQVDJZWFSZSGGA-QGZVFWFLSA-N\", \"cofactor_smiles\": \"CC1=CC(=CC=C1)[C@]12SCCN1C(=O)C1=CC=CC=C21\", \"cofactor_chem_comp_id\": \"BM1\", \"cofactor_name\": \"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE\", \"cofactor_resource_id\": \"DB07472\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"JYIHODAXBBPFQF-MAUKXSAKSA-N\", \"cofactor_smiles\": \"COC(=O)[C@@H]1CS[C@]2(N1C(=O)C1=CC=CC=C21)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"BM5\", \"cofactor_name\": \"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER\", \"cofactor_resource_id\": \"DB07473\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"PQSCCWFMTRVFDA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOC1=C(F)C(CCNC(=S)NC2=NC=C(C=C2)C#N)=NC=C1\", \"cofactor_chem_comp_id\": \"FPT\", \"cofactor_name\": \"N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA\", \"cofactor_resource_id\": \"DB07781\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"VEBKSFPYWMOUBR-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOC1=C(F)C(CCNC(=S)NC2=NC=C(Cl)C=C2)=NC=C1\", \"cofactor_chem_comp_id\": \"FTC\", \"cofactor_name\": \"N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA\", \"cofactor_resource_id\": \"DB07797\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"NVGVZWUORYLPAL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOCN1C(=O)NC(=O)C(C(C)C)=C1CC1=CC(C)=CC(C)=C1\", \"cofactor_chem_comp_id\": \"GCA\", \"cofactor_name\": \"6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL\", \"cofactor_resource_id\": \"DB07820\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"DTGVSZSMDOMAEB-UHFFFAOYSA-N\", \"cofactor_smiles\": \"ClC1=CC=C(OCC(=O)NC2=CC=CC=C2)C(=C1)C(=O)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"GFA\", \"cofactor_name\": \"2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide\", \"cofactor_resource_id\": \"DB07826\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"YVJFHKQYMKKIHK-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)C1=C(OC#CC2CC2)C2=CC(F)=CC=C2NC1=O\", \"cofactor_chem_comp_id\": \"GWB\", \"cofactor_name\": \"4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE\", \"cofactor_resource_id\": \"DB07864\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"BNZHKKGOSYAQSW-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC1=C(OC2CCCCC2)C2=CC(Cl)=CC=C2NC1=O\", \"cofactor_chem_comp_id\": \"H12\", \"cofactor_name\": \"6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE\", \"cofactor_resource_id\": \"DB07867\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"CLKFNGKDJYMUPK-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC1=C(SC2CCCCC2)C2=CC(Cl)=CC=C2NC1=O\", \"cofactor_chem_comp_id\": \"H16\", \"cofactor_name\": \"6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE\", \"cofactor_resource_id\": \"DB07868\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"QRBUGQMJMFAHKS-HSZRJFAPSA-N\", \"cofactor_smiles\": \"[H]N1C(=O)C(CCC)=C(C2=C1C=CC(Cl)=C2)[S@](=O)C1CCCCC1\", \"cofactor_chem_comp_id\": \"H18\", \"cofactor_name\": \"6-Chloro-4-[(R)-cyclohexylsulfinyl]-3-propyl-2(1H)-quinolinone\", \"cofactor_resource_id\": \"DB07869\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"OQCFORGSZJSAEL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)C1=C(OC2CCCCC2)C2=CC(Cl)=CC=C2NC1=O\", \"cofactor_chem_comp_id\": \"H20\", \"cofactor_name\": \"6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE\", \"cofactor_resource_id\": \"DB07871\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"KELNNWMENBUHNS-NSHDSACASA-N\", \"cofactor_smiles\": \"CC[C@@H]1N(C(=O)OC(C)C)C2=C(NC1=O)C=CC(F)=C2\", \"cofactor_chem_comp_id\": \"HBQ\", \"cofactor_name\": \"Opaviraline\", \"cofactor_resource_id\": \"DB07884\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"HDMHBHNRWDNNCD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C(SC2=CC=CC=C2)N(COCCO)C(=O)NC1=O\", \"cofactor_chem_comp_id\": \"HEF\", \"cofactor_name\": \"1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE\", \"cofactor_resource_id\": \"DB07892\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"IFTWVTAUEXLCHB-QMMMGPOBSA-N\", \"cofactor_smiles\": \"[H][C@](N)(CC1=CC=CC=C1)C(O)O\", \"cofactor_chem_comp_id\": \"HPH\", \"cofactor_name\": \"(2S)-2-amino-3-phenylpropane-1,1-diol\", \"cofactor_resource_id\": \"DB07910\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"WHCLIFOVZDANCU-UHFFFAOYSA-N\", \"cofactor_smiles\": \"ClC1=CC(=CC(OC2=C(Cl)C=CC(OCC3=NNC4=C3C=CC=C4)=C2)=C1)C#N\", \"cofactor_chem_comp_id\": \"M22\", \"cofactor_name\": \"3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile\", \"cofactor_resource_id\": \"DB08154\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"MLILORUFDVLTSP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOCN1C(=O)NC(=O)C(C(C)C)=C1CC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"MKC\", \"cofactor_name\": \"Emivirine\", \"cofactor_resource_id\": \"DB08188\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"FEPUPYVRZUWCQB-UHFFFAOYSA-N\", \"cofactor_smiles\": \"NC(=O)C1=C(C2=CC(Br)=CC=C2N1)S(=O)(=O)N1CCCC1\", \"cofactor_chem_comp_id\": \"MRX\", \"cofactor_name\": \"5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide\", \"cofactor_resource_id\": \"DB08211\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"GHRYSOFWKRRLMI-UHFFFAOYSA-N\", \"cofactor_smiles\": \"OC(=O)COC1=CC=CC2=CC=CC=C12\", \"cofactor_chem_comp_id\": \"NOA\", \"cofactor_name\": \"1-Naphthoxyacetic acid\", \"cofactor_resource_id\": \"DB08286\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"QOVMZMFNTIUFLU-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOC1=C(F)C(CCNC(=S)NC2=CC=C(C)C=N2)=NC=C1\", \"cofactor_chem_comp_id\": \"PC0\", \"cofactor_name\": \"1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA\", \"cofactor_resource_id\": \"DB08372\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"NOVPOXGMADEKPP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"FC1=C(CC2=NNC(=O)C=C2)C=CC(Cl)=C1OC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"PDZ\", \"cofactor_name\": \"6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one\", \"cofactor_resource_id\": \"DB08379\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"YYGZQXRLQMFHDH-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=CC(=CC(OC2=C(Br)C=C(CC3=NNC4=NN=CC=C34)C=C2)=C1)C#N\", \"cofactor_chem_comp_id\": \"PZ2\", \"cofactor_name\": \"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile\", \"cofactor_resource_id\": \"DB08444\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"OHQMEDBYNUAVNE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"FC1=C(CC2=NNC3=NN=CC=C23)C=CC(Br)=C1OC1=CC(=CC(Cl)=C1)C#N\", \"cofactor_chem_comp_id\": \"PZL\", \"cofactor_name\": \"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile\", \"cofactor_resource_id\": \"DB08446\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"SVMHTBVIPYVDIL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"ClC1=CC(OC2=C(Cl)C=CC(OCC3=NNC4=NC=CC=C34)=C2)=CC(=C1)C#N\", \"cofactor_chem_comp_id\": \"R8D\", \"cofactor_name\": \"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile\", \"cofactor_resource_id\": \"DB08459\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"KXDIHAQCVNNLIB-UHFFFAOYSA-N\", \"cofactor_smiles\": \"NC1=CC=C2C(COC3=CC=C(Cl)C(OC4=CC(=CC(Cl)=C4)C#N)=C3)=NNC2=N1\", \"cofactor_chem_comp_id\": \"R8E\", \"cofactor_name\": \"MK-4965\", \"cofactor_resource_id\": \"DB08460\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"AWAKIULNKVOBKE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=CC2=C(C=C1)N(CCC2)C(=O)SCC(=O)NC1=C(Cl)C=C(C=C1)S(N)(=O)=O\", \"cofactor_chem_comp_id\": \"RT3\", \"cofactor_name\": \"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate\", \"cofactor_resource_id\": \"DB08494\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"YQXCVAGCMNFUMQ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)C1=C(SC2=CC(Cl)=CC(Cl)=C2)N(CC2=CC=NC=C2)C(COC(N)=O)=N1\", \"cofactor_chem_comp_id\": \"S11\", \"cofactor_name\": \"Capravirine\", \"cofactor_resource_id\": \"DB08502\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 15205383], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"SWGDXLAZBZDUBR-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=CC(=CC(C)=C1)S(=O)(=O)C1=C(C#N)C(N)=CC=C1\", \"cofactor_chem_comp_id\": \"SBN\", \"cofactor_name\": \"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE\", \"cofactor_resource_id\": \"DB08528\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"RCSLUNOLLUVOOG-NSHDSACASA-N\", \"cofactor_smiles\": \"C[C@H]1CN2C(=S)NC3=CC(Cl)=CC(CN1CC=C(C)C)=C23\", \"cofactor_chem_comp_id\": \"TB9\", \"cofactor_name\": \"R-82913\", \"cofactor_resource_id\": \"DB08598\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"KSAAUHMSLCPIEX-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)C1=C(CC2=CC=CC=C2)N(COCC2=CC=CC=C2)C(=O)NC1=O\", \"cofactor_chem_comp_id\": \"TNK\", \"cofactor_name\": \"6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL\", \"cofactor_resource_id\": \"DB08634\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"YCFJZPGDTZVVSM-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCN1C2=CC(=CC=C2N(C)C(=O)C2=C1N=CC=C2)[N+]([O-])=O\", \"cofactor_chem_comp_id\": \"U05\", \"cofactor_name\": \"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE\", \"cofactor_resource_id\": \"DB08665\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"PLGIIOKXCKDKEU-VXLYETTFSA-N\", \"cofactor_smiles\": \"CC1=C(C=CO1)C(=S)NC1=CC(\\\\C=N\\\\OC(C)(C)C)=C(Cl)C=C1\", \"cofactor_chem_comp_id\": \"UC2\", \"cofactor_name\": \"N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid\", \"cofactor_resource_id\": \"DB08680\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"AXTNFJKQZPETJA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)OC(=S)NC1=CC(C(=O)OC(C)C)=C(Cl)C=C1\", \"cofactor_chem_comp_id\": \"UC3\", \"cofactor_name\": \"1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE\", \"cofactor_resource_id\": \"DB08681\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"FMQGUMRNTBJHEA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)OC(=O)C1=C(Cl)C=CC(NC(=O)C2=C(C)OCCS2)=C1\", \"cofactor_chem_comp_id\": \"UC4\", \"cofactor_name\": \"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE\", \"cofactor_resource_id\": \"DB08682\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"QWLNINWUBHHOLU-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CN1C(=O)C(C(=O)NCCO)=C(O)C2=NC=C(CC3=CC=C(F)C=C3)C=C12\", \"cofactor_name\": \"GSK-364735\", \"cofactor_resource_id\": \"DB13119\", \"neighbor_flag\": \"N\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"BRYXUCLEHAUSDY-WEWMWRJBSA-N\", \"cofactor_smiles\": \"[H][C@]12C[C@@]1([H])C(F)(F)C1=C2C(=NN1CC(=O)N[C@@H](CC1=CC(F)=CC(F)=C1)C1=NC(=CC=C1C1=CC=C(Cl)C2=C1N(CC(F)(F)F)N=C2NS(C)(=O)=O)C#CC(C)(C)S(C)(=O)=O)C(F)(F)F\", \"cofactor_chem_comp_id\": \"QNG\", \"cofactor_name\": \"Lenacapavir\", \"cofactor_resource_id\": \"DB15673\", \"mechanism_of_action\": \"HIV-1 co-opts various host factors during its replicative cycle, including during host cell entry, nuclear integration, replication, and virion assembly. Following the initial fusion with the host cell membrane, the viral capsid is released into the host cell cytoplasm. The capsid comprises approximately 250 hexamers and exactly 12 pentamers, each composed of monomeric capsid proteins (CA). Each CA monomer has an N-terminal and C-terminal domain (NTD/CTD) and offers an interaction surface for host cell machinery. Several important protein-protein interaction interfaces occur between CA monomers in the assembled multimers; the binding constants of these proteins are substantially lower for assembled multimers than individual capsid monomers.[A244170]\\r\\n\\r\\nTo facilitate HIV-1 genomic integration, the capsid must cross the nuclear envelope, for which it utilizes the nuclear pore complex (NPC). Two host proteins shown to be essential for capsid nuclear entry that directly bind to the capsid are cleavage and polyadenylation specificity factor subunit 6 (CPSF6) and nucleoporin 153 (Nup153, an NPC protein present on the nucleoplasmic face of the complex).[A244170] Both proteins bind the same phenylalanine-glycine binding pocket between the NTD and CTD of neighbouring CA monomers in multimeric CA assemblies.[A244170, A244175, A244180, A244185]\\r\\n\\r\\nLenacapavir contains a difluorobenzyl ring that occupies the same binding pocket as CPSF6/Nup153, overlapping with the benzyl group of F321 in CPSF6 and F1417 in Nup153 in the overlayed structures.[A244170, A244175, A244180, A244185] Crystal structures of lenacapavir bound to CA hexamers reveal that six lenacapavir molecules bind to each hexamer, establishing extensive hydrophobic interactions, two cation-\\u03c0 interactions, and seven hydrogen bonds, contacting ~2,000 \\u212b<sup>2</sup> of buried protein surface area.[A244175, A244180] Strong binding of lenacapavir, therefore competitively interrupts capsid interactions with CPSF6 and Nup153. _In vitro_ HIV-1 replication inhibition experiments in a variety of cell lines show EC<sub>50</sub> values of ~12-314 pM, with greater efficacy against early steps over later steps.[A244175, A244180] At very low concentrations (0.5 nM), lenacapavir inhibits viral nuclear entry, while at higher concentrations (5-50 nM), it additionally inhibits viral DNA synthesis and reverse transcription.[A244180] As CPSF6 and Nup153 are essential for nuclear entry, it is likely that lenacapavir binding inhibits these interactions and blocks capsid nuclear entry.\\r\\n\\r\\nLenacapavir may have additional effects beyond blocking interactions with host cell factors. Lenacapavir increases the rate and extent of CA assembly, dramatically extends the lifetime of assembled CA structures, even at high salt concentrations, and alters assembled capsid morphology.[A244175, A244180] The stabilizing concentration is ~1:1, closely mimicking the observed binding stoichiometry to isolated CA hexamers. Further analysis suggests that lenacapavir binding alters intra- and inter-hexamer interactions, altering the structure and stability of the resulting assemblies.[A244180]\\r\\n\\r\\nSerial passage of HIV-1 in increasing concentrations of lenacapavir resulted in the appearance of major resistance mutations Q67H and N74D, which remain sensitive to other antiretroviral drugs. Extended passage resulted in the additional mutations L56I, M66I, K70N, N74S, and T107N. All identified resistance mutations map to the lenacapavir binding site, and all but the Q67H variant show reduced replication capacity _in vitro_.[A244175] Additional studies have shown no lenacapavir resistance in variants associated with resistance to other antiretrovirals or naturally occurring polymorphisms, suggesting a very low potential for cross-resistance in combination therapy.[A244190]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [33807824, 32612233, 33060363, 31312185], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04585\"}, {\"cofactor_in_ch_ikey\": \"IFTWVTAUEXLCHB-QMMMGPOBSA-N\", \"cofactor_smiles\": \"[H][C@](N)(CC1=CC=CC=C1)C(O)O\", \"cofactor_chem_comp_id\": \"HPH\", \"cofactor_name\": \"(2S)-2-amino-3-phenylpropane-1,1-diol\", \"cofactor_resource_id\": \"DB07910\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04587\"}, {\"cofactor_in_ch_ikey\": \"PDCSQCHNOPNJMK-UHFFFAOYSA-N\", \"cofactor_smiles\": \"NCCOC(=O)CC1=C2C=CC=CC2=CC=C1\", \"cofactor_chem_comp_id\": \"LLG\", \"cofactor_name\": \"2-aminoethyl naphthalen-1-ylacetate\", \"cofactor_resource_id\": \"DB08115\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P04587\"}, {\"cofactor_in_ch_ikey\": \"AYGYLFIDAXGERM-UHFFFAOYSA-O\", \"cofactor_smiles\": \"OC1=CC=C(C=C1O)[As+](C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"TTO\", \"cofactor_name\": \"(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium\", \"cofactor_resource_id\": \"DB02086\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"OGGXGZAMXPVRFZ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"C[As](C)(O)=O\", \"cofactor_chem_comp_id\": \"CAD\", \"cofactor_name\": \"Cacodylic acid\", \"cofactor_resource_id\": \"DB02994\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"LKVXXMOMTRBUQI-WCIBSUBMSA-N\", \"cofactor_smiles\": \"O\\\\C(=C/C(=O)C1=CNC2=CC=C(Cl)C=C12)C1=NN=NN1\", \"cofactor_chem_comp_id\": \"100\", \"cofactor_name\": \"(2Z)-1-(5-Chloro-1H-indol-3-yl)-3-hydroxy-3-(1H-tetrazol-5-yl)-2-propen-1-one\", \"cofactor_resource_id\": \"DB03118\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"HBKZDQYWGRUTJX-BYPYZUCNSA-N\", \"cofactor_smiles\": \"[H][C@](N)(CS[As](C)(C)=O)C(O)=O\", \"cofactor_chem_comp_id\": \"CAF\", \"cofactor_name\": \"Cystein-S-Yl Cacodylate\", \"cofactor_resource_id\": \"DB03676\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"UKLXSOVDMSQHMM-BYPYZUCNSA-N\", \"cofactor_smiles\": \"[H][C@](N)(CS[As](C)C)C(O)=O\", \"cofactor_chem_comp_id\": \"CAS\", \"cofactor_name\": \"S-(Dimethylarsenic)Cysteine\", \"cofactor_resource_id\": \"DB03963\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"GZBLEJZADHZBBZ-HOTGVXAUSA-N\", \"cofactor_smiles\": \"[H][C@](N)(CC1=CC=CC=C1)C(O)[C@@]([H])(N)CC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"COR\", \"cofactor_name\": \"2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE\", \"cofactor_resource_id\": \"DB07575\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"WEYNBWVKOYCCQT-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CN(C)CC1=CC=C(CSCCNC(=O)NC2=CC=C(C)C(Cl)=C2)O1\", \"cofactor_chem_comp_id\": \"JPR\", \"cofactor_name\": \"CAP-1\", \"cofactor_resource_id\": \"DB08027\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"TUNFSRHWOTWDNC-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCCCCCCCCCCCC(O)=O\", \"cofactor_chem_comp_id\": \"MYR\", \"cofactor_name\": \"Myristic acid\", \"cofactor_resource_id\": \"DB08231\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}], \"rcsb_id\": \"4ZHR_1\"}, \"2\": {\"entity_poly\": {\"nstd_linkage\": \"no\", \"nstd_monomer\": \"no\", \"pdbx_seq_one_letter_code\": \"MGHHHHHHMVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFITPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQ\", \"pdbx_seq_one_letter_code_can\": \"MGHHHHHHMVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFITPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQ\", \"pdbx_strand_id\": \"B\", \"rcsb_artifact_monomer_count\": 0, \"rcsb_conflict_count\": 0, \"rcsb_deletion_count\": 0, \"rcsb_entity_polymer_type\": \"Protein\", \"rcsb_insertion_count\": 0, \"rcsb_mutation_count\": 0, \"rcsb_non_std_monomer_count\": 0, \"rcsb_sample_sequence_length\": 438, \"type\": \"polypeptide(L)\"}, \"entity_src_gen\": [{\"gene_src_common_name\": \"HIV-1\", \"pdbx_alt_source_flag\": \"sample\", \"pdbx_beg_seq_num\": 1, \"pdbx_end_seq_num\": 438, \"pdbx_gene_src_ncbi_taxonomy_id\": \"11676\", \"pdbx_gene_src_scientific_name\": \"Human immunodeficiency virus 1\", \"pdbx_host_org_ncbi_taxonomy_id\": \"562\", \"pdbx_host_org_scientific_name\": \"Escherichia coli\", \"pdbx_host_org_strain\": \"BL21(DE3)-RIL\", \"pdbx_host_org_vector_type\": \"plasmid\", \"pdbx_seq_type\": \"Biological sequence\", \"pdbx_src_id\": 1, \"plasmid_name\": \"pET28b\"}], \"rcsb_cluster_flexibility\": {\"avg_rmsd\": 1.522, \"label\": \"Low\", \"link\": \"http://pdbflex.org/cluster.html#!/1bqmB/335/4zhrB\", \"max_rmsd\": 13.691, \"provenance_code\": \"PDBFlex\"}, \"rcsb_cluster_membership\": [{\"cluster_id\": 650886, \"identity\": 100}, {\"cluster_id\": 4, \"identity\": 95}, {\"cluster_id\": 15, \"identity\": 90}, {\"cluster_id\": 26, \"identity\": 70}, {\"cluster_id\": 44, \"identity\": 50}, {\"cluster_id\": 46, \"identity\": 30}], \"rcsb_entity_host_organism\": [{\"beg_seq_num\": 1, \"end_seq_num\": 438, \"ncbi_common_names\": [\"Bacillus coli\", \"Bacterium coli\", \"Bacterium coli commune\", \"E. coli\", \"Enterococcus coli\", \"Escherichia/Shigella coli\"], \"ncbi_parent_scientific_name\": \"Bacteria\", \"ncbi_scientific_name\": \"Escherichia coli\", \"ncbi_taxonomy_id\": 562, \"pdbx_src_id\": 1, \"provenance_source\": \"Primary Data\", \"scientific_name\": \"Escherichia coli\", \"taxonomy_lineage\": [{\"depth\": 1, \"id\": \"131567\", \"name\": \"cellular organisms\"}, {\"depth\": 1, \"id\": \"131567\", \"name\": \"biota\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria (ex Cavalier-Smith 1987)\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria Woese et al. 2024\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteriobiota\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"bacteria\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"eubacteria\"}, {\"depth\": 3, \"id\": \"3379134\", \"name\": \"Pseudomonadati\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Pseudomonadota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"\\\"Alphaproteobacteriota\\\" Whitman et al. 2018\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Alphaproteobacteriota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Proteobacteria\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Proteobacteriota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"proteobacteria\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"purple photosynthetic bacteria and relatives\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Gammaproteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Proteobacteria gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Pseudomonadia\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Purple bacteria, gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"g-proteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma proteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma subgroup\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacterales\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriaceae and related endosymbionts\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriaceae group\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriales\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"Enterobacteriaceae\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"Enterobacteraceae\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"enterobacteria\"}, {\"depth\": 8, \"id\": \"561\", \"name\": \"Escherichia\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Escherichia coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacillus coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacterium coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacterium coli commune\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"E. coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Enterococcus coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Escherichia/Shigella coli\"}]}], \"rcsb_entity_source_organism\": [{\"beg_seq_num\": 1, \"common_name\": \"HIV-1\", \"end_seq_num\": 438, \"ncbi_common_names\": [\"HIV\", \"HIV-1\", \"HIV1\", \"Human immunodeficiency virus type 1\", \"LAV-1\", \"human immunodeficiency virus 1 HIV-1\", \"human immunodeficiency virus HIV-1\", \"human immunodeficiency virus type 1 HIV 1\", \"human immunodeficiency virus type 1 HIV-1\", \"human immunodeficiency virus type 1 HIV1\", \"human immunodeficiency virus type 1, HIV-1\", \"human immunodeficiency virus type I HIV-1\", \"human immunodeficiency virus type-1 HIV-1\", \"human immunodeficiency virus-1 HIV-1\"], \"ncbi_parent_scientific_name\": \"Riboviria\", \"ncbi_scientific_name\": \"Human immunodeficiency virus 1\", \"ncbi_taxonomy_id\": 11676, \"pdbx_src_id\": 1, \"provenance_source\": \"Primary Data\", \"scientific_name\": \"Human immunodeficiency virus 1\", \"source_type\": \"genetically engineered\", \"taxonomy_lineage\": [{\"depth\": 1, \"id\": \"10239\", \"name\": \"Viruses\"}, {\"depth\": 1, \"id\": \"10239\", \"name\": \"Vira\"}, {\"depth\": 1, \"id\": \"10239\", \"name\": \"Viridae\"}, {\"depth\": 2, \"id\": \"2559587\", \"name\": \"Riboviria\"}, {\"depth\": 2, \"id\": \"2559587\", \"name\": \"RNA viruses\"}, {\"depth\": 2, \"id\": \"2559587\", \"name\": \"RNA viruses and retroviruses\"}, {\"depth\": 2, \"id\": \"2559587\", \"name\": \"RNA viruses and viroids\"}, {\"depth\": 3, \"id\": \"2732397\", \"name\": \"Pararnavirae\"}, {\"depth\": 4, \"id\": \"2732409\", \"name\": \"Artverviricota\"}, {\"depth\": 5, \"id\": \"2732514\", \"name\": \"Revtraviricetes\"}, {\"depth\": 6, \"id\": \"2169561\", \"name\": \"Ortervirales\"}, {\"depth\": 7, \"id\": \"11632\", \"name\": \"Retroviridae\"}, {\"depth\": 8, \"id\": \"327045\", \"name\": \"Orthoretrovirinae\"}, {\"depth\": 9, \"id\": \"1233735\", \"name\": \"unclassified Orthoretrovirinae\"}, {\"depth\": 10, \"id\": \"11646\", \"name\": \"Lentivirus\"}, {\"depth\": 10, \"id\": \"11646\", \"name\": \"Lentivirinae\"}, {\"depth\": 11, \"id\": \"3418650\", \"name\": \"Lentivirus humimdef1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"Human immunodeficiency virus 1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"HIV\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"HIV1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"Human immunodeficiency virus type 1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"LAV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus 1 HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type 1 HIV 1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type 1 HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type 1 HIV1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type 1, HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type I HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus type-1 HIV-1\"}, {\"depth\": 12, \"id\": \"11676\", \"name\": \"human immunodeficiency virus-1 HIV-1\"}]}], \"rcsb_polymer_entity\": {\"formula_weight\": 51.264, \"pdbx_description\": \"RT p51 subunit\", \"pdbx_ec\": \"2.7.7.49,2.7.7.7\", \"pdbx_mutation\": \"T215I\", \"pdbx_number_of_molecules\": 1, \"rcsb_multiple_source_flag\": \"N\", \"rcsb_source_part_count\": 1, \"rcsb_source_taxonomy_count\": 1, \"src_method\": \"man\", \"rcsb_ec_lineage\": [{\"depth\": 1, \"id\": \"2\", \"name\": \"Transferases\"}, {\"depth\": 2, \"id\": \"2.7\", \"name\": \"Transferring phosphorus-containing groups\"}, {\"depth\": 3, \"id\": \"2.7.7\", \"name\": \"Nucleotidyltransferases\"}, {\"depth\": 4, \"id\": \"2.7.7.49\", \"name\": \"RNA-directed DNA polymerase\"}, {\"depth\": 1, \"id\": \"2\", \"name\": \"Transferases\"}, {\"depth\": 2, \"id\": \"2.7\", \"name\": \"Transferring phosphorus-containing groups\"}, {\"depth\": 3, \"id\": \"2.7.7\", \"name\": \"Nucleotidyltransferases\"}, {\"depth\": 4, \"id\": \"2.7.7.7\", \"name\": \"DNA-directed DNA polymerase\"}], \"rcsb_macromolecular_names_combined\": [{\"name\": \"RT p51 subunit\", \"provenance_code\": \"ECO:0000304\", \"provenance_source\": \"PDB Preferred Name\"}], \"rcsb_enzyme_class_combined\": [{\"depth\": 4, \"ec\": \"2.7.7.49\", \"provenance_source\": \"PDB Primary Data\"}, {\"depth\": 4, \"ec\": \"2.7.7.7\", \"provenance_source\": \"PDB Primary Data\"}], \"rcsb_polymer_name_combined\": {\"names\": [\"Gag-Pol polyprotein\"], \"provenance_source\": \"UniProt Name\"}}, \"rcsb_polymer_entity_align\": [{\"provenance_source\": \"SIFTS\", \"reference_database_accession\": \"P12497\", \"reference_database_name\": \"UniProt\", \"aligned_regions\": [{\"entity_beg_seq_id\": 11, \"length\": 428, \"ref_beg_seq_id\": 588}]}], \"rcsb_polymer_entity_annotation\": [{\"annotation_id\": \"PF06815\", \"assignment_version\": \"34.0\", \"name\": \"Reverse transcriptase connection domain (RVT_connect)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\"}, {\"annotation_id\": \"PF06817\", \"assignment_version\": \"34.0\", \"name\": \"Reverse transcriptase thumb domain (RVT_thumb)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\"}, {\"annotation_id\": \"PF00078\", \"assignment_version\": \"34.0\", \"name\": \"Reverse transcriptase (RNA-dependent DNA polymerase) (RVT_1)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\"}, {\"annotation_id\": \"IPR036397\", \"name\": \"Ribonuclease H superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR036397\", \"name\": \"Ribonuclease H superfamily\"}]}, {\"annotation_id\": \"GO:0016020\", \"name\": \"membrane\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0016020\", \"name\": \"membrane\"}]}, {\"annotation_id\": \"GO:0004533\", \"name\": \"exoribonuclease H activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0140098\", \"name\": \"catalytic activity, acting on RNA\"}, {\"id\": \"GO:0016896\", \"name\": \"RNA exonuclease activity, producing 5'-phosphomonoesters\"}, {\"id\": \"GO:0140640\", \"name\": \"catalytic activity, acting on a nucleic acid\"}, {\"id\": \"GO:0004532\", \"name\": \"RNA exonuclease activity\"}, {\"id\": \"GO:0004540\", \"name\": \"RNA nuclease activity\"}, {\"id\": \"GO:0016787\", \"name\": \"hydrolase activity\"}, {\"id\": \"GO:0016788\", \"name\": \"hydrolase activity, acting on ester bonds\"}, {\"id\": \"GO:0004518\", \"name\": \"nuclease activity\"}, {\"id\": \"GO:0004533\", \"name\": \"exoribonuclease H activity\"}, {\"id\": \"GO:0004527\", \"name\": \"exonuclease activity\"}, {\"id\": \"GO:0003824\", \"name\": \"catalytic activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0039657\", \"name\": \"symbiont-mediated suppression of host gene expression\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044068\", \"name\": \"symbiont-mediated perturbation of host cellular process\"}, {\"id\": \"GO:0039657\", \"name\": \"symbiont-mediated suppression of host gene expression\"}, {\"id\": \"GO:0044419\", \"name\": \"biological process involved in interspecies interaction between organisms\"}, {\"id\": \"GO:0044003\", \"name\": \"symbiont-mediated perturbation of host process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0039656\", \"name\": \"symbiont-mediated perturbation of host gene expression\"}, {\"id\": \"GO:0035821\", \"name\": \"modulation of process of another organism\"}, {\"id\": \"GO:0051701\", \"name\": \"biological process involved in interaction with host\"}, {\"id\": \"GO:0044403\", \"name\": \"biological process involved in symbiotic interaction\"}]}, {\"annotation_id\": \"IPR043128\", \"name\": \"Reverse transcriptase/Diguanylate cyclase domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR043128\", \"name\": \"Reverse transcriptase/Diguanylate cyclase domain\"}]}, {\"annotation_id\": \"IPR001995\", \"name\": \"Peptidase A2A, retrovirus, catalytic\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR001995\", \"name\": \"Peptidase A2A, retrovirus, catalytic\"}]}, {\"annotation_id\": \"GO:0046718\", \"name\": \"symbiont entry into host cell\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044419\", \"name\": \"biological process involved in interspecies interaction between organisms\"}, {\"id\": \"GO:0046718\", \"name\": \"symbiont entry into host cell\"}, {\"id\": \"GO:0016032\", \"name\": \"viral process\"}, {\"id\": \"GO:0044409\", \"name\": \"symbiont entry into host\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019058\", \"name\": \"viral life cycle\"}, {\"id\": \"GO:0051701\", \"name\": \"biological process involved in interaction with host\"}, {\"id\": \"GO:0044403\", \"name\": \"biological process involved in symbiotic interaction\"}]}, {\"annotation_id\": \"IPR001878\", \"name\": \"Zinc finger, CCHC-type\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR001878\", \"name\": \"Zinc finger, CCHC-type\"}]}, {\"annotation_id\": \"IPR008919\", \"name\": \"Retrovirus capsid, N-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR008919\", \"name\": \"Retrovirus capsid, N-terminal\"}]}, {\"annotation_id\": \"IPR012344\", \"name\": \"Matrix protein, lentiviral and alpha-retroviral, N-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR012344\", \"name\": \"Matrix protein, lentiviral and alpha-retroviral, N-terminal\"}]}, {\"annotation_id\": \"GO:0044826\", \"name\": \"viral genome integration into host DNA\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044826\", \"name\": \"viral genome integration into host DNA\"}, {\"id\": \"GO:0016032\", \"name\": \"viral process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019058\", \"name\": \"viral life cycle\"}]}, {\"annotation_id\": \"IPR036862\", \"name\": \"Integrase, C-terminal domain superfamily, retroviral\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR036862\", \"name\": \"Integrase, C-terminal domain superfamily, retroviral\"}]}, {\"annotation_id\": \"IPR018061\", \"name\": \"Retropepsins\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR018061\", \"name\": \"Retropepsins\"}]}, {\"annotation_id\": \"GO:0003887\", \"name\": \"DNA-directed DNA polymerase activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0140097\", \"name\": \"catalytic activity, acting on DNA\"}, {\"id\": \"GO:0003887\", \"name\": \"DNA-directed DNA polymerase activity\"}, {\"id\": \"GO:0034061\", \"name\": \"DNA polymerase activity\"}, {\"id\": \"GO:0140640\", \"name\": \"catalytic activity, acting on a nucleic acid\"}, {\"id\": \"GO:0016740\", \"name\": \"transferase activity\"}, {\"id\": \"GO:0016779\", \"name\": \"nucleotidyltransferase activity\"}, {\"id\": \"GO:0003824\", \"name\": \"catalytic activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0016772\", \"name\": \"transferase activity, transferring phosphorus-containing groups\"}]}, {\"annotation_id\": \"GO:0003677\", \"name\": \"DNA binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"IPR010661\", \"name\": \"Reverse transcriptase thumb\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR010661\", \"name\": \"Reverse transcriptase thumb\"}]}, {\"annotation_id\": \"IPR002156\", \"name\": \"Ribonuclease H domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR002156\", \"name\": \"Ribonuclease H domain\"}]}, {\"annotation_id\": \"IPR036875\", \"name\": \"Zinc finger, CCHC-type superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR036875\", \"name\": \"Zinc finger, CCHC-type superfamily\"}]}, {\"annotation_id\": \"IPR003308\", \"name\": \"Integrase, N-terminal zinc-binding domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR003308\", \"name\": \"Integrase, N-terminal zinc-binding domain\"}]}, {\"annotation_id\": \"GO:0072494\", \"name\": \"host multivesicular body\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0033648\", \"name\": \"host intracellular membrane-bounded organelle\"}, {\"id\": \"GO:0018995\", \"name\": \"host cellular component\"}, {\"id\": \"GO:0033646\", \"name\": \"host intracellular part\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0072494\", \"name\": \"host multivesicular body\"}, {\"id\": \"GO:0044217\", \"name\": \"other organism part\"}, {\"id\": \"GO:0033655\", \"name\": \"host cell cytoplasm part\"}, {\"id\": \"GO:0033647\", \"name\": \"host intracellular organelle\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0030430\", \"name\": \"host cell cytoplasm\"}, {\"id\": \"GO:0033643\", \"name\": \"host cell part\"}, {\"id\": \"GO:0044184\", \"name\": \"host cell late endosome\"}, {\"id\": \"GO:0044174\", \"name\": \"host cell endosome\"}, {\"id\": \"GO:0043656\", \"name\": \"host intracellular region\"}]}, {\"annotation_id\": \"IPR001584\", \"name\": \"Integrase, catalytic core\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR001584\", \"name\": \"Integrase, catalytic core\"}]}, {\"annotation_id\": \"GO:0075732\", \"name\": \"viral penetration into host nucleus\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044419\", \"name\": \"biological process involved in interspecies interaction between organisms\"}, {\"id\": \"GO:0075732\", \"name\": \"viral penetration into host nucleus\"}, {\"id\": \"GO:0075733\", \"name\": \"intracellular transport of virus\"}, {\"id\": \"GO:0016032\", \"name\": \"viral process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019058\", \"name\": \"viral life cycle\"}, {\"id\": \"GO:0046794\", \"name\": \"transport of virus\"}, {\"id\": \"GO:0044403\", \"name\": \"biological process involved in symbiotic interaction\"}]}, {\"annotation_id\": \"GO:0003964\", \"name\": \"RNA-directed DNA polymerase activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003964\", \"name\": \"RNA-directed DNA polymerase activity\"}, {\"id\": \"GO:0140097\", \"name\": \"catalytic activity, acting on DNA\"}, {\"id\": \"GO:0034061\", \"name\": \"DNA polymerase activity\"}, {\"id\": \"GO:0140640\", \"name\": \"catalytic activity, acting on a nucleic acid\"}, {\"id\": \"GO:0016740\", \"name\": \"transferase activity\"}, {\"id\": \"GO:0016779\", \"name\": \"nucleotidyltransferase activity\"}, {\"id\": \"GO:0003824\", \"name\": \"catalytic activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0016772\", \"name\": \"transferase activity, transferring phosphorus-containing groups\"}]}, {\"annotation_id\": \"GO:0035613\", \"name\": \"RNA stem-loop binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003723\", \"name\": \"RNA binding\"}, {\"id\": \"GO:0035613\", \"name\": \"RNA stem-loop binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0019013\", \"name\": \"viral nucleocapsid\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0019013\", \"name\": \"viral nucleocapsid\"}, {\"id\": \"GO:0019028\", \"name\": \"viral capsid\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0044423\", \"name\": \"virion component\"}]}, {\"annotation_id\": \"GO:0015074\", \"name\": \"DNA integration\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0006259\", \"name\": \"DNA metabolic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0015074\", \"name\": \"DNA integration\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}]}, {\"annotation_id\": \"IPR045345\", \"name\": \"Retroviral nucleocapsid Gag protein p24, C-terminal domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR045345\", \"name\": \"Retroviral nucleocapsid Gag protein p24, C-terminal domain\"}]}, {\"annotation_id\": \"GO:0075713\", \"name\": \"establishment of integrated proviral latency\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0075713\", \"name\": \"establishment of integrated proviral latency\"}, {\"id\": \"GO:0019042\", \"name\": \"viral latency\"}, {\"id\": \"GO:0016032\", \"name\": \"viral process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019043\", \"name\": \"establishment of viral latency\"}]}, {\"annotation_id\": \"GO:0075523\", \"name\": \"viral translational frameshifting\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0019080\", \"name\": \"viral gene expression\"}, {\"id\": \"GO:0016032\", \"name\": \"viral process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0075523\", \"name\": \"viral translational frameshifting\"}, {\"id\": \"GO:0019081\", \"name\": \"viral translation\"}]}, {\"annotation_id\": \"GO:0020002\", \"name\": \"host cell plasma membrane\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0020002\", \"name\": \"host cell plasma membrane\"}, {\"id\": \"GO:0018995\", \"name\": \"host cellular component\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0033643\", \"name\": \"host cell part\"}, {\"id\": \"GO:0033644\", \"name\": \"host cell membrane\"}, {\"id\": \"GO:0044217\", \"name\": \"other organism part\"}]}, {\"annotation_id\": \"IPR010999\", \"name\": \"Retroviral matrix protein\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR010999\", \"name\": \"Retroviral matrix protein\"}]}, {\"annotation_id\": \"IPR021109\", \"name\": \"Aspartic peptidase domain superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR021109\", \"name\": \"Aspartic peptidase domain superfamily\"}]}, {\"annotation_id\": \"IPR001969\", \"name\": \"Aspartic peptidase, active site\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR001969\", \"name\": \"Aspartic peptidase, active site\"}]}, {\"annotation_id\": \"GO:0006310\", \"name\": \"DNA recombination\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0006310\", \"name\": \"DNA recombination\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0006259\", \"name\": \"DNA metabolic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}]}, {\"annotation_id\": \"IPR012337\", \"name\": \"Ribonuclease H-like superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR012337\", \"name\": \"Ribonuclease H-like superfamily\"}]}, {\"annotation_id\": \"IPR017856\", \"name\": \"Integrase-like, N-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR017856\", \"name\": \"Integrase-like, N-terminal\"}]}, {\"annotation_id\": \"IPR000071\", \"name\": \"Immunodeficiency lentiviral matrix, N-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR000071\", \"name\": \"Immunodeficiency lentiviral matrix, N-terminal\"}]}, {\"annotation_id\": \"GO:0043657\", \"name\": \"host cell\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0018995\", \"name\": \"host cellular component\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0043657\", \"name\": \"host cell\"}, {\"id\": \"GO:0044217\", \"name\": \"other organism part\"}]}, {\"annotation_id\": \"GO:0004190\", \"name\": \"aspartic-type endopeptidase activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0070001\", \"name\": \"aspartic-type peptidase activity\"}, {\"id\": \"GO:0008233\", \"name\": \"peptidase activity\"}, {\"id\": \"GO:0140096\", \"name\": \"catalytic activity, acting on a protein\"}, {\"id\": \"GO:0016787\", \"name\": \"hydrolase activity\"}, {\"id\": \"GO:0004190\", \"name\": \"aspartic-type endopeptidase activity\"}, {\"id\": \"GO:0003824\", \"name\": \"catalytic activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0004175\", \"name\": \"endopeptidase activity\"}]}, {\"annotation_id\": \"GO:0055036\", \"name\": \"virion membrane\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0044423\", \"name\": \"virion component\"}, {\"id\": \"GO:0055036\", \"name\": \"virion membrane\"}]}, {\"annotation_id\": \"GO:0008289\", \"name\": \"lipid binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0008289\", \"name\": \"lipid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"IPR043502\", \"name\": \"DNA/RNA polymerase superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR043502\", \"name\": \"DNA/RNA polymerase superfamily\"}]}, {\"annotation_id\": \"IPR001037\", \"name\": \"Integrase, C-terminal, retroviral\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR001037\", \"name\": \"Integrase, C-terminal, retroviral\"}]}, {\"annotation_id\": \"GO:0004523\", \"name\": \"RNA-DNA hybrid ribonuclease activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0004519\", \"name\": \"endonuclease activity\"}, {\"id\": \"GO:0016891\", \"name\": \"RNA endonuclease activity producing 5'-phosphomonoesters, hydrolytic mechanism\"}, {\"id\": \"GO:0140098\", \"name\": \"catalytic activity, acting on RNA\"}, {\"id\": \"GO:0004523\", \"name\": \"RNA-DNA hybrid ribonuclease activity\"}, {\"id\": \"GO:0140640\", \"name\": \"catalytic activity, acting on a nucleic acid\"}, {\"id\": \"GO:0004540\", \"name\": \"RNA nuclease activity\"}, {\"id\": \"GO:0016787\", \"name\": \"hydrolase activity\"}, {\"id\": \"GO:0016788\", \"name\": \"hydrolase activity, acting on ester bonds\"}, {\"id\": \"GO:0004518\", \"name\": \"nuclease activity\"}, {\"id\": \"GO:0004521\", \"name\": \"RNA endonuclease activity\"}, {\"id\": \"GO:0003824\", \"name\": \"catalytic activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"IPR034170\", \"name\": \"Retropepsin-like catalytic domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 2, \"id\": \"IPR034170\", \"name\": \"Retropepsin-like catalytic domain\"}, {\"depth\": 1, \"id\": \"IPR018061\", \"name\": \"Retropepsins\"}]}, {\"annotation_id\": \"IPR000477\", \"name\": \"Reverse transcriptase domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR000477\", \"name\": \"Reverse transcriptase domain\"}]}, {\"annotation_id\": \"GO:0042025\", \"name\": \"host cell nucleus\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0033648\", \"name\": \"host intracellular membrane-bounded organelle\"}, {\"id\": \"GO:0018995\", \"name\": \"host cellular component\"}, {\"id\": \"GO:0033646\", \"name\": \"host intracellular part\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0033643\", \"name\": \"host cell part\"}, {\"id\": \"GO:0043656\", \"name\": \"host intracellular region\"}, {\"id\": \"GO:0042025\", \"name\": \"host cell nucleus\"}, {\"id\": \"GO:0044217\", \"name\": \"other organism part\"}, {\"id\": \"GO:0033647\", \"name\": \"host intracellular organelle\"}]}, {\"annotation_id\": \"GO:0052151\", \"name\": \"symbiont-mediated activation of host apoptosis\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044068\", \"name\": \"symbiont-mediated perturbation of host cellular process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0052042\", \"name\": \"symbiont-mediated activation of host programmed cell death\"}, {\"id\": \"GO:0044419\", \"name\": \"biological process involved in interspecies interaction between organisms\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0052151\", \"name\": \"symbiont-mediated activation of host apoptosis\"}, {\"id\": \"GO:0052040\", \"name\": \"symbiont-mediated perturbation of host programmed cell death\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0051709\", \"name\": \"regulation of killing of cells of another organism\"}, {\"id\": \"GO:0141061\", \"name\": \"disruption of cell in another organism\"}, {\"id\": \"GO:0051701\", \"name\": \"biological process involved in interaction with host\"}, {\"id\": \"GO:0044403\", \"name\": \"biological process involved in symbiotic interaction\"}, {\"id\": \"GO:0044003\", \"name\": \"symbiont-mediated perturbation of host process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0031341\", \"name\": \"regulation of cell killing\"}, {\"id\": \"GO:0052150\", \"name\": \"symbiont-mediated perturbation of host apoptosis\"}, {\"id\": \"GO:0141060\", \"name\": \"disruption of anatomical structure in another organism\"}, {\"id\": \"GO:0035821\", \"name\": \"modulation of process of another organism\"}, {\"id\": \"GO:0001907\", \"name\": \"symbiont-mediated killing of host cell\"}, {\"id\": \"GO:0031640\", \"name\": \"killing of cells of another organism\"}, {\"id\": \"GO:0001906\", \"name\": \"cell killing\"}]}, {\"annotation_id\": \"IPR010659\", \"name\": \"Reverse transcriptase connection\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR010659\", \"name\": \"Reverse transcriptase connection\"}]}, {\"annotation_id\": \"GO:0005198\", \"name\": \"structural molecule activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005198\", \"name\": \"structural molecule activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0008270\", \"name\": \"zinc ion binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0043169\", \"name\": \"cation binding\"}, {\"id\": \"GO:0046914\", \"name\": \"transition metal ion binding\"}, {\"id\": \"GO:0008270\", \"name\": \"zinc ion binding\"}, {\"id\": \"GO:0043167\", \"name\": \"ion binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0046872\", \"name\": \"metal ion binding\"}, {\"id\": \"GO:0036094\", \"name\": \"small molecule binding\"}]}, {\"annotation_id\": \"GO:0006508\", \"name\": \"proteolysis\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0006508\", \"name\": \"proteolysis\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0019538\", \"name\": \"protein metabolic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}]}, {\"annotation_id\": \"IPR008916\", \"name\": \"Retrovirus capsid, C-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR008916\", \"name\": \"Retrovirus capsid, C-terminal\"}]}], \"rcsb_polymer_entity_container_identifiers\": {\"asym_ids\": [\"B\"], \"auth_asym_ids\": [\"B\"], \"chem_comp_monomers\": [\"ALA\", \"ARG\", \"ASN\", \"ASP\", \"CYS\", \"GLN\", \"GLU\", \"GLY\", \"HIS\", \"ILE\", \"LEU\", \"LYS\", \"MET\", \"PHE\", \"PRO\", \"SER\", \"THR\", \"TRP\", \"TYR\", \"VAL\"], \"entity_id\": \"2\", \"entry_id\": \"4ZHR\", \"rcsb_id\": \"4ZHR_2\", \"uniprot_ids\": [\"P12497\"], \"reference_sequence_identifiers\": [{\"database_accession\": \"P12497\", \"database_name\": \"UniProt\", \"entity_sequence_coverage\": 0.9771689497716894, \"provenance_source\": \"SIFTS\", \"reference_sequence_coverage\": 0.29825783972125436}]}, \"rcsb_polymer_entity_feature\": [{\"assignment_version\": \"34.0\", \"feature_id\": \"PF06817\", \"name\": \"Reverse transcriptase thumb domain (RVT_thumb)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\", \"feature_positions\": [{\"beg_seq_id\": 251, \"end_seq_id\": 314}]}, {\"assignment_version\": \"34.0\", \"feature_id\": \"PF00078\", \"name\": \"Reverse transcriptase (RNA-dependent DNA polymerase) (RVT_1)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\", \"feature_positions\": [{\"beg_seq_id\": 73, \"end_seq_id\": 244}]}, {\"assignment_version\": \"34.0\", \"feature_id\": \"PF06815\", \"name\": \"Reverse transcriptase connection domain (RVT_connect)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\", \"feature_positions\": [{\"beg_seq_id\": 328, \"end_seq_id\": 429}]}, {\"name\": \"Hydropathy values\", \"provenance_source\": \"biojava-7.2.4\", \"type\": \"hydropathy\", \"feature_positions\": [{\"beg_seq_id\": 5, \"values\": [-1.76, -1.5, -1.63, -0.78, -0.51, -0.33, 0.52, 0.49, 0.77, 1.02, 0.38, 1.02, 0.09, 0.6, 0.34, -0.33, 0.01, 0.3, -0.56, -0.42, -1.07, -1.07, -1.02, -1.02, -1.23, -1.29, -1.68, -0.87, -0.9, -1.11, -1.07, -1.97, -1.03, -1.08, -0.78, -0.18, -0.13, -0.44, 0.44, 1.11, 1.47, 0.58, 1.22, 0.63, -0.22, -1.08, -0.73, -1.67, -1.44, -1.46, -1.5, -1.21, -0.87, -0.61, -0.61, -0.96, -0.7, -1.34, -1.64, -1.29, -1.97, -1.46, -0.97, -0.38, 0.51, 0.26, -0.03, -0.08, -0.39, -0.3, -0.84, -1.59, -1.89, -2.89, -2.89, -2.03, -1.13, -1.13, -0.73, -1.16, -1.11, -0.59, -0.48, -0.48, -1.4, -1.94, -1.94, -2.64, -1.83, -1.54, -2.36, -1.5, -1.46, -0.53, -0.5, 0.39, 0.6, -0.07, -0.14, 0.44, -0.07, 0.74, -0.11, -0.46, -1.39, -1.64, -1.38, -0.73, -1.01, -0.5, -0.5, -0.46, 0.4, 0.79, 0.83, 1.12, 0.51, 0.9, 0.34, 0.39, 0.6, 0.56, 0.21, 0.17, -0.42, 0.03, -0.78, -1.12, -1.73, -1.63, -1.86, -1.16, -0.8, 0.09, -0.4, 0.01, 0.94, 0.7, 0.39, -0.2, -0.59, -0.69, -1.23, -0.56, -0.97, -1.61, -1.61, -1.37, -1.37, -0.82, -0.22, -0.36, -1.24, -0.79, -0.74, -0.79, -0.69, -0.39, -1.03, -1.26, -0.58, 0.12, -0.22, 0.16, 0.5, 0.76, 0.77, 0.51, 0.81, 0.73, 0.03, 0.24, 0.28, -0.13, -0.78, -1.09, -1.04, -1.72, -2.53, -1.64, -1.0, -0.81, -0.46, -0.41, -0.17, 0.43, 0.22, 0.22, 0.14, -0.47, -0.5, -0.4, -0.1, -0.34, -0.13, -0.13, 0.76, 0.29, 0.04, -0.78, -1.23, -1.22, -1.27, -1.19, -1.19, -2.08, -1.61, -1.72, -1.76, -1.61, -1.11, -0.26, -1.26, -0.97, -0.62, -0.73, 0.27, 0.58, 0.76, -0.06, -0.91, -0.84, -1.1, -1.44, -2.19, -3.08, -3.18, -3.18, -2.48, -1.62, -1.29, -0.72, -0.38, -0.09, -0.09, 0.51, 0.33, -0.16, -0.97, -1.3, -1.61, -1.64, -1.03, -1.03, -1.63, -0.78, -0.13, 0.68, 0.93, 0.64, 0.29, -0.57, -0.27, -0.19, -0.77, -0.77, -1.58, -1.79, -0.9, -0.86, -0.9, -0.39, 0.18, 0.21, -0.69, 0.12, 0.12, -0.48, 0.11, 0.46, -0.36, -0.32, -0.42, 0.21, -0.26, 0.63, 0.3, 0.57, 0.16, 0.16, 0.08, 0.5, -0.13, 0.33, 0.26, 0.19, -0.32, 0.1, 0.06, -0.17, -0.02, 0.33, -0.48, -0.43, 0.53, 0.4, 0.9, 1.26, 0.67, -0.14, 0.13, 0.13, 0.09, -0.77, -0.17, -0.39, -0.7, -0.7, -0.81, -1.4, -0.51, -0.51, -0.56, -1.37, -1.74, -0.89, -0.86, -0.4, 0.46, -0.19, -0.76, -0.71, -0.5, -0.41, -1.31, -1.34, -0.88, -0.84, -0.5, -0.74, 0.14, -0.07, -0.41, -0.37, -0.02, -0.83, -1.38, -1.97, -1.68, -2.26, -2.01, -1.97, -1.08, -1.18, -1.18, -1.52, -1.31, -0.9, -1.26, -1.5, -0.69, -1.62, -1.56, -1.21, -1.26, -1.22, -1.33, -1.4, -0.8, -1.66, -1.27, -0.99, -1.3, -0.94, -1.19, -1.78, -0.81, -1.46, -1.41, -0.94, -1.22, -1.26, -0.98, -0.12, -0.12, -1.02, -0.09, 0.5, 0.0, -0.31, -0.01, 0.29, 0.29, 1.18, 1.51, 0.97, 0.33, 0.33, 0.54, 0.2, 0.01, -0.89, -0.97, -1.04, -0.5, -0.46, -0.81, -1.02, -0.67, -1.08, -1.03, -1.26, -1.18, -1.78, -1.47, -1.42, -1.18, -1.2, -1.49, -0.9, -1.18, -1.18, -0.58, -0.68, -0.68, -0.63, -0.92, -0.22, 0.04, -0.27, -0.24, -0.92, -0.92, -0.11, 0.46, 0.41, 0.52, -0.04, 0.2, -0.11]}]}, {\"name\": \"Disordered regions\", \"provenance_source\": \"IUPred2(short)\", \"type\": \"disorder\", \"feature_positions\": [{\"beg_seq_id\": 1, \"values\": [0.98, 0.94, 0.93, 0.91, 0.85, 0.82, 0.78, 0.7, 0.68, 0.6, 0.57, 0.53, 0.53, 0.54, 0.53, 0.49, 0.49, 0.47, 0.47, 0.5, 0.48, 0.47, 0.53, 0.46, 0.47, 0.46, 0.45, 0.45, 0.5, 0.47, 0.47, 0.46, 0.5, 0.45, 0.39, 0.38, 0.35, 0.3, 0.29, 0.28, 0.26, 0.31, 0.31, 0.31, 0.37, 0.34, 0.34, 0.34, 0.33, 0.26, 0.27, 0.35, 0.35, 0.37, 0.44, 0.41, 0.41, 0.47, 0.53, 0.49, 0.43, 0.44, 0.38, 0.38, 0.37, 0.36, 0.37, 0.43, 0.42, 0.43, 0.42, 0.41, 0.39, 0.33, 0.27, 0.25, 0.26, 0.26, 0.26, 0.17, 0.22, 0.27, 0.29, 0.34, 0.35, 0.35, 0.28, 0.21, 0.2, 0.16, 0.17, 0.17, 0.18, 0.12, 0.19, 0.23, 0.27, 0.31, 0.31, 0.24, 0.3, 0.31, 0.3, 0.29, 0.3, 0.23, 0.22, 0.23, 0.23, 0.24, 0.23, 0.22, 0.3, 0.27, 0.28, 0.18, 0.18, 0.11, 0.15, 0.1, 0.16, 0.16, 0.16, 0.1, 0.11, 0.1, 0.1, 0.1, 0.12, 0.12, 0.11, 0.1, 0.12, 0.11, 0.08, 0.13, 0.18, 0.19, 0.25, 0.24, 0.31, 0.23, 0.24, 0.16, 0.25, 0.17, 0.18, 0.18, 0.13, 0.17, 0.26, 0.27, 0.27, 0.24, 0.24, 0.32, 0.35, 0.31, 0.23, 0.17, 0.16, 0.12, 0.17, 0.13, 0.19, 0.18, 0.18, 0.12, 0.18, 0.28, 0.17, 0.16, 0.16, 0.23, 0.23, 0.26, 0.27, 0.17, 0.15, 0.15, 0.15, 0.15, 0.13, 0.12, 0.16, 0.17, 0.11, 0.11, 0.12, 0.12, 0.1, 0.17, 0.11, 0.12, 0.07, 0.07, 0.06, 0.06, 0.09, 0.12, 0.17, 0.17, 0.17, 0.24, 0.19, 0.17, 0.17, 0.24, 0.24, 0.24, 0.23, 0.13, 0.13, 0.14, 0.1, 0.16, 0.17, 0.17, 0.17, 0.18, 0.17, 0.19, 0.27, 0.27, 0.29, 0.4, 0.34, 0.26, 0.19, 0.23, 0.32, 0.23, 0.35, 0.26, 0.32, 0.4, 0.41, 0.38, 0.29, 0.28, 0.23, 0.25, 0.26, 0.19, 0.15, 0.08, 0.08, 0.13, 0.17, 0.26, 0.29, 0.2, 0.28, 0.21, 0.28, 0.31, 0.2, 0.19, 0.19, 0.19, 0.14, 0.18, 0.17, 0.09, 0.14, 0.12, 0.16, 0.14, 0.13, 0.08, 0.04, 0.04, 0.06, 0.04, 0.05, 0.03, 0.03, 0.05, 0.03, 0.02, 0.03, 0.03, 0.01, 0.01, 0.03, 0.03, 0.04, 0.04, 0.03, 0.03, 0.05, 0.05, 0.04, 0.05, 0.05, 0.05, 0.09, 0.1, 0.09, 0.15, 0.13, 0.15, 0.15, 0.19, 0.21, 0.21, 0.2, 0.23, 0.18, 0.21, 0.19, 0.2, 0.31, 0.31, 0.28, 0.38, 0.31, 0.24, 0.17, 0.22, 0.25, 0.33, 0.31, 0.41, 0.37, 0.29, 0.26, 0.27, 0.19, 0.27, 0.32, 0.34, 0.32, 0.3, 0.36, 0.36, 0.27, 0.32, 0.32, 0.39, 0.31, 0.21, 0.21, 0.23, 0.24, 0.24, 0.31, 0.35, 0.28, 0.35, 0.33, 0.34, 0.33, 0.26, 0.23, 0.24, 0.2, 0.29, 0.3, 0.34, 0.34, 0.39, 0.47, 0.46, 0.39, 0.35, 0.42, 0.36, 0.35, 0.41, 0.38, 0.33, 0.34, 0.34, 0.34, 0.34, 0.32, 0.36, 0.36, 0.29, 0.27, 0.2, 0.17, 0.17, 0.16, 0.2, 0.23, 0.2, 0.2, 0.19, 0.13, 0.16, 0.15, 0.14, 0.13, 0.18, 0.2, 0.17, 0.17, 0.16, 0.17, 0.16, 0.22, 0.27, 0.15, 0.12, 0.13, 0.1, 0.11, 0.12, 0.09, 0.15, 0.13, 0.15, 0.16, 0.11, 0.07, 0.07, 0.1, 0.1, 0.12, 0.09, 0.09, 0.08, 0.04, 0.06, 0.04, 0.04, 0.06, 0.08, 0.14, 0.24, 0.27, 0.31, 0.41, 0.46, 0.57, 0.67]}]}, {\"name\": \"Disordered binding sites\", \"provenance_source\": \"Anchor2\", \"type\": \"disorder_binding\", \"feature_positions\": [{\"beg_seq_id\": 1, \"values\": [0.62, 0.61, 0.61, 0.6, 0.59, 0.58, 0.56, 0.54, 0.53, 0.51, 0.49, 0.48, 0.47, 0.46, 0.46, 0.46, 0.45, 0.45, 0.45, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.44, 0.43, 0.43, 0.43, 0.42, 0.42, 0.42, 0.43, 0.43, 0.43, 0.43, 0.42, 0.42, 0.42, 0.42, 0.41, 0.41, 0.41, 0.4, 0.4, 0.4, 0.41, 0.41, 0.42, 0.42, 0.43, 0.43, 0.42, 0.42, 0.42, 0.42, 0.42, 0.43, 0.43, 0.43, 0.43, 0.43, 0.42, 0.42, 0.42, 0.42, 0.42, 0.42, 0.42, 0.42, 0.43, 0.43, 0.43, 0.42, 0.41, 0.41, 0.41, 0.41, 0.42, 0.43, 0.43, 0.43, 0.42, 0.42, 0.42, 0.42, 0.43, 0.43, 0.41, 0.4, 0.38, 0.37, 0.36, 0.35, 0.34, 0.33, 0.32, 0.33, 0.34, 0.35, 0.36, 0.37, 0.38, 0.39, 0.41, 0.42, 0.43, 0.41, 0.41, 0.42, 0.42, 0.43, 0.43, 0.42, 0.41, 0.41, 0.4, 0.38, 0.36, 0.35, 0.34, 0.34, 0.33, 0.32, 0.31, 0.3, 0.29, 0.29, 0.28, 0.28, 0.27, 0.27, 0.26, 0.26, 0.27, 0.27, 0.26, 0.26, 0.25, 0.24, 0.24, 0.24, 0.24, 0.24, 0.25, 0.26, 0.26, 0.28, 0.29, 0.31, 0.34, 0.36, 0.38, 0.4, 0.41, 0.41, 0.41, 0.4, 0.39, 0.39, 0.38, 0.37, 0.36, 0.35, 0.34, 0.33, 0.33, 0.34, 0.36, 0.38, 0.39, 0.4, 0.42, 0.43, 0.43, 0.42, 0.41, 0.42, 0.43, 0.43, 0.4, 0.38, 0.36, 0.34, 0.32, 0.3, 0.29, 0.27, 0.26, 0.25, 0.23, 0.23, 0.23, 0.24, 0.24, 0.25, 0.26, 0.27, 0.29, 0.3, 0.33, 0.35, 0.36, 0.36, 0.37, 0.36, 0.36, 0.35, 0.33, 0.32, 0.31, 0.31, 0.31, 0.32, 0.34, 0.35, 0.37, 0.39, 0.42, 0.42, 0.4, 0.39, 0.39, 0.4, 0.42, 0.43, 0.41, 0.39, 0.37, 0.35, 0.33, 0.31, 0.29, 0.27, 0.27, 0.28, 0.28, 0.28, 0.28, 0.28, 0.27, 0.28, 0.28, 0.29, 0.3, 0.3, 0.29, 0.28, 0.28, 0.29, 0.29, 0.29, 0.29, 0.29, 0.29, 0.29, 0.3, 0.31, 0.32, 0.31, 0.29, 0.28, 0.28, 0.28, 0.27, 0.27, 0.26, 0.26, 0.26, 0.25, 0.25, 0.27, 0.28, 0.28, 0.28, 0.28, 0.28, 0.28, 0.29, 0.29, 0.29, 0.29, 0.28, 0.27, 0.27, 0.28, 0.28, 0.29, 0.28, 0.28, 0.28, 0.28, 0.28, 0.29, 0.29, 0.29, 0.29, 0.29, 0.29, 0.3, 0.32, 0.33, 0.35, 0.36, 0.38, 0.39, 0.41, 0.43, 0.42, 0.39, 0.37, 0.36, 0.36, 0.36, 0.36, 0.37, 0.37, 0.38, 0.41, 0.43, 0.4, 0.38, 0.36, 0.34, 0.34, 0.34, 0.34, 0.34, 0.36, 0.38, 0.39, 0.41, 0.42, 0.43, 0.43, 0.43, 0.43, 0.43, 0.43, 0.42, 0.4, 0.39, 0.38, 0.38, 0.38, 0.37, 0.38, 0.38, 0.37, 0.35, 0.35, 0.34, 0.33, 0.32, 0.3, 0.29, 0.29, 0.28, 0.27, 0.27, 0.27, 0.27, 0.27, 0.28, 0.29, 0.31, 0.34, 0.37, 0.39, 0.4, 0.41, 0.43, 0.41, 0.4, 0.4, 0.4, 0.43, 0.4, 0.36, 0.33, 0.31, 0.3, 0.28, 0.27, 0.28, 0.3, 0.32, 0.35, 0.41, 0.4, 0.33, 0.3, 0.26, 0.22, 0.21, 0.23, 0.24, 0.25, 0.24, 0.26, 0.28, 0.3, 0.32, 0.39, 0.4, 0.36, 0.34, 0.29, 0.26, 0.2, 0.16, 0.13, 0.1, 0.09, 0.09, 0.09, 0.08, 0.08, 0.08, 0.07, 0.07]}]}], \"rcsb_polymer_entity_feature_summary\": [{\"count\": 3, \"coverage\": 0.77169, \"type\": \"Pfam\"}], \"rcsb_polymer_entity_group_membership\": [{\"aggregation_method\": \"sequence_identity\", \"group_id\": \"46_30\", \"similarity_cutoff\": 30.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 158, \"ref_beg_seq_id\": 196}, {\"entity_beg_seq_id\": 159, \"length\": 91, \"ref_beg_seq_id\": 366}, {\"entity_beg_seq_id\": 250, \"length\": 22, \"ref_beg_seq_id\": 458}, {\"entity_beg_seq_id\": 272, \"length\": 69, \"ref_beg_seq_id\": 482}, {\"entity_beg_seq_id\": 341, \"length\": 14, \"ref_beg_seq_id\": 560}, {\"entity_beg_seq_id\": 355, \"length\": 68, \"ref_beg_seq_id\": 575}, {\"entity_beg_seq_id\": 423, \"length\": 7, \"ref_beg_seq_id\": 647}, {\"entity_beg_seq_id\": 430, \"length\": 9, \"ref_beg_seq_id\": 655}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"44_50\", \"similarity_cutoff\": 50.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 35, \"ref_beg_seq_id\": 196}, {\"entity_beg_seq_id\": 36, \"length\": 49, \"ref_beg_seq_id\": 238}, {\"entity_beg_seq_id\": 85, \"length\": 173, \"ref_beg_seq_id\": 295}, {\"entity_beg_seq_id\": 258, \"length\": 28, \"ref_beg_seq_id\": 481}, {\"entity_beg_seq_id\": 286, \"length\": 68, \"ref_beg_seq_id\": 516}, {\"entity_beg_seq_id\": 354, \"length\": 63, \"ref_beg_seq_id\": 585}, {\"entity_beg_seq_id\": 417, \"length\": 19, \"ref_beg_seq_id\": 649}, {\"entity_beg_seq_id\": 436, \"length\": 3, \"ref_beg_seq_id\": 669}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"650886_100\", \"similarity_cutoff\": 100.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 438, \"ref_beg_seq_id\": 1}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"26_70\", \"similarity_cutoff\": 70.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 438, \"ref_beg_seq_id\": 199}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"15_90\", \"similarity_cutoff\": 90.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 438, \"ref_beg_seq_id\": 199}]}, {\"aggregation_method\": \"matching_uniprot_accession\", \"group_id\": \"P12497\", \"aligned_regions\": [{\"entity_beg_seq_id\": 11, \"length\": 428, \"ref_beg_seq_id\": 588}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"4_95\", \"similarity_cutoff\": 95.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 438, \"ref_beg_seq_id\": 196}]}], \"rcsb_related_target_references\": [{\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL2366516\", \"target_taxonomy_id\": 11676, \"aligned_target\": [{\"entity_beg_seq_id\": 11, \"length\": 254, \"target_beg_seq_id\": 1}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P12497\", \"target_taxonomy_id\": 11698, \"aligned_target\": [{\"entity_beg_seq_id\": 11, \"length\": 427, \"target_beg_seq_id\": 588}]}], \"rcsb_target_cofactors\": [{\"binding_assay_value\": 2.45, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"NQDJXKOVJZTUJA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1\", \"cofactor_chem_comp_id\": \"NVP\", \"cofactor_name\": \"NEVIRAPINE\", \"cofactor_resource_id\": \"CHEMBL57\", \"mechanism_of_action\": \"Human immunodeficiency virus type 1 reverse transcriptase inhibitor\", \"neighbor_flag\": \"Y\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2366516\"}, {\"binding_assay_value\": 1.52, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"UHMLHIRSNCDVOO-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COc1cc(-c2ccc(C#N)cc2)ccc1C(O)c1ccnc(Nc2ccc(C#N)cc2)n1\", \"cofactor_resource_id\": \"CHEMBL4795242\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2366516\"}, {\"binding_assay_value\": 1.4, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"XUQMYSDQQXQODI-AREMUKBSSA-N\", \"cofactor_smiles\": \"Cc1cc(-c2ccc(C#N)cc2)cc(C)c1[C@H](O)c1ccnc(Nc2ccc(C#N)cc2)n1\", \"cofactor_resource_id\": \"CHEMBL4796383\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2366516\"}, {\"binding_assay_value\": 0.28, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"LRGUYOVPBIAHKP-XMMPIXPASA-N\", \"cofactor_smiles\": \"N#Cc1ccc(Nc2nccc([C@H](O)c3ccc(-c4ccc(C#N)cc4)cc3Cl)n2)cc1\", \"cofactor_resource_id\": \"CHEMBL4789602\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2366516\"}, {\"cofactor_in_ch_ikey\": \"AYGYLFIDAXGERM-UHFFFAOYSA-O\", \"cofactor_smiles\": \"OC1=CC=C(C=C1O)[As+](C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"TTO\", \"cofactor_name\": \"(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium\", \"cofactor_resource_id\": \"DB02086\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"OGGXGZAMXPVRFZ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"C[As](C)(O)=O\", \"cofactor_chem_comp_id\": \"CAD\", \"cofactor_name\": \"Cacodylic acid\", \"cofactor_resource_id\": \"DB02994\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"LKVXXMOMTRBUQI-WCIBSUBMSA-N\", \"cofactor_smiles\": \"O\\\\C(=C/C(=O)C1=CNC2=CC=C(Cl)C=C12)C1=NN=NN1\", \"cofactor_chem_comp_id\": \"100\", \"cofactor_name\": \"(2Z)-1-(5-Chloro-1H-indol-3-yl)-3-hydroxy-3-(1H-tetrazol-5-yl)-2-propen-1-one\", \"cofactor_resource_id\": \"DB03118\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"HBKZDQYWGRUTJX-BYPYZUCNSA-N\", \"cofactor_smiles\": \"[H][C@](N)(CS[As](C)(C)=O)C(O)=O\", \"cofactor_chem_comp_id\": \"CAF\", \"cofactor_name\": \"Cystein-S-Yl Cacodylate\", \"cofactor_resource_id\": \"DB03676\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"UKLXSOVDMSQHMM-BYPYZUCNSA-N\", \"cofactor_smiles\": \"[H][C@](N)(CS[As](C)C)C(O)=O\", \"cofactor_chem_comp_id\": \"CAS\", \"cofactor_name\": \"S-(Dimethylarsenic)Cysteine\", \"cofactor_resource_id\": \"DB03963\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17139284, 17016423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"GZBLEJZADHZBBZ-HOTGVXAUSA-N\", \"cofactor_smiles\": \"[H][C@](N)(CC1=CC=CC=C1)C(O)[C@@]([H])(N)CC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"COR\", \"cofactor_name\": \"2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE\", \"cofactor_resource_id\": \"DB07575\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"WEYNBWVKOYCCQT-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CN(C)CC1=CC=C(CSCCNC(=O)NC2=CC=C(C)C(Cl)=C2)O1\", \"cofactor_chem_comp_id\": \"JPR\", \"cofactor_name\": \"CAP-1\", \"cofactor_resource_id\": \"DB08027\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}, {\"cofactor_in_ch_ikey\": \"TUNFSRHWOTWDNC-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCCCCCCCCCCCC(O)=O\", \"cofactor_chem_comp_id\": \"MYR\", \"cofactor_name\": \"Myristic acid\", \"cofactor_resource_id\": \"DB08231\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P12497\"}], \"rcsb_id\": \"4ZHR_2\"}}, \"interface_chains\": {\"chain1\": \"A\", \"chain2\": \"A\", \"assembly_chain1\": \"A\", \"assembly_chain2\": \"B\"}, \"enrichment_timestamp\": \"2025-12-24T06:20:40.623522\", \"interface_sequence_analysis\": {\"chain1_sequence_length\": 562, \"chain2_sequence_length\": 562, \"sequences_identical\": true, \"sequence_identity\": 100.0}}",
        "valueReference": {
          "@type": "PropertyValue",
          "name": "ParsedPDBMetadata",
          "value": {
            "resolution": 2.601,
            "experimentalMethod": null,
            "depositionDate": "2015-04-27T00:00:00+0000",
            "releaseDate": "2015-11-11T00:00:00+0000",
            "sourceOrganism": [
              "Human immunodeficiency virus 1"
            ],
            "spaceGroup": null,
            "rFactor": null,
            "entityCount": 3,
            "chainCount": 2,
            "uniqueSequences": 2,
            "isHomomer": false,
            "homomerType": null,
            "taxonomyIds": [
              11676
            ],
            "primaryTaxonomyId": 11676
          }
        }
      },
      {
        "@type": "PropertyValue",
        "name": "PDBMetadataStatus",
        "value": "Complete metadata available",
        "description": "This PDB entry is current and all metadata has been fetched successfully"
      },
      {
        "@type": "PropertyValue",
        "name": "Resolution",
        "value": 2.601,
        "unitCode": "",
        "description": "X-ray crystallography resolution"
      },
      {
        "@type": "PropertyValue",
        "name": "SourceOrganism",
        "value": "Human immunodeficiency virus 1",
        "description": "Human immunodeficiency virus 1 (taxonomy ID: 11676)",
        "taxonomyId": 11676,
        "taxonomyUrl": "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=11676"
      },
      {
        "@type": "PropertyValue",
        "name": "ChainCount",
        "value": 2,
        "description": "Number of chains in the structure (from RCSB API)"
      },
      {
        "@type": "PropertyValue",
        "name": "UniqueSequenceCount",
        "value": 2,
        "description": "Number of unique amino acid sequences (from RCSB API)"
      },
      {
        "@type": "PropertyValue",
        "name": "Chain_A_Sequence",
        "value": "MVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPMGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAIHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIRKVL",
        "description": "Amino acid sequence for chain A (length: 562) from RCSB API",
        "chainId": "A",
        "entityId": "1",
        "sequenceLength": 562,
        "sequenceSource": "RCSB API",
        "sourceUrl": "https://www.rcsb.org/structure/4ZHR"
      },
      {
        "@type": "PropertyValue",
        "name": "Chain_B_Sequence",
        "value": "MGHHHHHHMVPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFITPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQ",
        "description": "Amino acid sequence for chain B (length: 438) from RCSB API",
        "chainId": "B",
        "entityId": "2",
        "sequenceLength": 438,
        "sequenceSource": "RCSB API",
        "sourceUrl": "https://www.rcsb.org/structure/4ZHR"
      },
      {
        "@type": "PropertyValue",
        "name": "PrimaryCitation",
        "value": "Structure of the HIV-1 reverse transcriptase Q151M mutant: insights into the inhibitor resistance of HIV-1 reverse transcriptase and the structure of the nucleotide-binding pocket of Hepatitis B virus polymerase.",
        "description": "Primary publication for this structure"
      },
      {
        "@type": "PropertyValue",
        "name": "PublicationDOI",
        "value": "10.1107/S2053230X15017896",
        "description": "DOI of the primary publication"
      },
      {
        "@type": "PropertyValue",
        "name": "Entity_1",
        "value": "Chains: A, Length: 562",
        "description": "Entity 1 information",
        "organism": "Human immunodeficiency virus 1",
        "taxonomyId": 11676,
        "taxonomyUrl": "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=11676"
      },
      {
        "@type": "PropertyValue",
        "name": "Entity_2",
        "value": "Chains: B, Length: 438",
        "description": "Entity 2 information",
        "organism": "Human immunodeficiency virus 1",
        "taxonomyId": 11676,
        "taxonomyUrl": "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=11676"
      },
      {
        "@type": "PropertyValue",
        "name": "NCBI_Taxonomy_ID",
        "value": "11676",
        "description": "NCBI Taxonomy ID for Human immunodeficiency virus 1",
        "url": "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=11676"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterID",
        "value": "4ZHR_4",
        "description": "Sequence cluster ID from BLASTClust analysis"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterSize",
        "value": 3,
        "description": "Number of interfaces in this cluster"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterMembers",
        "value": [
          "1MML_2",
          "5DZM_3"
        ],
        "description": "List of other interfaces in the same cluster (excluding current interface)"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterMethod",
        "value": "BLASTClust sequence clustering",
        "description": "Method used for sequence-based clustering"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterMethodOptions",
        "value": "-S 25 -L 0.5 -b F",
        "description": "BLASTClust parameters used for sequence clustering"
      }
    ],
    "hasMolecularFunction": {
      "@type": "DefinedTerm",
      "name": "protein binding",
      "inDefinedTermSet": "http://purl.obolibrary.org/obo/GO_0005515"
    },
    "bioChemInteraction": {
      "@type": "Protein",
      "name": "Homodimer partner for interface 4ZHR_4",
      "description": "Homodimer interaction partner in chain A"
    }
  },
  "additionalProperty": [
    {
      "@type": "PropertyValue",
      "name": "InterfaceSource",
      "value": "ProtCID",
      "description": "Source of interface ID: ProtCID"
    },
    {
      "@type": "PropertyValue",
      "name": "physio",
      "value": false,
      "description": "Physiological (TRUE) or non-physiological (FALSE)"
    },
    {
      "@type": "PropertyValue",
      "name": "label",
      "value": 0,
      "description": "Numeric label (1=physio, 0=non-physio)"
    },
    {
      "@type": "PropertyValue",
      "name": "PDB_ID",
      "value": "4ZHR",
      "description": "Protein Data Bank identifier"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain1",
      "value": "A",
      "description": "First chain in interface"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain2",
      "value": "A",
      "description": "Second chain in interface"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain1",
      "value": "A",
      "description": "First chain in the interface (may be updated from assembly)"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain2",
      "value": "A",
      "description": "Second chain in the interface (may be updated from assembly)"
    },
    {
      "@type": "PropertyValue",
      "name": "SymmetryOp1",
      "value": "1_555",
      "description": "Symmetry operation for chain 1"
    },
    {
      "@type": "PropertyValue",
      "name": "SymmetryOp2",
      "value": "4_556",
      "description": "Symmetry operation for chain 2"
    },
    {
      "@type": "PropertyValue",
      "name": "LabelChain1",
      "value": "A",
      "description": "First chain in the assembly interface"
    },
    {
      "@type": "PropertyValue",
      "name": "LabelChain2",
      "value": "B",
      "description": "Second chain in the assembly interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Buried Surface Area (BSA)",
      "value": 2595.87,
      "unitCode": "",
      "description": "Total buried surface area at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Atomic Contacts",
      "value": 57,
      "description": "Number of atomic contacts at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Gene",
      "value": "gag-pol",
      "description": "Gene name associated with the protein"
    },
    {
      "@type": "PropertyValue",
      "name": "Superfamily",
      "value": "3.30.70.270;3.30.420.10;3.10.10.10",
      "description": "Protein superfamily classification"
    },
    {
      "@type": "PropertyValue",
      "name": "Pfam",
      "value": "PF06817;PF00075;PF06815;PF00078",
      "description": "Pfam domain classification"
    },
    {
      "@type": "PropertyValue",
      "name": "BSA Polar",
      "value": 1425.04,
      "unitCode": "",
      "description": "Polar component of buried surface area"
    },
    {
      "@type": "PropertyValue",
      "name": "BSA Apolar",
      "value": 1170.83,
      "unitCode": "",
      "description": "Apolar component of buried surface area"
    },
    {
      "@type": "PropertyValue",
      "name": "Fraction Polar",
      "value": 0.54896431639489,
      "description": "Fraction of polar contacts at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Fraction Apolar",
      "value": 0.451035683605113,
      "description": "Fraction of apolar contacts at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterID",
      "value": "4ZHR_4",
      "description": "Sequence cluster ID from BLASTClust analysis"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterSize",
      "value": 3,
      "description": "Number of interfaces in this cluster"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterMembers",
      "value": [
        "1MML_2",
        "5DZM_3"
      ],
      "description": "List of other interfaces in the same cluster (excluding current interface)"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterMethod",
      "value": "BLASTClust sequence clustering",
      "description": "Method used for sequence-based clustering"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterMethodOptions",
      "value": "-S 25 -L 0.5 -b F",
      "description": "BLASTClust parameters used for sequence clustering"
    }
  ]
}